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Thesis Summary 
Thesis summary 	  
Circadian rhythms are self-sustained endogenous biological oscillations with a 
period of approximately 24 hours. These rhythms are observed widely across 
kingdoms and at all levels of biological scale. Recent work has shown there to 
be circadian variation in metabolism, both at the organismal and cellular level. 
It has also been posited that rhythmic production of metabolites might be 
essential for maintenance of circadian rhythmicity within cells, even in the 
absence of nascent transcription. The first portion of this thesis investigates 
the contribution of primary carbohydrate metabolism to cellular timekeeping, 
with particular emphasis on the pentose phosphate pathway. I also describe 
and validate a new 13C labelling technique for accurate determination of the 
relative flux through early primary metabolic pathways. This is accompanied 
by the development and optimisation of a microfluidic system for long-term 
perfused tissue culture, which allows for longitudinal study of metabolic flux 
within the same population of cells with simultaneous recording of clock gene 
activity. This perfused system provides several advantages over static tissue 
culture. 
   The second portion considers the effects of the metabolic hormone insulin 
on circadian rhythmicity, both at the level of the cell and of the whole 
organism. It shows that administration of insulin is sufficient to shift the phase 
of circadian gene expression and elicits induction of clock protein PER2. 
Strikingly, manipulation of insulin signalling is sufficient to determine all the 
essential parameters of the cellular clock (phase, period and amplitude) in a 
dose-dependent but glucose independent fashion. Using pharmacological and 
genetic approaches, a molecular explanation for this effect is determined. This 
data suggests that insulin is a primary determinant of rhythms in peripheral 
tissues and is most likely a major signal for circadian entrainment to feeding in 
mammals, for which I now propose a mechanistic basis. 
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Chapter 1: Introduction 
1.0.1 Circadian rhythms 
The term ‘circadian rhythm’ (derived from the Latin “circa”, meaning “around” 
and “diēs" meaning “a day”) refers to an endogenous biological oscillation with 
a period of ~24 hours. This confers the ability to anticipate, and resonate with 
the day/night cycle and has been evolutionarily selected for over the 1.5 billion 
years since the emergence of eukaryotes, such that the majority of plant, fungi 
and animal species possess intrinsic circadian timekeeping (Bell-Pedersen et 
al. 2005). In mammals, circadian rhythms are manifest in the temporal 
organization of behavioral, physiological, cellular and subcellular processes, 
influencing phenomena as varied as sleep/wake cycles (Lazar et al. 2015), 
glucose homeostasis (Rudic et al. 2004), innate immunity (Gibbs et al. 2011) 
and cell division (Matsuo et al. 2003). 
 
Recent investigations have found that an estimated third of protein-coding 
genes in the mouse genome undergo daily oscillations in one or more tissues 
(Zhang et al. 2014). Because these endogenous oscillations interact with 
myriad biological systems, circadian disruption has significant impacts upon 
human health and diseased states. For example, the chronic circadian 
dysregulation experienced by long‐term shift workers (around 15% of the 
workforce in developed nations) is associated with an increased susceptibility to 
cardiovascular disease, type II diabetes, and various forms of cancer (Pan et al. 
2011; Haus & Smolensky 2013). Conversely, circadian disruption is an early 
symptom of a number of neurodegenerative disorders (Mattis & Sehgal 2016). 
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The earliest recorded observation of a circadian process comes from the 
writings of Androsthenes of Thasos, who noted diurnal leaf movements in the 
tamarind tree in the 4th century B.C.E., whilst the first record of a truly 
endogenous circadian observation occurred some two millennia later, when 
Jean-Jacques d'Ortous de Mairan noted that 24 hour rhythms in the movement 
of leaves of the plant Mimosa pudica persisted in constant darkness (De Mairan 
1729). 
 
1.0.2 Defining a circadian rhythm 
The exact definition of a true circadian rhythm was outlined by Colin Pittendrigh 
at the Cold Spring Harbor Symposia on Quantitative Biology in 1960 
(Pittendrigh 1960). This states that a rhythm can be described as circadian in 
nature if it: 
1. Has a free-running period of approximately 24 hours. This must be the 
period in constant conditions and in the absence of environmental cues. 
2. Is capable of entraining to appropriate external cues. Entrainment is the 
process of resetting the phase of the oscillation in response to 
environmental stimuli, known as zeitgebers (from the German “time-
givers”). 
3. Is temperature compensated. Unlike the majority of reactions, the Q10 of 
a circadian rhythm is always approximately 1 (0.8-1.2), allowing it to 




The primary features of a circadian rhythm are, as for almost all periodic 
oscillations, the period (τ, defined as the distance between two equivalent 
points on the oscillation), the amplitude (A, defined as the distance from the 
peak to the trough of the oscillation) and the phase or phase-shift (θ, defined as 
the distance or angle from zero phase) (Figure 1.1). Shifts in phase can be 
described as either type 0, meaning that the oscillation resets to the same 
phase regardless of the phase at which it is perturbed or type 1, where the 
phase at which the oscillation was perturbed influences phase to which the 
rhythm resets. 
 
It is most likely that rhythms with these properties have been evolutionarily 
selected for as they confer increased fitness. In the cyanobacterium 
Synechococcus elongatus, a prokaryote, cells with a functioning circadian clock 
out-compete mutant strains under normal light-dark cycles (Woelfle et al. 2004). 
In mammals, animals in which behavioural timekeeping has been disrupted 
show greatly increased mortality in the wild, with the result that few survive to 
Figure 1.1 
Schematic defining the features of a periodic wave 
Schematic defining the features of a periodic wave. τ denotes period, A is 
amplitude and θ phase angle. 
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go on to produce offspring (DeCoursey et al. 2000). The hypothesis is that 
intrinsic circadian rhythmicity confers an advantage by allowing organisms to 
predict the timing of external events, be they nutrient availability, predators, 
prey or DNA damage due to light; this last being proposed to have initially 
driven the selection for circadian rhythmicity (Pittendrigh 1993). 
 
1.0.3 Molecular Circadian Mechanisms 
The first circadian mutant was described by Ronald Konopka and Seymour 
Benzer in Drosophila melanogaster and was mapped to the X-linked Period 
gene (Konopka & Benzer 1971). Subsequent work across a number of 
organisms led to the identification of other genes that are essential for the 
maintenance of circadian behaviour. 
 
At the same time, lesion studies identified the suprachiasmatic nucleus (SCN) 
of the hypothalamus as being essential for generation of circadian rhythms in 
mammalian behavior (Rusak 1979), as well as levels of many circulating 
hormones and possibly rhythms in body temperature (Ishida et al. 2005; 
Refinetti & Menaker 1991). This nucleus of approximately 20,000 cells is often 
referred to as the “master clock” in mammals, due to its role in the appropriate 
synchronization of circadian rhythmicity throughout the animal, particularly with 
regards to entraining to lighting cues. Ex vivo study of the SCN informs us that 
the singular robustness of timekeeping in the SCN is attributable partly to its 
particular neuronal circuitry and partly to a cell-autonomous circadian rhythm 
sustained within every neuron of the SCN (Takahashi 1993; Welsh et al. 1995). 
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Later work has extended this second observation, showing that almost all 
mammalian cells are capable of exhibiting a cell autonomous circadian rhythm 
(Balsalobre et al. 1998; Yoo et al. 2004).  
 
The mechanistic model for how this rhythm is maintained in mammals consists 
of a transcriptional/translational feedback loop (TTFL, Figure 1.2). Briefly, 
transcriptional activators circadian locomotor output cycles kaput (CLOCK) and 
BMAL1 positively regulate Per1,2,3 and Cry1,2 though action at their respective 
E‐box‐containing promoter regions. This group of genes are commonly referred 
to as “clock genes”. The PER and CRY proteins dimerise in the cytosol and 
form a complex which then translocates to the nucleus, where it interacts with 
CLOCK and BMAL to repress Per and Cry transcription, and the transcription of 
other “clock-controlled genes” in a tissue-specific fashion. The PER and CRY 
Figure 1.2  
Schematic describing the core mammalian TTFL 
The core mammalian TTFL consists of a delayed negative feedback loop of 
CRY, PER, BMAL1 and CLOCK proteins. 
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proteins are then slowly degraded over time, thus allowing the cycle to begin 
again (Figure 1.2). There are also a number other feedback loops interlinked 
with this central CLOCK‐BMAL1/PER‐CRY loop. In particular, retinoic acid 
orphan receptor‐α (ROR‐α) and nuclear receptor REV‐ERBα/β, which are also 
direct transcriptional targets of BMAL1 and CLOCK, in turn inhibit the 
transcription of Bmal1, thereby resulting in an oscillation in BMAL1 which is in 
antiphase to the oscillation of PER and CRY (Partch et al. 2014; Koike et al. 
2013). 
 
This TTFL model for maintenance of circadian timekeeping is mimicked across 
kingdoms. In the bread mold Neurospora crassa, the first organism in which a 
TTFL mechanism was elucidated, the Frequency (FRQ) protein regulates its 
own transcription (Aronson et al. 1994). Drosophila, in turn, possess a 
mechanism that is highly reminiscent of that observed in mammals. Here, 
CLOCK and CYCLE (orthologous to CLOCK and BMAL1 in mammals) drive 
transcription of PER and TIM, which repress their own transcription (Tataroglu 
& Emery 2015). In Arabidopsis, the central loop consists of transcriptional 
activators CCA1 and LHY, which are morning‐expressed, whilst PRR9, PRR7, 
PRR5 and TOC1 are expressed sequentially and act successively throughout 
the afternoon and evening to repress CCA1 and LHY transcription and their 
own transcription. In the evening, TOC1 represses all of the previously 
expressed proteins (Nohales & Kay 2016). 
 
What is striking about all of these TTFL mechanisms for timekeeping in 
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eukaryotes is that, although all conform to the same basic principle of a delayed 
negative feedback loop, the identity of the genes and proteins concerned differs 
greatly between organisms, with very little clear homology across kingdoms or 
even phyla (Tei et al. 1997; Sun et al. 1997). This makes the dissection of any 
core timekeeping mechanism difficult, and has led some to argue for the 
convergent evolution of eukaryotic circadian timing mechanisms (Rosbash 
2009).  
 
An issue not often highlighted when discussing the TTFL model of circadian 
timekeeping is that of periodicity. Neither transcription nor translation proceed 
at rates closely comparable to a circadian timescale; indeed, the initial model 
proposed by Hardin and colleagues could quite plausibly have a period of 
around 4 hours (Hardin et al. 1990; Johnson 2010). Whilst large bodies of work 
attempt to address this issue, through the addition of accessory loops 
(Guillaumond et al. 2005), essential phosphorylation events (Mahesh et al. 
2014) and other post-transcriptional regulation (Chen et al. 2013), all of which 
vary between phyla, it is still difficult to conceive of a 24 hour rhythm 
constructed from these events, particularly one that is relatively insensitive to 
temperature.  
 
This argument has led some in the field to posit the existence of an additional 
post-transcriptional timekeeping mechanism within the cell, functionally 
comparable to the circadian oscillator in cyanobacteria (Johnson 2010; Lakin-
Thomas 2000). Here, the clock mechanism is entirely post-transcriptional, 
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consisting of the proteins KaiA, B and C. This oscillator can be reconstituted in 
vitro and revolves around the rhythmic phosphorylation of KaiC and the 
subsequent formation of complexes between the Kai proteins, facilitated by the 
hydrolysis of ATP. The kinetics of this reaction are such that the periodicity of 
the oscillation is around 24 hours across a range of temperatures. (Nakajima et 
al. 2005). This post-translational oscillator is coupled to a TTFL, which acts as a 
slave oscillator to the Kai loop (Qin et al. 2010).  
 
It is proposed that the existence of such a post-transcriptional oscillator might 
provide increased robustness against events such as changes in metabolic rate 
and cell division, through which circadian timekeeping is conserved (Nagoshi et 
al. 2004), than an oscillation based on transcription and translation, which 
would likely be perturbed by the change in gene dosage following S-phase. For 
those wishing to test this hypothesis in eukaryotes, it is therefore of interest to 
consider a number of post-translational circadian events, particularly those that 
are more broadly conserved in clock function that those proteins involved in the 
canonical TTFL models. 
 
1.0.4 Conservation of circadian molecular features 
Despite the apparent differences in canonical TTFL mechanisms between 
different organisms, the functional contribution of a small number of post‐
translational mechanisms to circadian timekeeping do appear to be conserved 
across phyla. For example, the tau mutation (the first mammalian circadian 
mutant described (Ralph & Menaker 1988)) is not situated in any of the core 
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canonical clock genes but is in fact a point mutation in the enzyme casein 
kinase 1ε (CK1ε). This results in a shortening of the circadian period of both 
whole animal behavior and also the cellular molecular rhythm (Maywood et al. 
2014). Other work suggests that the CK1δ isoform also plays a role in the 
maintenance of cellular timekeeping (Meng et al. 2010). In both cases, it is 
proposed that CK1 can form complexes with PER and CRY and so 
phosphorylate PER proteins, promoting their nuclear translocation and 
degradation (Meng et al. 2008). Gain‐of‐function mutations (such as CK1εtau) or 
loss of function through genetic knock‐out or pharmacological inhibition, results 
in shortening or lengthening of circadian period respectively. However, the 
effect of casein kinase on circadian rhythmicity is not restricted to mammals, 
and despite not having conserved targets across phyla, manipulation of CK 
activity shows effects on cellular timekeeping across a large number of model 
organisms (van Ooijen, Hindle, et al. 2013; van Ooijen, Martin, et al. 2013; Lin 
et al. 2002; Yang et al. 2003). 
 
A second example of a general regulator of circadian period is glycogen 
synthase kinase 3β (GSK3β). A proline‐directed serine‐threonine kinase, GSK‐
3β has been proposed to phosphorylate mammalian CRY2, targeting it for 
degradation (Kurabayashi et al. 2010), whilst phosphorylation of REV-ERBα by 
GSK‐3β increases its stability (Sahar et al. 2010). It has been identified that 
both pharmacological inhibition and siRNA‐mediated knock‐down of GSK‐3β 
results in a shortening of circadian period in mammalian cell culture (Hirota et 
al. 2008; Yin et al. 2006). In contrast, in Drosophila, it is over expression of 
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GSK‐3 ortholog shaggy that results in a shortening of behavioral period, 
probably as a result of phosphorylation of TIMELESS and PER (Martinek et al. 
2001). As with CK1, manipulation of GSK‐3 activity has a clear effect on 
circadian effect across a number of phyla (O’Neill et al. 2011; Tataroğlu et al. 
2012). 
 
These and similar observations of circadian period effects as a result of 
modulation of post‐translational mechanisms, even across organisms with 
highly non‐homologous TTFL components, lends credence to the idea that, 
despite their apparent dissimilarity, there are some common underlying features 
across eukaryotic timekeeping networks. As such, it is postulated that the 
varied eukaryotic timekeeping mechanisms might represent the result of a 
divergent process of evolution from the biological oscillation in an early 
eukaryotic ancestor. 
 
The realization that circadian timekeeping is not just a phenomenon observed 
at the level of the whole organism, but is a fundamental autonomous feature of 
every individual cell, is one of the most significant advances made in the field in 
recent times. As a result of this, there has been increasing interest in the 
circadian rhythmicity of many processes at the cellular level. The previously 
described TTFL is certainly the most documented example of a cell 
autonomous circadian rhythm. However, there are an increasing number of 
cases where cell autonomous rhythms appear to occur in the absence of direct 
input from the canonical TTFL clockwork. For example, one of the earliest 
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observations concerning cellular metabolic rhythms was the realization that 
uptake of the 2‐deoxyglucose – a glucose analogue which is capable of being 
taken up by classical glucose transporter – is rhythmic with a period of around 
24 hours in both the SCN and peripheral cells (Cassone et al. 1988). This 
rhythm is observed even in the absence of TTFL activity (Paulose et al. 2012). 
 
The idea that rhythmic TTFL expression is not essential for circadian activity is 
supported by the observation that in the arrhythmic tim01 fly, expression of the 
tim transgene can be sufficient to restore behavioral rhythms, without restoring 
rhythmicity in the levels of tim mRNA. The same also applies for constitutive 
Per expression in its null line (Yang & Sehgal 2001). This indicates that 
rhythmic transcription and translation of the canonical clock genes, the central 
theme of the TTFL model, may not be absolutely required for cellular 
rhythmicity. Instead, it may be the case that these proteins are merely required 
to be present within a certain range for clear rhythmic outputs to be observed. 
 
1.0.5 Peroxiredoxins as a circadian marker 
Peroxiredoxins (Prx) are a family of highly abundant cellular proteins that play a 
major role in the reduction of endogenously produced peroxides: it is estimated 
that over 99% of cytosolic and 90% of mitochondrial peroxides react with Prx 
proteins (Winterbourn 2008; Adimora et al. 2010). Reaction of peroxides with a 
cysteine residue in the Prx active site results in the formation of disulphide‐
linked dimer of Prx. The oxidised protein is then ultimately reduced by NADPH, 
mostly through the thioredoxin system, although some specific Prx reductases 
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exist (Takeda et al. 2004). In some cases, this final recycling step is avoided 
and instead a second (and even a third) peroxide can react with the protein, 
converting it to Cys‐SO2/3. This second reaction has been has been reported to 
be around 1000 times slower than the disulphide formation step (Perkins et al. 
2015) and the rate of this so‐called “hyperoxidation” appears to increase almost 
linearly with an increase in peroxide concentration. All Prx proteins appear to be 
capable of undergoing this hyperoxidation step, although some are more 
sensitive to it than others (Cox et al. 2009). 
 
Screening of mouse hepatic proteins has previously shown that Prx6 is 
rhythmically translated in mouse liver and in addition, has an anti‐phasic rhythm 
in post‐ translational modification (Reddy et al. 2006). This was subsequently 
found to be the case for other members of the Prx family (O’Neill & Reddy 
2011; Edgar et al. 2012). Use of a polyclonal antibody for the SO2/3 modification 
showed that this rhythm in post‐translational modification of the Prx active site 
is observed across a broad spectrum of circadian model organisms. 
Furthermore, this rhythm persists in classical circadian mutants, but the free‐
running period of the oscillation is clearly perturbed compared to WT controls 
(O’Neill et al. 2011). In addition, circadian rhythmicity in the abundance of 
hyperoxidised Prx persists in isolated erythrocytes (O’Neill and Reddy, 2011). 
This last observation is of particular interest, as mature mammalian 
erythrocytes are enucleate and therefore lack the capacity to maintain the 
canonical circadian TTFL. This rhythm in erythrocytes conforms to the technical 
definition of a circadian rhythm, in that the 24‐hr rhythm in post‐translational 
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modification is also temperature compensated and capable of entraining to 
appropriate external cues. Observations in the marine algae Ostreococcus tauri 
under transcriptional inhibition display similar trends (O’Neill et al. 2011). As 
such, rhythms in the hyperoxidation Prx proteins act as a rhythmic marker even 
in the absence of the TTFL. 
 
A rhythm in the abundance of hyperoxidised Prx is the result of three possible 
events: rhythmic oxidation of Prx, rhythmic reduction of Prx or rhythmic 
degradation of hyperoxidised Prx (or a combination of these three). As cellular 
metabolism is the primary source of both ROS and cellular reducing 
equivalents, particularly NADPH and H2O2, we must consider whether potential 
drivers of this rhythm lie within the pathways of primary metabolism. 
 
1.1 Metabolism 
1.1.1 Conserved pathways of primary metabolism in eukaryotes 
Primary metabolism – the set of reactions by which substances are both broken 
down and synthesised in order to provide energy and essential cellular building‐
blocks – represents one of the defining features of a living organism, and the 
enzymes that catalyse these reactions are amongst the oldest and most 
conserved of their kind (Keller et al. 2014). Consequently, the metabolic 
pathways to which these enzymes contribute are exceptionally similar, with the 
core pathways involved in carbohydrate, lipid and amino‐acid metabolism 
(Figure 1.3) widely represented across all three phylogenetic domains. For this 
reason, it is generally accepted that all of these pathways were almost certainly 
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present in some form in the Last 
Universal Common Ancestor 
(LUCA) and also, following further 
spatial compartmentalization of 
these processes, in the Last 
Eukaryotic Common Ancestor 
(LECA) (Margulis et al. 2006). 
These are further described below. 
 
1.1.2 Glycolysis 
Glycolysis refers to the sequence of 
ten enzymatic reactions that convert 
glucose to pyruvate. A number of pathways fall under the name glycolysis, the 
most common of which is the Embdeb‐
Meyerhof‐Parnas (EMP) pathway. 
Glycolysis does not directly require oxygen 
and is therefore a major pathway for 
carbohydrate metabolism in both aerobic 
and anaerobic organisms. The process can 
be considered as two main stages: an initial 
investment stage, where two molecules of 
ATP are consumed in the process of 
converting each 6 carbon glucose molecule 
Figure 1.3 








to two 3 carbon glyceraldehyde 3‐phosphate molecules and a subsequent “pay‐
off phase”, where each glyceraldehyde‐3 phosphate molecule is further 
converted to pyruvate, producing two molecules of NADH and four molecules of 
ATP (Alberts et al. 2002). Thus, as a net total, glycolysis produces 2 molecules 
of NADH and 2 molecules of ATP for every molecule of glucose that passes 
through the pathway (Figure 1.4). 
 
1.1.3 Pentose Phosphate Pathway (PPP) 
Also known as the hexose monophosphate shunt, the PPP runs in parallel with 
the early steps of glycolysis. Again, this pathway is divided in to two main 
stages. The first, known as the “oxidative” phase, converts 6‐carbon glucose 6‐
phosphate to 5‐ carbon ribulose 5‐phosphate, producing two molecules of 
NADPH and releasing one molecule of CO2 for every glucose molecule. This 
stage of the pathway is particularly critical for cells that are sensitive to 
oxidative damage by peroxides, as the NADPH produced here is used for the 
formation of reduced glutathione and the reduction of other cellular disulphides, 
as well as many biosynthetic reactions such as fatty acid synthesis. The second 
– known as the non‐oxidative phase – coverts ribulose 5‐phosphate to either 
glyceraldehyde 3‐phosphate or fructose 6‐phosphate (Alberts et al. 2002). 
Crucially, this stage of the pathway also produces ribose 5‐phosphate as an 
intermediate, which is required for the synthesis of nucleotides and nucleic 
acids. In total, the stoichiometry of the PPP is such that for every three glucose 
6‐phosphate molecules that enter the pathway, two molecules of fructose 6‐
phosphate, one molecule of glyceraldehyde 3‐ phosphate and 6 molecules of 
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NADPH are produced (Figure 1.5). 
 
 
1.1.4 The Tricarboxylic Acid Cycle (TCA) 
The tricarboxylic acid cycle (also known as the Krebs cycle or the citric acid 
cycle) is often considered to be the unifying pathway of metabolism in 
eukaryotes. Compartmentalised within mitochondria, the TCA cycle oxidises 
intermediates derived from carbohydrates, lipids and amino acids, whilst also 
providing intermediates for a large number of anabolic processes, including 
gluconeogenesis, lipogenesis and amino acid metabolism. Briefly, the TCA 
cycle oxidises acetyl‐ CoA, which is either formed from pyruvate by pyruvate 
dehydrogenase or is obtained directly from β‐oxidation of fatty acids, to two 
molecules of CO2. As the name suggests, this is achieved through a cyclical 
process where the two acetyl groups of acetyl CoA are donated to oxaloacetate 
to form 6 carbon citrate. Two of the carbons that formed the original 
Figure 1.5  
Schematic equation of the Pentose Phosphate Pathway 
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oxaloacetate back‐bone are lost sequentially in the cycle as CO2, the carbons 
that were originally donated from acetyl CoA are formed in to a new 
oxaloacetate back‐bone and the cycle begins again (Alberts et al. 2002). The 
energy released following the loss of the two carbon molecules is stored in the 
form of GTP, NADH and FADH2, with a final stoichiometry of one 
GTP, three NADH and one FADH2 per molecule of acetyl CoA 
(Figure 1.6). 
 
1.1.5 Oxidative Phosphorylation 
Oxidative phosphorylation is the process by which the electron 
donors generated through the citric acid cycle – namely NADH 
and FADH2 – are made to donate their electrons in order to provide energy for 
the synthesis of ATP within mitochondria. This is brought about through a 
series of redox reactions, which are catalysed by a sequence of four protein 
complexes situated within the inner mitochondrial membrane and which have 
the collective name of the “electron transport chain”. The energy produced from 
the flow of electrons through this chain is used to drive protons across the inner 
mitochondrial membrane, thereby creating an electrochemical H+ gradient. This 
gradient is then relieved as protons are able to flow back in to the inner 
mitochondrial space through ATP synthase, a large multi‐unit transporter also 
situated within the inner mitochondrial membrane. The energy from the 
dissipation of this gradient is used to synthesise ATP (Alberts et al. 2002). This 
is, however, by no means a perfectly efficient process, and it is important to 




note that electron leakage across the mitochondrial membrane is the major 




Beta‐oxidation is the process by which fatty acids are formed from the 
circulating ester triacylglycerol and subsequently oxidised to form acetyl CoA 
for further oxidation in the citric acid cycle. Initially, triacylglycerol is broken 
down in the cytosol to form 3 molecules of palmitate and one of glycerol. The 
palmitate is then converted to palmityol CoA – consuming ATP to AMP in the 
process. This is then transported in to the mitochondria, where it is 
progressively oxidised and cleaved to form 8 molecules of acetyl CoA per 
molecule of palmitate, producing seven NADH and seven FADH2 in the 
process. The acetyl CoA then enters the TCA cycle (Alberts et al. 2002). 
 
What is hopefully is clear when considering all of these metabolic pathways is 
that they all produce or utilise the reducing equivalents NADH and NADPH as 
co‐factors and that all catabolic processes ultimately result in a degree of ROS 
generation. Metabolism is therefore the primary source of both reducing and 
oxidising agents within the cell. As such, primary metabolism is a key modulator 
of cellular redox state and control of metabolism therefore plays a major role in 





1.2 Circadian metabolism 
1.2.1 Circadian metabolism in the whole animal 
When considering metabolism, in addition to the pathways of primary cellular 
metabolism described above, it is also important to consider metabolism at the 
level of the whole organism, including systems such as digestion and 
associated hormonal and neuronal signaling. There is a long history of 
observation of clear links between circadian timekeeping and metabolism at the 
level of physiology. For example, it has been well documented that animals that 
display a significant disruption in timekeeping, such as the arrhythmic bma1l‐/‐ 
and cry1‐/‐cry2‐/‐ mice, show a strong metabolic phenotype, with increased 
propensity to diabetic and obesity‐related disorders (Barclay et al. 2013; 
Marcheva et al. 2010). Bmal-/- mice also exhibit profound hyperglycemia (Lee et 
al. 2011). 
 
A distinct feature of timekeeping in whole mammals is the role of the 
suprachiasmatic nucleus (SCN) of the hypothalamus. In vivo, the SCN has 
neuronal projections from the SCN to the paraventricular nucleus of the 
hypothalamus (PVN). This gives the SCN the capacity to influence endocrine 
regulation both humourally through the hypothalamic-pituitary-adrenal (HPA) 
axis and also neuronally via projections from the PVN to the autonomic nervous 
system (Kalsbeek et al. 2012). As levels of many adrenal hormones known to 
regulate cellular metabolism, particularly glucocorticoids, are rhythmically 
expressed (Oster et al. 2006), it is therefore entirely plausible to propose that 
the SCN might regulate rhythmic metabolism in this manner. This is idea is 
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supported by the observation that ablation of the SCN or adrenalectomy leads 
to a loss of rhythmicity in levels of these hormones (Ishida et al. 2005). 
 
The process of sleep is also a major regulator of changes in metabolism at the 
level of the whole organism – primarily as a result of the fact that the sleep 
wake cycle is intrinsically linked to cycles in energy intake. As the SCN is the 
principal effector of the circadian drive to sleep, it is often considered to 
influence metabolic rhythms via sleep patterns, in addition to direct regulation 
as previously described. 
 
There is also a large body of work demonstrating that time of feeding and the 
associated whole animal metabolism pathways are capable of influencing the 
phase of circadian behaviour. Mammals normally feed during their active 
phase, which is generally driven by signals from the light-entrained SCN. In 
these cases, animals are active according to their diurnal or nocturnal 
preference, and behavioural and gene expression cycles reflect this. However, 
if animals are subjected to restricted feeding (RF) protocols, where food is only 
available at certain times throughout the circadian day, it is possible to 
uncouple SCN signals from circadian oscillations in the rest of the organism. It 
has thus been shown that food consumption only during the normally inactive 
phase can result in a phase shift in the rhythmic expression of clock genes and 
metabolic activity in peripheral tissues, as well as a shift in body temperature 
and activity rhythms (Saini et al. 2013). As such, the mammalian circadian 
clock, both at cellular and the behavioral level, is entrained by time of feeding. 
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It is of note that, unlike in peripheral tissues, this shift in circadian molecular 
expression in response to feeding is not observed in the SCN (Damiola et al. 
2000), nor is the SCN, nor even a functioning TTFL required for the effect on 
behaviour or the molecular clock to be observed (Storch & Weitz 2009). This 
suggests that, although the SCN generally synchronizes such processes in the 
periphery, it is not the sole determinant. Indeed, it appears that the influence of 
the SCN on behaviour can be overridden by time of feeding and associated 
metabolism, as nocturnal mice with food availability restricted only to the light 
phase will shift their behavioural rhythms towards diurnality such that they 
become most active prior to the anticipated timing of food availability (Stokkan 
et al. 2001). However, the exact mechanism by which timed feeding influences 
circadian animal behaviour is not currently well understood. Perhaps influenced 
by the SCN, which acts as a central cite for co-ordination of light inputs, many 
have proposed that entrainment to feeding must require a central locus – 
referred to as the “Food Entrainable Oscillator” (FEO), although no anatomical 
site for such a locus has been identified, despite great endeavor towards this 
end (Stephan 2002; Davidson et al. 2003; Mistlberger 2006) .  
 
Similar observations are made in the Drosophila fat body, which serves an 
analogous function to the mammalian liver. Here tissue‐specific expression of a 
dominant negative CLOCK, an essential gene in the Drosophila TTFL, only in 
the fat body, results in either dampening or loss of transcriptional rhythms in a 
large number of metabolically active genes across all tissues, despite the fact 
that clock gene expression cycles of the central clock in the brain remain 
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These observations suggest that gross metabolism might well be capable of 
influencing circadian rhythmicity, as well being influenced by circadian 
rhythmicity at the level of the whole organism (Fig 1.7). 
 
1.2.2 Circadian cellular metabolism 
The interplay between circadian timekeeping and metabolism, in the form of 
primary metabolism, is also clearly demonstrated at the cellular level. For 
example, cells derived from the arrhythmic Bmal1-/- mouse show increased 
levels of oxidative stress (Musiek et al. 2013), potentially as a result of 
mitochondrial dysfunction (Jacobi et al. 2015). 
Figure 1.7 Behavioural regulation by the SCN and feeding 
Diagram outlining the current knowledge of circadian behavioural regulation 





Recent work from Peek et al. has shown there to be a self‐sustained 24 hour 
rhythm in both cellular β-oxidation and, offset in phase by around 4 hours, in 
glucose oxidation (Peek et al. 2013). Both of these being primarily 
mitochondrial metabolic activities, we can thus envisage that there might be a 
rhythm in other mitochondrial activities. Meanwhile, Altman et al. have 
demonstrated a rhythm in glucose utilization in U2OS cells (Altman et al. 2015). 
Most strikingly here, manipulations that suppressed expression of clock 
proteins also suppressed the rhythm in glucose uptake. 
 
Given the diurnal difference in the metabolic demands of an organism, the 
temporal segregation of antagonistic metabolic processes – such as 
glycogenesis and glycogenolysis – makes intuitive sense. Such temporal 
segregation is observed in a wide number of circadian model organisms and at 
all levels of biological scale, from transcription of relevant proteins at the cellular 
level to rhythms of whole organism gross metabolism (Tu & McKnight 2006; 
Fustin et al. 2012). This has led to the general belief that circadian variation in 
metabolism is a result of the rhythmic regulation of metabolic enzymes driven 
by the canonical circadian TTFL (Gerhart-Hines & Lazar 2015).  
 
1.2.3 The interplay between circadian timekeeping and metabolism 
The current prevailing paradigm for how metabolism is rhythmically regulated is 
that the genes, or a subset of genes, involved in certain metabolic pathways 
possess a promoter element that is under circadian control via the binding of 
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one of the canonical “clock genes” (Harmer et al. 2000; Shinohara et al. 1998). 
This idea is not without support. It is most certainly the case that many genes 
do exhibit circadian rhythms in transcription as a result of this kind of control. 
Work from Zhang et al. suggest that over a third of protein coding genes had 
observable rhythms in transcription in at least one mouse tissue, but that 
exactly which transcripts oscillated was highly tissue specific (Zhang et al. 
2014). However, genes that coded for proteins with known metabolic functions 
are generally over‐represented across tissues. 
 
In addition to rhythmic transcription of crucial metabolic genes, there is also a 
growing understanding that there exists the potential for circadian regulation at 
the level of translation. Through the use of ribosomal profiling experiments, 
Jang et al. show that not only is there significant circadian regulation at the 
translational level, but that it can be observed both in addition to rhythms in 
transcription and in the absence of transcriptional oscillations. Again, there 
appears to be an enrichment of genes associated with metabolism amongst 
those genes that show oscillations in ribosomal association (Jang et al. 2015). 
Recent work has shown that canonical clock gene bmal1 is able to act as a 
translational regulator, in addition to its well‐ documented transcriptional role 
(Lipton et al. 2015), which indicates at least one mechanism by which such 
circadian regulation of translation might be facilitated. 
 
Regardless of whether transcription or translation of a metabolic enzyme is 
rhythmic, the current prevailing explanation for circadian rhythmicity in 
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metabolism is that abundance of certain enzymes that form nodal points in 
these pathways is rhythmically regulated by TTFL components. A number of 
examples for this kind of regulation exist. For example, Glyceraldehyde-3-
phosphate has been proposed to be regulated by the TTFL in Neurospora 
(Shinohara et al. 1998). 
 
It must be noted, however that even in the absence of rhythmic protein 
production, rhythmic metabolic flux is still both entirely plausible and has been 
reported. Work by Paulose et al. observed there to be a rhythm in both glucose 
uptake and glucose transporter expression in mouse embryonic stem cells prior 
to the development of rhythmic clock gene expression (Paulose et al. 2012), 
suggesting that the rhythmic transcription and translation of these proteins is 
not necessarily required for occurrence of cellular rhythms. This resonates with 
the previously described observations that rhythms in Prx hyperoxidation 
persist in enucleate cells and in the absence of nascent transcription or 
translation (O’Neill & Reddy 2011; O’Neill et al. 2011).The combined 
observations that firstly, rhythmic transcription and translation is not essential 
for rhythmic activity, secondly, that rhythmic Prx hyperoxidation continues in the 
absence of any nascent transcription and thirdly, that metabolism, the primary 
source of intracellular peroxides and reducing equivalents, also exhibits 
circadian rhythmicity in a number of pathways has led some to posit an 
alternative hypothesis with regards to the nature of the link between circadian 
rhythmicity and metabolism. This postulates that some of the pathways of 
metabolism might constituent an essential, evolutionarily conserved component 
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of cellular timekeeping (Haydon et al. 2013; Asher & Schibler 2011). Such a 
post-transcriptional circadian mechanism has been proposed to be analogous 
to the Kai oscillator in cyanobacteria, acting as the dominant oscillator within 
the cell, providing the essential 24 hour periodicity of the circadian rhythm with 
the TTFL acting as a slave oscillation providing a functional output in the form 
of protein expression, but not as a competent circadian oscillator in its own right 
(Johnson 2010) (Fig 1.8). Some preliminary work suggests that the hypothesis 
that cellular metabolism might contribute to such an oscillator is not implausible 




In this thesis, I investigate the complex relationships between metabolism and 
circadian rhythmicity and attempt to elucidate the nature of the relationship 
between these two processes. The first results chapter describes the 
development of a new technique to assist in study of metabolism in a circadian 
context. The second chapter carries out this investigation at the intracellular 
level, considering the contribution of primary metabolism to cellular circadian 
Figure 1.8 Reciprocal regulation 
between primary metabolism and the 
TTFL   
Diagram outlining potential reciprocal 
regulation between primary metabolism 
and the TTFL. Unknown elements are 
indicated as ‘?’. 
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rhythms. The final chapter considers metabolism at the intercellular level, 
investigating how feeding and associated changes in metabolism in the whole 
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Chapter 2: Materials and Methods 
2.0 Common solutions 
Common stock solutions were obtained from the media kitchen of the MRC 
Laboratory of Molecular Biology. These included LB (Luria-Bertani) media, 
PBS (phosphate buffer saline), 0.1 M EDTA (Ethylenediaminetetraacetic 
acid), trypsin, 1 M MgCl2, 1 M Tris-HCl pH 7.4, S.O.B. (Super Optimal Broth), 
glycerol, 1 M CaCl2, penicillin/streptomycin, Millipore water and antibiotic-




All materials were obtained from Sigma-Aldrich unless otherwise stated. MHY 
1485 was a kind gift from Madeleine Lancaster (MRC Laboratory of Molecular 
Biology).  
 
2.1.2 Cell Lines 
U2OS and NIH 3T3 cells were obtained from ATCC. PER2::LUC fibroblasts 
were derived in-house. FH1-/- embryonic kidney cells and pFH controls were a 
kind gift from Christian Frezza (MRC Cancer Unit, Cambridge). 
 
2.1.3 Plasmids 
Plasmids for the expression luciferase reporters of clock gene transcription 
contained promoters for Bmal1 or Per2 (originally cloned by Hiroki Ueda, 
RIKEN Quantitative Biology Centre), subcloned in pGL4.20 (Promega). 
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2.1.4 Antisera 
Antisera were obtained from the following sources and used at the following 
dilutions: 
 
Anti-6-phosphogluconate dehydrogenase (ab129199) – abcam – 1:2000 
Anti-b-actin (SC-47778) – Santa Cruz – 1:5000 
Anti-Bmal1 was a gift from the Hastings lab (MRC Laboratory of Molecular 
Biology) - 1: 2000 
Anti-Cry1 was a gift from the Lamia lab (The Scripps Research Institute) - 
1:2000 
Anti-Cry2 was a gift from the Lamia lab – 1:2000 
Anti-GAPDH (G99545) – Sigma 1:5000 
Anti-Glucose 6-phosphate dehydrogenase (ab66340) – abcam – 1:2000 
Anti-Myc-tag – in house – 1:500 
Anti-PER1 was a gift from the Hastings lab – 1:2000 
Anti-PER2 was a gift from the Lamia lab – 1:2000 
Anti-Phosphoglucose isomerase (ab993) – abcam – 1:2000 
Anti-Tubulin – in-house – 1:5000 
Anti-rabbit IgG conjugated to HRP– Sigma – 1:5000 
Anti-mouse secondary IgG conjugated to HRP– Sigma – 1:5000 
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2.1.5 NS21 
Serum replacement NS21 was made in-house as described in Chen et al. 
2008. Unless otherwise specified, the composition of this supplement when 
diluted in cell culture media was as in the table below: 
Component Concentration (μM) 




Superoxide dismutase 0.077 
Holo-transferrin 0.062 





Sodium Selenite 0.083 
Corticosterone 0.058 
Linoleic Acid 3.5 
Linolenic Acid 3.5 
Lipoic Acid 0.2 
Progesterone 0.02 
Retinol acetate 0.2 
Retinol, all trans 0.3 
Materials and Methods 
 45 
D,L-alpha-Tocopherol 2.3 
D,L-alpha-Tocopherol acetate 2.1 
 
 
2.2 Tissue and Cell Culture 
2.2.1 Animal Methods 
All experiments were licenced under 1986 Home Office Animal Procedures 
Act (UK) and carried out in accordance with local animal welfare committee 
guidelines. PERIOD2::LUCIFERASE (PER2::LUC) mice were originally 
supplied by Joe Takahashi (University of Texas Southwestern; Yoo et al. 
2004) and subsequently bred locally.  
 
2.2.2 Organotypic Slices 
For organotypic slice culture, brains and other tissues were removed from 
pups (9-10 day old) and adult mice, respectively, and sectioned to 300μm 
slices using a McIlwain “Tissue Chopper”. Areas of interest were further 
microdissected and cultured on a Millipore membrane insert at 37°C as 
previously described (House et al., 1998). For bioluminescent recording, SCN 
slices were transferred in to 1.2ml serum-free, HEPES buffered “air medium” 
(Hasting et al., 2005), with 100μm firefly luciferin (Biosynth), supplemented 
with 6% corticosterone and insulin-free NS21 (made in-house, as for Chen et 
al. 2008). Other tissues were cultured and recorded in DMEM, with 5.5mM 
glucose, 1% glutamax, 2% corticosterone and insulin-free NS21 and 1mM 
firefly luciferase. Slices were placed in a 35mm polystyrene petri dish and 
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sealed with circular 44mm No. 1 coverslips (Thermo Fisher) and vacuum 
grease before recording. SCN slices were taken and cultured by Ryan 
Hamnett. 
 
2.2.3 Isolation of primary fibroblasts and immortalisation 
Isolation 
Lung tissue was isolated from recently euthanized mice and immediately 
placed in ice-cold PBS and transferred to a tissue culture hood. Here the 
tissue was further dissected to approximately 1mm3 sections. The dissected 
tissue was then transferred in to 10ml DMEM/F12 medium (Gibco) containing 
Liberase (0.14 Wunsch unit/ml) and 1x penicillin/streptomycin and stirred 
slowly for 60 minutes at 37°C. 30ml DMEM/F12 containing 15% HycloneTM 
FetalcloneTM III and 1x penicillin/streptomycin was then added to the existing 
tissue media and centrifuged at 524xg for 5 minutes. The supernatant was 
removed and the cell pellet resuspended and centrifuged a time a total of 
three times. Following this, the resultant pellet was resuspended in 10ml 
DMEM/F12 containing 15% HycloneTM FetalcloneTM III (GE Healthcare), 1x 
penicillin/streptomycin and 1x MycozapTM plus-PR (Lonza), transferred to a 
10cm dish and incubated at 37°C, 5% CO2, 3% O2 for two weeks, with media 
changed every 3-5 days. After two weeks, cells were then split and continued 
to be cultured at 37°C, 5% CO2, 3% O2. 
Immortalisation 
For production of immortalised lines, cells underwent serial passage at 37°C, 
5% CO2, 20% O2. After around 15 passages, the doubling time of the cells 
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decreased and cells continued to be split 1:1 until approximately 20 passages, 
when the rate of doubling was seen to increase again to approximately 48 
hours. At this stage, cells were considered immortalised. 
 
2.2.4 Primary Dissociated Neuron Cultures 
Primary cortical neuron cultures were obtained from PER2::LUC mice at birth 
(P0). Cortical tissue was dissected in a solution of EBSS without Mg2+ and 
Ca2+ (Invitrogen), 100mM HEPES and Penicillin/Streptomycin. Cells were then 
digested using enzymes and buffers provided in the MACS Neural Tissue 
Dissociation Kit – Postnatal Neurons (Miltenyl Biotec), following the 
manufacturers instructions. Briefly, this is a follows: cells were incubated at 
37°C for 15 minutes with 650 μl enzyme mix 1 per pup. Cells were then 
titurated x6 using a fire-polished glass pipette. Cells were then incubated for a 
further 10 minutes at 37°C with 10μl enzyme mix 2 per pup. An additional 5μl 
enzyme mix 2 was added per pup and cells were titurated again. The entire 
mixture was then passed through a 50μm filter (Partec) and EBSS + 0.5% 
BSA (3.33ml per pup) was added immediately before centrifugation for 5 
minutes at 300xg. Cells were resuspended in MEM, 20mM glucose, 1mM 
NaPyruvate, 25mM HEPES, 1x N2 (ThermoFisher), 10% horse Serum and 
penicillin-streptomycin to a density of 2x106 cells per ml and 250μl per well 
was seeded in PEI Borate-coated 24 well plates. Plates were left for 12 hours 
and then an additional 250μl Neurobasal A Medium, supplemented with 2% 
B27, 1% glutamax and PenStrep was added per well. Cells subsequently 
underwent a half media change every week for 3 weeks before 
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experimentation. Prior to experimentation, cells were changed in to insulin-
free media containing luciferin by serial half media change, subjected to 
temperature cycles and placed in an ALLIGATOR (Cairn Research). 
 
2.2.5 Cell Culture – maintenance of lines  
Cells were maintained in 75cm2 flasks (Falcon) in 10ml DMEM (Thermo 
Fisher) supplemented with 10% serum and Penicillin/Streptomycin. 
PER2::LUC immortalised fibroblasts and NIH 3T3s were maintained in 
Hyclone™ FetalClone™ III bovine fetal serum (GE Healthcare) whilst 
Hyclone™ FetalClone™ II bovine fetal serum (GE Healthcare) was used to 
maintain U2OS and FH1-/-  and pFH lines. Cells were passaged when the 
monolayer reached 90% confluence. This was achieved by washing cells in 
warm PBS and then treating with 2.5ml trypsin in EDTA for 5 minutes at 37°C, 
or until most cells had detached. 250μl of cells in EDTA and trypsin was then 
added to a new flask with 10ml complete medium and the flask incubated at 
37°C. 
 
2.2.6 Cell culture - experimental 
Unless otherwise stated, cells were grown to confluence (passage no. <50) in 
either 35mm dishes, 24-well plates or 96-well plates in DMEM (GIBCO) 
supplemented with 10% serum and penicillin/streptomycin. Cultures were kept 
for up to 4 weeks with media refreshed every 5-7 days. Before the start of 
recording, unless otherwise described, cells were subjected to temperature 
entrainment cycles of 12hrs at 32°C followed by 12hrs at 37°C for a minimum 
Materials and Methods 
 49 
of 48 hours. Cells were then changed to “Air Media” (Hastings et al. 2005) or 
stated variations of this medium, and dishes sealed using either vacuum 
grease and circular 44mm No. 1 coverslips (Thermo Fisher) or gas-
impermeable PCR Adhesive film (Thermo Fisher). Cells were then transferred 
to a Lumicycle®32 luminometer (Actimetrics), an ALLIGATOR (Cairn 
Research) or a Luminescence microplate reader (Bertold).  
 
2.2.7 Perfusion cell culture 
For experiments carried out under perfused media conditions, cells were 
seeded and grown to confluence in a fluidics slide (µ-Slide I 0.6 Luer, Ibidi) in 
DMEM (Gibco) supplemented with 10% serum and penicillin-streptomycin. 
Cultures were incubated for 1-2 weeks, with DMEM media refreshed every 5-
7 days. Cells were also subjected to temperature entrainment cycles during 
this time, as previously described. Before the start of recording, cells were 
changed to low-glucose DMEM (Sigma, D5921) supplemented with 1% 
glutamax, penicillin-streptomycin, 0.1mM luciferin and, unless otherwise 
stated, 2% serum and 2% B27. Cells were then perfused with the same 
media, driven by syringe pump (NE-1600) at a flow rate of 50μl/hr for the 
duration of the experiment. Syringes and slides were connected using 1mm 
I.D. ETFE tubing (GE Healthcare), elbow, male and female luer fittings (Ibidi). 
Tubing was sterilised prior to use with 70% ethanol. Recording was performed 
using a bioluminescence incubator (Cairn Research). Boli were applied using 
three-way luer fittings (Cole-Parmer) to produce a diversion of flow, with no 
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change in flow rate or detectable flow disturbance. Further details of this 
method and its optimisation can be found in chapter 2. 
 
2.2.8 Experimental cell handling 
Air Medium 
Unless otherwise stated, bioluminescence experiments were carried out using 
“Air Medium” (Hastings et al. 2005). The composition of 500ml of “Air 
Medium” stock is: 
 
DMEM (powder, D5030)      4.15g 
NaHCO3         0.175g 
Glucose        2.25g 
1M HEPES        5ml 
Penicillin/Streptomycin      5ml 
Millipore Water       up to 500ml 
 
Stock was then adjusted to pH 7.4 at ambient temperature and sterile filtered. 
 
Prior to recording, a working stock was made. 50ml of “Working Air Medium”, 
unless otherwise stated, consists of: 
 
Air Medium Stock       45ml 
Foetal Bovine Serum (HycloneTM FetalcloneTM )  5ml 
B27/NS21 (Life Technologies/in house)    1ml 
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Firefly luciferin (Biosynth AG)     1mM 
GlutaMAX™ (Thermo Fisher)     500μl 
 
Working stock was sterile filtered and osmolarity adjusted to 350mOsm/L 
before use. 
 
Addition of pharmacological agents 
For addition of pharmacological agents during an experiment, maintaining 
cells at 37°C was crucial. This was achieved by placing dishes directly onto 
an isothermal pad for the duration of the treatment. When cells were to be 
treated with multiple drugs, cells were placed in 37°C incubators and given 5-
30 minutes to equilibrate (as appropriate) before a second drug was applied. 
 
2.3 Molecular Biology 
2.3.1 Isolation of DNA for bacterial enzymes 
To obtain genomic DNA for bacterial pentose phosphate pathway enzymes, 
pelleted k12 E. coli was resuspended in 350μl 10 mM Tris-HCl, pH 8.0, with 
0.1 M NaCl, 1 mM EDTA, and 5% TRITON X. 25μl 10mg/ml lysozyme in 10 
mM Tris-HCl, pH 8.0 was added, the mixture vortexed and incubated at 37°C 
for 30 minutes. The mixture was then boiled for 40 seconds, before 
centrifuging at maximum speed in a bench-top centrifuge for 5 minutes and 
the pellet discarded. The resulting supernatent was then used as the starting 
material for PCR. Here, PCR tubes were each filled with 5μl Q5 reaction 
buffer (New England BioLabs), 0.5μl 10mM dNTPs, 1.25μl forward primer, 
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1.25μl reverse primer, 0.5μl genomic DNA, 0.25μl High-Fidelity DNA 
Polymerase (New England BioLabs) and 16.25μl nuclease-free water. 
Samples were then subjected to 30 seconds at 98°C, followed by 35 cycles of 
98°C for 10 seconds, a variable annealing temperature for 30 seconds (Tm 
determined using NEB Tm calculator, New England BioLabs) and 72°C for 20 
seconds. Sampled were then cleaned up using the QIAquick PCR purification 
kit (Qiagen) as per manufacturers intructions. Following PCR, samples were 
run on a 0.8% agarose E-Gel® DNA gel (Thermo Fisher) using an E-Gel® 
iBase™ (Thermo Fisher) to confirm fragment size. 
 
Primer sequences used were: 
PGI Forward – TTCTGTGACTGGCGCTACAA 
PGI Reverse – ACCGCGCCACGCUUUAUAGCG 
GND Forward – TAGCTGAAGACGGTGAACCA 
GND Reverse – ATCCAGCCATTCGGTATGGAA 
ZWF Forward – TAAGTACCGGGTTAGTTAAC 
ZWF Reverse - CTCAAACTCATTCCAGGAACG 
 
2.3.2 Colony PCR 
Colony PCR was performed by PCR using Q5® High-Fidelity DNA 
Polymerase (New England BioLabs). Wells of a 96-well PCR plate were each 
filled with 5μl Q5 reaction buffer, 0.5μl 10mM dNTPs, 1.25μl forward primer, 
1.25μl reverse primer, 0.25μl High-Fidelity DNA Polymerase and 16.75μl 
nuclease-free water and stored on ice. Single colonies were selected using a 
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sterile toothpick, which was subsequently dipped directly in to the PCR 
reaction mixture before being stored in LB at 4°C. Once all colonies had been 
selected, the plate was subjected to 10 minutes at 98°C, followed by 35 
cycles of 98°C for 10 seconds, 55-65°C for 30 seconds (dependent on 
predicted annealing temperature) and 72°C for 20 seconds. Following PCR, 
samples were run on a 0.8% agarose E-Gel® DNA gel (Thermo Fisher) using 
an E-Gel® iBase™ (Thermo Fisher) to identify those samples containing 
fragments of the appropriate size. 
 
2.3.3 Production of stable over-expression lines 
For generation of stable overexpression lines, recently immortalised 
PER2::LUC fibroblasts were transfected with the Tet repressor plasmid 
pcDNA6/TR© (Thermo Fisher) and Tet operon vector plasmid 
pcDNA™4/TO/myc-His A (Thermo Fisher).  
 
Cloning 
The plasmids were propagated using One Shot® TOP10 chemically 
competent E. coli (Thermo Fisher), as per the manufacturers recommended 
protocol. In short, per transformation, 50μl of E. coli was thawed on ice, 1μg 
of the plasmid DNA added, mixed by gently agitating the vial and then 
returned to ice for 30 minutes Vials were then placed in a 42°C water bath for 
45 seconds before returning to ice. 250μl of pre-warmed S.O.B was added to 
the vial, before cells were place in a 37°C shaking incubator for 1 hour at 
225rpm. 100μl of this mix was then spread on an LB agar plate containing 
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100μg/ml ampicillin an incubated at 37°C overnight. The following day, 3 
distinct colonies per plasmid were selected and grown up overnight in 6ml LB 
containing 100μg/ml ampicillin in a 37°C shaking incubator at 225rpm. 
Samples were then centrifuged at 1000rpm for 5 minutes and the supernatant 
discarded. Plasmid DNA was then prepared using the QIAprep spin miniprep 
kit (Qiagen), as recommended by the manufacturer. DNA was stored at -20°C 
until required. 
 
The pcDNA™4/TO/myc-His A plasmid was further processed to act as a 
vector for the overexpression of bacterial isoforms of pentose phosphate 
pathway enzymes, which were isolated as described above. Following elution, 
DNA underwent restriction digest using BamHI-HF® and HindIII-HF® (New 
England BioLabs) for 60 minutes at 37°C. The digest was then cleaned-up 
using QIAquick PCR purification kit (Qiagen) as per the manufacturer’s 
instructions. The digested production was then ligated to the appropriate 
insert using T4 Ligase (New England BioLabs), with 50ng of the digested 
vector, 37.5ng of the insert and 2μl of ligase, made up to 20μl with nuclease-
free water. The reaction mixture was left at room temperature for 10 minutes, 
before being heat-inactivated by heating to 65°C for 10 minutes. The ligation 
reaction was then chilled on ice before being transformed into One Shot® 
TOP10 chemically competent E. coli (Thermo Fisher) as described above and 
plated on to LB agar plates containing 100μg/ml ampicillin. The next day, 3 
colonies of each insert were selected, grown up overnight in liquid LB and the 
plasmid DNA isolated using the QIAprep spin miniprep kit (Qiagen), as 
Materials and Methods 
 55 
described above. Samples of each insert were sent for Sanger sequencing 
using the CMV forward and BGH reverse primers, which flank the multiple 
cloning site, to confirm sequence identity. Due to contamination of the ligation 
reaction, the pcDNA™4/TO/myc-His C plasmid containing the bacterial 
isoform of phosphoglucose isomerase was selected using colony PCR prior to 
sequencing, as described above. 
 
Primers used for sequencing were: 
CMV Forward Primer – CGCAAATGGGCGGTAGGCGTGT 
BGH Reverse Primer – TAGAAGGCACAGTCGAGG 
 
Transfection 
Cells were transfected with the pcDNA6/TR© plasmid using a forward 
transfection method to produce a line stably expressing the tet-repressor. 
Briefly, cells were seeded in 100μl complete medium a 24-well plate, such 
that they reached 70% confluencey after 24 hours. Transfection medium was 
made up to consist of 2μg pcDNA6/TR© and 6μl FuGENE® transfection 
reagent (Promega), made up to 100μl with Opti-MEM® (Thermo Fisher). 24μl 
of this medium was added to each well. Cell were incubated for 24 hours at 
37°C for 24 hours before undergoing a full media change to complete 
medium. Cells were subsequently selected for stable expression of 
pcDNA6/TR© using 3μg/ml blastcidin, media changed every 3-5 days. 
Once appropriate sequences had been obtained for all inserts, these were 
transfected in to PER2::LUC lung fibroblasts which stably expressed the 
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pcDNA6/TR© Tet repressor using FuGENE® transfection reagent (Promega) 
as described above. Cells were selected in complete media containing both 
3μg/ml blasticidin and 250μg/ml Zeocin™ (Invitrogen). Once selection was 
complete, cells were maintained in complete media containing 3μg/ml 
blasticidin and 250μg/ml Zeocin™ (Invitrogen) until experimentation. 
 
2.3.4 Gel Electrophoresis and Western Blotting 
Protein Preparation 
To prepare protein for western blotting, cells were removed from the 37°C 
incubator and placed on ice. Cell culture media was removed and the cells 
washed with ice-cold PBS. Cells were then lysed on ice in lysis buffer 
containing 50mM Tris-HCl (pH 7.5), 1% TritonX100, 1.5mM MgCl2, 5mM 
EDTA and 100mM NaCl in the presence of ptrotease and phosphatase 
inhibitors for 10 minutes. Lysate was then transferred to an ice-cold 
microcenrifuge tube and centrifuged at max in a bench-top centrifuge for 5 
minutes. The supernatant was removed and added to 1/3 volume SDS 
sample buffer containing 4% BME (β-mercaptoethanol). The sample was then 
warmed at 70°C for 10 minutes. 
 
Gel Electrophoresis and Western Blotting 
NuPAGE Novex 4–12% Bis-Tris gradient gels (Life Technologies) were run 
using the manufacturer’s protocol with a reducing MES-SDS buffer system at 
200V for 35 minutes. Protein transfer to nitrocellulose membrane for blotting 
was performed using the iBlot system (Life Technologies), with a standard 
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(P0, 9 min) protocol. The nitrocellulose membrane was washed briefly in 
water, and then blocked for 1hr in blocking buffer (0.5% BSA/non-fat dried 
milk (Marvel) in Tris buffered saline with 0.05% Tween-20 (TBST)). 
Membranes were then incubated with antibody diluted in blocking buffer 
overnight at 4°C. The following day, membranes were washed for 3 x 10 
minutes in TBST and then incubated with 1:5,000 HRP-conjugated secondary 
antibody (Sigma-Aldrich) for 60 min. 3 x 10 minute washes in TBST were then 
performed before performing chemiluminescence detection using Immobilon 
reagent (Millipore). Membranes that were probed with antibodies multiple 
times were washed in 0.2% sodium azide for 15 minutes before being blocked 
and probed with primary antibody as before. 
 
2.3.5 Quantitative PCR for mRNA 
For qPCR, cells were grown to confluence in 35mm dishes, subjected to 
temperature cycles and changed in to “Air Media” as previously described for 
bioluminescence recording. At an appropriate time point, cells were harvested 
in 350μl RLT buffer and RNA was extracted with the RNAeasy mini kit 
(Qiagen) using the recommended protocol. On column DNase digestion was 
performed. cDNA was generated from these samples using the iScript cDNA 
synthesis kit (BioRad) using a total RNA quantity of 100-500ng per sample. 
RNA quantity was kept consistent across all samples within a given 
experiment. 20μl reactions were processed using a Veriti™ thermal cycler 
(ThermoFisher) for 5 minutes at 25°C, 20 minutes at 46°C, 1 minute at 95°C 
and then held at 4°C. The generated cDNA was then diluted with 80μl 
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nuclease-free water to give a total sample volume to 100μl. 10μl of each of 
these samples was then pooled to give the highest concentration standard. 
This standard was then serially diluted 1:5 in nuclease-free water to produce a 
total of 6 standards. Experimental samples were then further diluted 1:10 in 
order to ensure that samples lay within the range of the standard curve. qPCR 
was carried out using a Prime Pro 48 machine (Techne) and KAPA SYBR 
Fast qPCR reagents (KAPA Biosystems). Each sample well had a total 
volume of 12.5μl, consisting of 6.5μl KAPA SYBER master mix, 0.5μl forward 
primer, 0.5μl reverse primer, 2.25μl nuclease-free water and 2.5μl cDNA. 
Plates were sealed, vortexed and centrifuged briefly before placing in the 
Prime Pro 48. Plates were initially heated to 95°C for 2 minutes, before cycling 
between 5 seconds at 95°C and 30 seconds at an empirically determined 
annealing temperature (see below) for 40 cycles. A melt curve was then 
determined by heating to 95°C for 15 seconds, 55°C for 15 seconds before 
returning to 95°C for a further 15 seconds. Data was analysed using the 
Prime Pro Study software, using the determined thresholds. Wells with 
unexpected melting curves were excluded at this stage. All remaining 
samples were then compared to the standard curve in order to determine 
relative mRNA quantity. All quantities were subsequently normalised to 
RNS18 quantity. 
 
Sequences and annealing temperatures for all primers used were as follows: 
PER1 Forward – CACCACTGCCGATCTAAAGC 
PER1 Reverse – TCGAGGGGAGAATACTGGGA - 59°C 
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PER2 Forward – CCTACAGCATGGAGCAGGTTG A 
PER2 Reverse – TTCCCAGAAACCAGGGACACA - 58°C 
RNS18 Forward – CGCCGCTAGAGGTGAAATTC 
RNS18 Reverse – TTGGCAAATGCTTTCGCTC - 58°C 
 
2.3.6 Isolation of cellular fractions 
In order to obtain separate nuclear and cytoplasmic fractions, confluent cells 
in 60mm dishes were scraped in 1ml ice-cold PBS, transferred to an ice-cold 
1.5ml microcentrifuge tube and centrifuged at 200xg at 4°C for 5 minutes. The 
supernatant was discarded and the resulting pellet resuspended in 50 μl 
Gentle Lysis Buffer (0.5% NP40, 0.14M NaCl, 10mM Tris-HCl (pH 8.0), 
1.5mM MgCl2 and 10mM EDTA) and incubated on ice for 5 minutes. Samples 
were then centrifuged for 5 minutes at 410 x g and the supernatant removed 
and set aside. The pellet was then resuspended in a further 50μl gentle lysis 
buffer and centrifuged for a further 5 minutes at 410 x g. The supernatant 
taken here was added to the previously removed supernatant and is the 
cytoplasmic fraction. The remaining pelleted nuclei were resuspended in 50μl 
gentle lysis buffer. Fractions were then processed using the RNAeasy mini kit 
(Qiagen) as per manufacturers instructions.  
 
2.3.7 qPCR primer design and optimisation 
Primers for qPCR were designed using Primer3 (Untergasser et al. 2012) to 
be 20bp in length and to flank regions of approximately 150bp within the 
mRNA of interest. Preference was given to primer pairs that spanned an exon 
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junction. Specificity of primer pairs was confirmed by checking primers against 
appropriate libraries in the NCBI Basic Local Alignment Search Tool 
(BLAST®). Primers were synthesised in a desalted form by Sigma Aldrich. 
Optimised annealing temperatures were determined empirically by making up 
multiple wells as for qPCR with cDNA known to contain the mRNA of interest. 
Wells were then subjected to temperature cycles as for qPCR, with a gradient 
of annealing temperatures around the predicted annealing temperature (NEB 
Tm Calculator, New England Biosciences) in 2°C steps. Following PCR, 
samples were run on a 0.8% agarose E-Gel® DNA gel (Thermo Fisher) using 
an E-Gel® iBase™ (Thermo Fisher). The annealing temperature that 
produced the highest quantity of single product was chosen as the annealing 
temperature for qPCR. 
 
2.3.8 qPCR for miRNA 
In order to perform qPCR for miRNA, cells were harvested in 350μl RLT as for 
mRNA and miRNA isolated using an RNAeasy miRNA isolation kit (Qiagen) 
as per the manufacturers protocol. On column DNase digestion was not 
performed. cDNA was generated using the miScript II RT kit (Qiagen). A total 
reaction volume of 20μl consisted of 4μl HiSpec Buffer, 2μl miScript nucleics 
mix, 2μl reverse transcriptase mix and 500ng RNA, made up to volume with 
nuclease-free water. Samples were the incubated at 37°C for 60 mins, 
followed by 5 minutes at 95°C. Samples were then kept on ice whilst they 
were made up to a volume of 100μl with nuclease-free water. Pooled 
standards and further dilution of samples was performed as for qPCR for 
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mRNA. qPCR was performed using the miScript SYBR green PCR kit. Wells 
consisted of 5μl QuantiTect SYBR green PCR master mix, 1μl miScript 
Universal primer, 1μl Primer Assay, 1ng cDNA, made up to 10μl with 
nuclease-free water. The plate was then sealed, vortexed and centrifuged 
briefly before placing in the Prime Pro 48 qPCR machine. Wells were then 
subjected to 15 minutes at 95°C, followed by 40 cycles of 15 seconds 94°C, 
30 seconds at 55°C and 30 seconds at 70°C. A melting step was also 
performed as above. Results were analysed and outliers excluded using the 
Prime Pro Study software, as above. All values were then normalised to 
RNU6 and SNORD6. 
 
2.3.9 Transient knockdown of mRNAs  
Knockdown of mRNA was performed using the appropriate ON-TARGETplus 
siRNA SMARTpool (Dharmacon). Cells were transfected using HiPerFect 
transfection reagent (Qiagen) in a fast-forward transfection protocol in 24-well 
plates. Briefly, each well of a 24-well plate was filled with 100μl Opti-MEM®, 
supplemented with 5nM microRNA inhibitor and 3μl HiPerFect transfection 
reagent. Cells in 500μl complete medium were then seeded in to these wells 
at a density of 3x106 cells per well and plates incubated for 20 hours at 37°C. 
Medium was then changed and cells were maintained in temperature cycles 
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2.3.10 Transient knockdown of miRNAs 
Knockdown of miRNAs was performed using miRCURY LNA™ microRNA 
Inhibitors and miRCURY LNA™ microRNA Power Inhibitors (Exiqon). Cells 
were transfected using HiPerFect transfection reagent (Qiagen) using a fast-
forward transfection protocol, as described above. Cells were subjected to 
temperature cycles for 48 hours before being changed in to experimental 
conditions as previously described. 
 
2.3.11 Polyribosome Fractionation 
To obtain polysome fractions, cells were grown to confluence in a 125cm2 
flask. Immediately prior to harvesting, cells were incubated with 100μg/ml 
cycloheximide for 5 minutes at 37°C. Cells were then placed on ice and 
washed twice with 10ml ice-cold PBS containing 100μg/ml cycloheximide. 
Cells were then scraped in 5ml ice-cold PBS with 100μg/ml cycloheximide 
and centrifuged at 200 x g at 4°C for 5 minutes. The resultant pellet was 
resuspended in 425μl hypotonic buffer (5mM Tris-HCl, 2.5mM MgCl2, 1.5mM 
KCl, 1x protease inhibitor cocktail (Roche)). 5 μl 10 mg/ml CHX, 1 μl of 1 M 
DTT and 100 units of RNAse inhibitor (ThermoFisher) were added and the 
mixture vortexed for 5 seconds. Triton X-100 and sodium deoxycholate were 
added to total 0.5% of each and vortexed again for 5 seconds. The lysate was 
then centrifuged at 16,000 x g at 4°C for 7 minutes and the pellet discarded. 
The remaining supernatant was made up 750μl using RNA-free water and 
added to 750μl Trizol. 500μl of sample was then loaded on to pre-poured 
sucrose gradients (5-50% sucrose in H2O with 200 mM HEPES, 1 M KCl, 50 
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mM MgCl2, 100μg/ml cycloheximide, 1x protease inhibitor cocktail and100 
units/ml RNase inhibitor). The gradients were then ultracentrifuged at 222,228 
x g for 2 hr at 4 °C using SW41Ti rotor in ‘low brake’ mode. Following 
centrifugation, the samples were separated in to 10x 1ml fractions using a 
fraction collector with simultaneous detection of UV absorbance at 254 nm. 
 
2.3.12 NADP+:NADPH ratio 
Assays to determine NADP+:NADPH ratio were performed using the 
NADP+/NADPH-Glo(TM) Assay (Promega) as per manufacturer’s instructions. 
250 µM diamide was used as a positive control. 
 
2.4 Bioluminescent Recording 
2.4.1 Photon Multiplier Tube (PMT) recording set up 
Recordings of cells or SCN slices within 35mm dishes were made using the 
LumiCycle® 32 (Actimetrics). Here, 4 photomultiplier tubes are used to record 
from 32 dishes, with each recording from 8 individual dishes. Recordings were 
made in 108 second bins every 15 minutes. Conditions were maintained at 
constant 37°C and ambient by housing the LumiCycle® 32 within a light-tight 
incubator which was not humidified.  
 
2.4.2 EMCCD Camera Recording 
Recordings of any dish or plate size were made using an ALLIGATOR (Cairn 
Research). Here, a New Brunswick Galaxy 170R (Eppendorf) was adapted 
with a top camera port. Both Hamamatsu ImagEM and Andor iXon Ultra 
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EMCCD digital cameras were used. Imaging time ranged between 10 minutes 
and 1 hour as required. 
 
2.4.3 Luminescence Microplate Reader 
Recordings from cells in 96-well plates were made using CentroPRO LB 962 
Microplate Luminometer. Recording time was 37.5 seconds per well per hour. 
Cells were maintained at constant 37°C by housing the plate reader within a 
light-tight incubator which was not humidified.  
 
2.5 Data Analysis 
2.5.1 Circadian analyses 
Bioluminescent traces of cells were fitted with damped cosine waves using 
the following equation:  
 
y = (mx) + C + amplitude*exp(-k*x)*cos(((2*pi*(x-phase))/period)) 
 
where y is the signal, x the corresponding time, amplitude is the height of the 
peak of the waveform above the trend line, k is the decay constant (such that 
1/k is the half-life), phase is the shift in x relative to a cosine wave and the 
period is the time taken for a complete cycle to occur (Hirota et al. 2008).  
 
This enables an estimation of period, amplitude and phase to be made, with 
goodness-of-fit determined using R2 values. 
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Bioluminescent signal is given as relative light units (RLU) or counts per 
second (cps) as appropriate. 
 
SCN analysis was performed using BioDare (Zielinski et al. 2011). 
 
2.5.2 Statistics 
Data is presented as mean +/- SEM, and statistical significance of mean 
differences determined using student’s t-test or ANOVA as appropriate. 
Statistical analyses were performed using Graphpad Prism. P values are 
reported using the following symbolic representation: ns = p>0.05, * = p≤0.05, 
** = p≤0.01, *** = p≤0.001, **** = p≤0.0001.
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Chapter 3: Development of a system for perfused cell culture 
3.0.1 Cell culture for circadian experimentation 
The methodology for maintaining cell cultures ex vivo or in vitro, commonly 
known as tissue or cell culture, has been in use for a little over a century 
(Harrison 1912) and has become an extremely widely used laboratory 
technique, as it confers a number of advantages over work in vivo. Firstly, it 
limits the need to use live animals, thereby reducing the time and financial 
costs associated with maintaining an animal colony. Secondly, cells have a far 
faster generation time than animals, allowing for vastly increased throughput 
of study. Thirdly, use of cells in culture can allow for the closer study of certain 
processes in isolation, without the conflicting humoural or neuronal cues and 
associated variability that occur within a living animal. Instead, it is possible to 
control the extracellular environment, through the use of well-defined media 
conditions and constant temperature. 
 
However, in vitro culture does possess limitations. For example, cells are 
constantly metabolising components of the extracellular media. As in tissue 
culture, unlike in vivo, there is no means of clearing and replacing these 
media components, media composition will change over time. This means 
that cells no longer experience truly constant extracellular conditions if 
maintained in culture media for prolonged lengths of time. As a large number 
of media components, by their very nature, are essential for the maintenance 
of cellular health and viability, it is quite possible that changes in their levels in 
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the extracellular media could impact upon experimental results achieved 
under these conditions.   
 
This is of particular relevance when wishing to investigate circadian 
timekeeping in vitro. As media change is associated with resetting of the 
cellular molecular clock, cells for circadian experimentation are maintained in 
the same media for weeks at a time. This means that changes in the 
extracellular environment of these cells have the potential to be highly 
significant. This problem can potentially be solved through use of techniques 
that allow for clearance and renewal of cellular media in a physiological 
manner. One candidate for this technique is microfluidic culture. 
 
3.0.2 Microfluidics 
Microfluidics is concerned with the movement of small volumes of a fluid 
within a contained, often artificially manufactured, space. In the context of 
experimental cell biology, microfluidic systems can be used as cell culture 
technique. The use of such systems has grown steadily over the almost two 
decades since the methodology was first described for tissue culture (Tilles et 
al. 2001), and has been employed in applications as wide ranging as toxicity 
assays, migration assays and organoid culture. However, it is still by no 
means a common cell culture method. This is possibly due in part to the 
relative novelty of the technique compared to traditional cell culture methods, 
but also possibly due to the myriad challenges faced when attempting to 
design new microfluidic devices and experiments, such as appropriate cell 
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adhesion, mechanics of flow and maintenance of cell viability (Halldorsson et 
al. 2015). 
 
When well implemented, microfluidic techniques provide a number of 
advantages over traditional cell culture models. It is possible to more closely 
mimic the in vivo cellular microenvironment in such systems, as they allow for 
removal and renewal of extracellular media components. This comes hand-in-
hand with the capacity to produce chemical gradients and also the possibility 
of perfused cell culture. Perfusion of cells in culture is of particular interest, as 
it allows for downstream analysis of extra cellular media (Croushore et al. 
2012), as well as real-time analysis of the cellular response to the 
environment and environmental changes without the confounding factors 
associated with media change (Ges & Baudenbacher 2010; Grossmann et al. 
2011). 
 
3.0.3 The advantage of perfused circadian cellular experimentation 
To date, there have been relatively few published reports of perfused cell 
culture in a circadian context (Lee et al. 2013; Teng et al. 2013). Indeed, there 
are no commonly used microfluidic systems that have been demonstrated to 
be able to sustain viable cells culture under perfused flow for the time periods 
necessary for circadian experimentation. However, it is clear that 
development of a reliable perfused system for circadian experimentation 
would be of great utility to the field for a number of reasons. Firstly, it allows 
for observation of circadian behaviour of cells and tissues under truly constant 
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conditions, as the constant removal and renewal of extracellular media is such 
that the extracellular environment remains constant, thereby removing the 
variability this produces. In addition, such maintenance of a constant 
extracellular environment is appreciably more physiologically relevant than 
standard tissue culture methods, as it mimics the maintenance of the milieu 
intérieur found in vivo. 
 
The second major advantage of a perfused cell culture system for circadian 
assays is the ability to take repeat measurements from the same population. 
As further outlined for the metabolomics assay in the next chapter, a number 
of experimental techniques require sampling of extracellular media. Within a 
traditional static tissue culture model, sampling of any great media volume is 
effectively an end-point procedure, due to the disturbance caused to a cell 
population or tissue by changes in the extracellular environment. As such 
changes in the extracellular media are sufficient to influence the subsequent 
phase of the circadian oscillation in cells (Balsalobre et al. 1998), it would in 
inappropriate to repeatedly sample the same static population for circadian 
experiments. The solution generally used for this is to have multiple, 
identically treated populations running in parallel and to sample a number of 
these at each time point. However, using different dishes does introduce 
increased variance, which can be sufficient to obscure more subtle 
longitudinal trends. A perfused tissue culture technique removes this source of 
technical error, as samples of media can be taken repeatedly from the same 
population of cells simply by collecting media at from the system outflow. 
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3.0.4 Challenges 
There are number of obstacles to overcome when designing a new 
microfluidic cell culture system, including some that are specific to the 
development of a system for study of circadian phenomena. First and 
foremost, a system for circadian perfused culture must be capable of 
sustaining a cell population under perfused flow for much longer periods of 
time than most existing systems: weeks as opposed to the hours currently 
used for migration or growth assays. 
 
Secondly, as rhythmic activity in cells and tissues can be reset by relatively 
small changes in extracellular temperature (Buhr et al. 2010), serum 
(Balsalobre et al. 1998), or glucose (Hirota et al. 2002), to name but three, the 
conditions within a perfused circadian cell culture system must remain almost 
entirely constant for the duration of the experiment. 
 
These challenges are in addition to the considerations that must be made 
when building any microfluidic system for biological use, such as rate of flow, 
fluid dynamics of the system, cell type, media composition and growth 
surface. 
 
In this chapter, I discuss the development and optimisation of such a 
microfluidic system for constantly perfused circadian assays, highlighting both 
the challenges of constructing such a system, as well some of the many 
advantages of the functioning technique. I also demonstrate the difference in 
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experimental result that can be observed when studying cells under perfusion 
compared with static conditions. 
 
3.1 Results 
3.1.1 Experimental approach 
A number of factors require optimisation when designing a new microfluidic 
system, such as flow rate, media composition and cell adhesion surface 
(Halldorsson et al. 2015). However, as this system has a comparatively low 
throughput, with a capacity to run a maximum of 9-12 independent chambers 
at any one time, it is not feasible to test all factors at once. Instead, the 
system was optimised iteratively, testing only one or two factors at once. 
Details of the various set-ups tested are given in the table below, with further 
information about the optimisation of each component given in further detail in 
the subsequent chapters. 













U2OS Per2:LUC Kirstall 200 5 10 2 -- -- Cells died within 70 
hours 
U2OS Per2:LUC Kirstall 200 1 10 2 + --  
U2OS Per2:LUC Kirstall 200 1 7 2 -- --  
U2OS Per2:LUC Kirstall 200 1 5 2 -- --  
U2OS Per2:LUC Kirstall 200 1 2 2 + + Rhythmicity not 
always seen 
U2OS Per2:LUC Kirstall, 
no 
coverslip 
200 1 2 2 -- -- Cells dead with 12 
hours 
U2OS Per2:LUC Kirstall 200 1 2 1 + + No improvement with 
low B27 
3T3 Bmal1:LUC Ibidi, 0.2 50 1 2 2 -- -- Channel too shallow 
3T3 Bmal1:LUC Ibidi, 0.4 50 1 2 2 ++ -- Lack of rhythms may 
have been due to 
inconsistent flow rate 
3T3 Bmal1:LUC Ibidi, 0.6 100 1 2 2 ++ + No improvement with 
higher flow rate 
3T3 Bmal1:LUC Ibidi, 0.6 50 1 2 2 ++ +  
3T3 Bmal1:LUC Ibidi, 0.6, 
in series 
50 1 2 2 ++ + Use of buffer slide 
greatly reduces noise 
Immortalised 
Fibroblast 
PER2::LUC Ibidi, 0.6, 
in series 
50 1 2 2 ++ ++  
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3.1.2 Initial perfusion setup 
As a starting point for the development of a perfused cell culture system, a 
Quasi Vivo® 500 (Kirstall) system was selected. This system consists of a 
number of cylindrical polydimethylsiloxane (PDMS) chambers connected with 
tygon tubing (Figure 3.1A). The inflow tubing has an internal diameter (I.D.) of 
1/6”, whilst the outflow tubing has an ID of 3/32”. The total chamber volume is 
2ml. Media was driven through the system using an NE-1600 syringe pump 
(Figure 3.1B). U2OS cells expressing the Bmal1:LUC reporter were made up 
to a 200,000 cells/ml suspension in DMEM supplemented with 10% serum 
and 200µl of this was seeded on to a poly-L-lysine coated coverslip placed at 
the base of the PDMS chamber. Cells were left at room temperature for 1 
hour. A further 500µl supplemented DMEM was added to the chamber, which 
was then incubated under temperature cycles until required. For 
bioluminescent recording, chambers were connected to a syringe and pre-
warmed air media flushed through the system. The syringe was then 
connected to a syringe pump and media driven across the cells at a constant 
flow rate. Cell chambers were maintained at 37°C, at atmospheric CO2 and O2 
for the duration of the experiment. 
Table 3.1 
Summary of perfusion conditions tested 
Summary table of perfusion conditions tested. Due to low throughput, 
systems were tested iteratively. Cell viability and rhythmicity were scored by 
observation as lacking (-), poor (--), fair (+) or good (++). 
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3.1.3 Media composition determines cell survival under perfusion 
For initial perfusion experiments, cells were grown to confluence on a poly-L-
lysine-coated coverslip and subjected to temperature cycles in PDMS 
chambers as described above. Cells were perfused with a standard “air 
medium” (AM) formulation (Hastings et al. 2005). This consists of a stock 
Figure 3.1 
Initial perfusion setup 
A Schematic diagram of the Quasi Vivo® 500 system. B Image of a Quasi 
Vivo® 500 chamber (image: Kirkstall). C Per2:LUC bioluminescence from 
initial perfusion conditions. Per2:LUC U2OS cells were perfused at 200µl/hr 
with complete air medium containing 10% HY2 serum (n=2, all replicates 
shown). 
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solution of Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma D5030), 
supplemented with: 
- 5 g/L glucose 
- 0.35 g/L sodium bicarbonate 
- 0.01 M HEPES 
- Penicillin/streptomycin (25 mg/L each) 
This stock solution was adjusted to pH 7.4 at room temperature. Prior to 
experimentation, this stock solution was further supplemented with: 
- 10 % serum (HyClone™ FetalClone™ II or III as appropriate) 
- 2 % B-27® supplement 
- 1 % Glutamax 
- 1 mM Luciferin 
 
This working solution was then adjusted to an osmolarity of 350mOsm. 
 
As Figure 3.1C shows, perfusion with AM was not comparable with the static 
control condition. Furthermore, those cells under perfusion ceased to produce 
a light signal substantially above background at around 48 hours and upon 
examining the cells under a light microscope after 72 hours, the vast majority 
of the cell population was dead. The cell monolayer in the static condition 
remained both alive and intact. This was indicative that the act of perfusion 
was the cause of cell death, rather than the unusual cell culture conditions. 
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High levels of both glucose and serum are reported to have adverse effects 
on cellular viability (Risso et al. 2001; Rajah et al. 1999), as well as acute 
changes in these factors having the capacity to reset the cellular circadian 
oscillation (Balsalobre et al. 1998; Hirota et al. 2002).  It was thus 
hypothesised that the continual renewal of glucose and serum that occurs 
Figure 3.2 
Low glucose and serum aid cell survival under perfusion 
A Bioluminescence from Per2:LUC U2OS cells under perfusion with either 
reduced glucose (1g/L vs 5g/L) or reduced serum (2% vs 10%). Flow rate 
was 200µl/hr (n=2, representative). B, C, D Bioluminescence from Per2:LUC 
U2OS cells all in media containing 1g/L (5.4mM) glucose, with 2, 5 or 7% 
serum and 1 or 2 % B27. Flow rate was 200µl/hr. Those perfused chambers 
that showed measurable circadian rhythmicity in bioluminescence have 
period indicated. Static chambers contain 5% serum (n≥2, representative). 
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under perfusion might be responsible for the high level of cell death in this 
condition. To test this, the experiment was repeated with the same setup, but 
with either the glucose concentration reduced to 1g/L or the serum proportion 
reduced to 2% (Figure 3.2A). Under these conditions, cells perfused with low 
glucose media showed increased survival, whilst those that were maintained 
in high glucose continued to show a high level of cell death, regardless of the 
level of serum available, suggesting that the high level of glucose was the 
primary cause of apoptosis in this circumstance.  However, reducing the 
serum concentration in addition to the glucose concentration did allow for 
observation of cellular rhythmicity over 3 days under perfusion in some, 
although not all, chambers (Figure 3.2B,D), a feature not observed at higher 
serum levels. It is plausible that this is a result of continual resetting of the 
cellular circadian oscillation at higher serum concentrations. Reducing the 
concentration of cell culture supplement B-27®, a product that was initially 
designed as a serum-replacement, did not result in a clear improvement in 
cell survival or circadian gene expression. 
 
These changes to the medium used for perfusion result in a formulation much 
closer to the original formation of Dulbecco’s Modified Eagle’s Medium 
(Dulbecco & Freeman 1959). Furthermore, the glucose concentration in this 
lower glucose media (5.4mM) lies well within the normal range for mammalian 
blood sugar levels, making this a much more physiologically relevant 
condition, as it more closely represent the milieu intérieur that cells 
experience in vivo. However, despite these changes, the ability to observe 
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rhythms in reporter gene expression in perfusion was highly inconsistent, for 






Cell viability on PDMS and poly-l-lysine 
A Bioluminescence from perfused Per2:LUC U2OS cells grown either 
directly on to PDMS or on poly-l-lysine coated glass coverslips. Media 
conditions were 2% serum, 2% B27, 1g/L glucose. Flow rate was 200μl/hr. 
B 24-hour de-trended (n=3, representative). C,D Representative images 
demonstrating uneven bioluminescence due to cell death on coverslips in 
kirkstall chambers. 
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3.1.4 Cell culture surface influences robustness under perfusion 
 A large proportion of microfluidic cell culture devices are made from 
polydimethylsiloxane (PDMS). This form of silicone is particularly popular as a 
result of the ease with which it can used to make microfluidic chambers using 
a technique known as soft lithography (Halldorsson et al. 2015). It is also 
transparent and has a low autofluoresence, making it attractive for 
bioluminescence assays. In addition, the surface is thought to be relatively 
biocompatible. It was therefore attempted to culture cells directly on the 
PDMS surface of the Quasi Vivo® chambers, rather than on coverslips 
(Figure 3.3A). Although cells initially formed a confluent monolayer on this 
surface, their expression of circadian reporter constructs was low. 
Furthermore, after several days under perfusion, most cells were no longer 
viable. In contrast, cells grown in parallel on poly-L-lysine cover slips were still 
viable and showed far higher basal circadian reporter expression, as well as 
circadian variation in the expression of these reporters in some chambers. 
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3.1.5 Maintenance of constant rate of flow 
As outlined in the introduction to this chapter, one crucial feature required for 
a system for perfused circadian assays is a constant extracellular 
Figure 3.4 
Variable rate of flow affects expression of reporter genes 
A Bioluminescence from Per2:LUC U2OS cells perfused at 200µl/hr with an 
NE-1600 syringe pump (n=3, all replicates shown). B Bioluminescence from 
Per2:LUC U2OS cells perfused at 200µl/hr with a Harvard PHD ULTRA™ 
syringe pump (n=6, representative). C Bioluminesence from Per2:LUC U2OS 
cells perfused at 200µl/hr with a NE-1600 syringe pump following drive-
screw lubrication (n=3, all replicates shown). All cells were perfused with 
media containing 1g/L glucose, 2% serum and 2% B27. 
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environment. In order to obtain this in a system under flow, it is therefore 
important that the rate of flow of media across the cells remains as constant 
as possible. If instead, flow rate of media across the cellular monolayer is 
variable, it is possible that acute changes in the cellular microenvironment 
might stimulate gene expression that masks or inhibits circadian gene 
expression under true constant conditions. This was observed to be the case 
to a greater or lesser extent in a large number of perfused experiments 
(Figure 3.4A,B), although the effects observed on circadian reporter gene 
expression were highly variable even within the same experiment.  
 
However, a number of experiments showed the same pattern of acute 
reporter changes in multiple replicates, although at different amplitudes 
(Figure 3.4B). This was indicative of a systematic problem with the setup, 
rather than chamber or tubing specific issues, which would not be expected to 
show the same timing of effect across more than one chamber. As each cell 
culture chamber exists independently of any others in the same experiment, 
the only common element between different chambers is the syringe pump 
driving the media through the system, which can drive up to six syringes 
simultaneously. We can therefore assume that systematic fluctuations in flow 
rate occur primarily as a result of an uneven rate of syringe compression, 
most likely due to an uneven rate in the turning of the drive-screw. To 
counteract this, the drive screw was lubricated with a silicone grease (Super 
Lube®). This eliminated acute changes in gene expression when using the 
Quasi Vivo® system, although it did not necessarily increase the frequency 
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with which circadian oscillations in reporter gene expression was observed 
(Figure 3.4C). 
 
3.1.6 Laminar and equal flow 
Another important consideration when designing perfused system is the 
nature of fluid flow through the system. In order for extracellular conditions to 
remain as constant as possible, flow through the system, and particularly 
across the cellular monolayer should be laminar, as the eddies produced by 
turbulent flow might lead to an uneven extracellular microenvironment. 
Whether or not flow through a system will be laminar can be predicted by 
calculation of its Reynold’s number, defined as: 
 
𝑅𝑒 =  𝑄𝐷!𝜐𝐴  
 
where Re is the Reynold’s number, Q the volumetric flow rate (m3/s), DH the 
hydraulic diameter (m), ν the kinematic viscosity (m2/s) and A the cross 
sectional area (m2) of the channel or duct (Stokes 1922). Generally, a 
Reynold’s number of greater than 2000 is indicative of turbulent flow, although 
there is a transitional range slightly below and slightly above this number. If 
we assume the kinematic viscosity of cell culture media to be comparable to 
that of water at 37°C, then the Reynold’s number of the tubing of the perfusion 
system can be calculated using the following values: 
 𝑄 = 2×10!!, 𝐷! = 1×10!!, 𝜈 =  6.96×10!!, 𝐴 = (5×10!!)!𝜋 
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This gives a Reynold’s number of 365.8, well within the range for laminar flow. 
 
This model of flow breaks down when one considers the structure of the 
Quasi Vivo® chamber, which sits as a cylinder at 90° to the direction of flow, 
with a diameter of 15mm and a height of 10mm (Fig 3.1). Modelling the flow in 
and around such a chamber could easily constitute another thesis in its own 
right, but given it’s non-linear shape, it is certain that the flow within such a 
chamber would not be of an equal rate at all points within the chamber and 
may well also not be laminar. This may account for some of the uneven areas 
of cell death observed in a number of perfusion experiments (Fig 3.3C,D). 
Furthermore if, as proposed in the introduction, one wishes to use such a 
perfused system to collect media outflow samples that correspond to discrete 
time intervals, then it is crucial that flow through the chamber occurs at a 
similar rate at all points, which is not possible with this chamber shape. 
In order to solve this problem, the Quasi Vivo® 500 chambers were 
substituted with Ibidi µ-slide I luer chambers and the tygon tubing used with 
this system replaces with 1mm I.D ETFE tubing (Figure 3.5A,B). These 
chambers consist of a 5mm wide, 50mm long channel, are gas permeable 
and are available in a number of different depths. The inside of the channel is 
not coated, but the plastic is texturized in order to aid cell adhesion. Given the 
simple internal shape of these chambers, it is easy to calculate a Reynold’s 
number for these chambers. Depending on depth, Re rages from 65.4 to 196 
when the flow rate is 100µl/hr, well within the range for laminar flow. 
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Upon initial testing with these chambers, it was noted that cell survival and 
circadian reporter gene expression was much improved in chamber with a 
depth of 0.4mm or greater when compared to chambers of 0.2mm depth 
(Figure 3.5C). Given that fibroblasts are generally 10-15µm in diameter, it is 
possible that seeding cells within these chambers significantly affected or 
even obstructed flow within the system, with the resulting sheer stress 
Figure 3.5 
Depth of chamber influences cell tolerance of perfusion 
A Schematic diagram of the ibidi chamber system .B Image of an ibidi µ-
slide (image: ibidi). C Bioluminescence from Bmal1:LUC 3T3 cells seeded in 
ibidi µ-slide I luer channels of 0.2 and 0.4 mm depth (n=3, representative). 
Media contained 1g/L glucose, 2% serum and 2% B27. Flow rate was 
50µl/hr 
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contributing to greater cell death. As such, chambers with a depth of 0.6mm 
were chosen as being optimal for this system. 
 
3.1.7 Introduction of a gas permeable bubble trap 
The use of the µ-slide chambers greatly reduced variability in the 
bioluminescent signal between different chambers within the same 
Figure 3.6 
Unequilibrated media and bubbles affects reporter expression 
A,B,C Bioluminescence from Bmal1:LUC 3T3 cells grown in ibidi  µ-slide I 
0.6 luer channels. Cells were perfused with media containing 1g/L glucose, 
2% serum and 2% B27 at 100µl/hr (n=9, all replicates shown). D Image 
showing uneven bioluminescence along the length of an ibidi slide. 
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experiment (Figure 3.6A). However, a number of experiments showed acute 
changes in reporter gene expression. Often, these changes were not 
comparable between different chambers (Figure 3.6B,C). Unlike the earlier 
flow rate variability, which was solved through greater lubrication of the 
syringe pump drive-screw, these changes were suggestive of variations in 
flow that were specific to each chamber, possibly as a result of individual 
variations in the chambers or tubing. Close observation of the raw data 
images of these experiments showed that those chambers that showed acute 
changes in reporter expression often did so after a bubble of air passed 
through the chamber. It was also observed that there was some variability in 
the brightness of cells along the length of the cell culture chamber (Figure 
3.6D). As the media within the system has not been previously oxygenated at 
the same temperature and partial pressures as the incubator in which the 
cells are contained, it was hypothesised that this difference in brightness 
might be the result of varying partial pressures of oxygen along the length of 
the gas-permeable chamber. In order to try to both prevent bubbles from 
reaching the cell culture chamber and to equilibrate the perfusion media with 
the temperature and pressures inside the experimental incubator before 
passing across the cells, a new setup was devised which ran two ibidi µ-slide 
in series (Figure 3.7A), the idea being that the first slide acts as a gas-
permeable bubble trap, to equilibrate media to atmospheric gas 
concentrations and to prevent bubbles from entering the rest of the perfusion 
system. Although for most experiments this first chamber does not contain 
any cells, seeding cells in both chambers and measuring the bioluminescence 
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produced provides a visual indication of how well this buffering slide works, 
with cells is the second slide (slide 2) showing dramatically less acute 
variation in bioluminescence than those cells  in slide 1 (Figure 3.7B). 
 
3.1.8 Cell type-specific tolerance of perfusion 
All initial perfusion experiments were performed using either U2OS or later, 
NIH 3T3 cell lines, stably transfected with firefly luciferase under the control of 
either the Bmal1 or Per2 promoter. These lines were selected for the clear 
circadian rhythmicity they display in expression of these reporters and also for 
their ability to contact-inhibit, allowing them to remain confluent in culture for 
the long periods of time required for circadian assays. It is important to 
remember that the reporters used here are reporters of the transcriptional 
activity of these genes and are not necessarily reflective of the relative 
abundance of their associated proteins. 
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In contrast, using cells derived from the PER2::LUC mouse (Yoo et al. 2004), 
where luciferase is fused directly to the endogenous PER2 protein, it is 
possible to infer information about the translation and abundance of PER2 
protein from the bioluminescent signal given off by these cells. When 
immortalised fibroblasts derived from the PER2::LUC mouse were cultured 
under perfusion at a flow rate of 50 µl/hr in the perfusion setup outlined in 
Figure 3.7A, the oscillations in bioluminescence had an appreciably larger 
relative amplitude and showed substantially less noise than in the two 
transcriptional reporter lines (Figure 3.8A, B). 
Figure 3.7 
Buffer devices can eliminate variable flow rate 
A Diagram of the perfusion system with ibidi µ-slides connected in series. 
The first of these slides acts as a buffer slide. B Bioluminescence from 
Bmal1:LUC 3T3 cells in ibidi µ-slide I 0.6 luer channels connected in 
series, as in A. Slide 1 indicates the slide nearest to the syringe (n=4, 
representative). 
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There are two potential reasons as to why observation of rhythmicity under 
perfusion is appreciably clearer when using cells expressing PER2::LUC. The 
first is simply that untransformed fibroblasts are more amenable to healthy 
culture under perfusion, possibly because this more closely reflects 
environment in vivo. In contrast, U2OS and 3T3 cells are transformed lines, 
which have been grown using traditional cell culture methods for over 100 
passages, which may well have been inadvertently selected for survival under 
static conditions over perfusion. 
Figure 3.8 
Final perfusion setup 
A Bioluminescence from immortalised PER2::LUC fibroblasts perfused with 
media containing 1g/L glucose. 2% serum and 2% B27 at 50 µl/hr (n=3, all 
replicates shown). Period=24.9±0.8. B Series of images of cells under 
perfusion from A taken over 50 hours showing clear variation in 
bioluminescence. 
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Alternatively, it is possible that the nature of the circadian reporter is important 
in explaining the difference in bioluminescent oscillations observed between 
the PER2::LUC fibroblasts and the U2OS and 3T3 lines. Anecdotally, it has 
been noted that smaller changes in the external environment are required 
perturb reporter expression in cells expressing the transcriptional reporters 
than in the translational reporter PER2::LUC line. Circadian gene expression 
is regulated post-transcriptionally by a number of mechanisms (Kojima et al. 
2011; Chen et al. 2013), so it may be the case that these extra mechanisms 
of regulation, not all of which will be capable of regulating expression of the 
transcriptional reporters but will regulate PER2::LUC, provide increased 
robustness against acute, non-circadian changes in transcription of these 
circadian genes. Given that small acute changes in the cellular environment 
are clearly possible within a perfused cell culture system, it might be that 
translational reporters are better suited to accurately reporting cellular 
circadian state under such conditions. 
 
3.1.9 Optimised perfusion conditions 
As a result of all of the iterative optimisation steps described above in detail, 
the final setup for perfused circadian cell culture, and the system used for all 
further experiments in this chapter, is: 
 
Cell culture media 
Stock: 
- DMEM (5030) 
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- 1 g/L glucose 
- 3.7 g/L sodium bicarbonate 
- Penicillin/streptomycin (25 mg/L each) 
 
Working solution (Perfusion Air Medium, PAM): 
- 2 % serum (HyClone™ FetalClone™ III) 
- 2 % B-27® supplement 
- 1 % Glutamax 
- 1 mM Luciferin 
 
Maintained in an incubator at 37°C with atmospheric oxygen and 5% CO2. 
 
Depending on experimental requirements, it is also possible to use HEPES-
buffered stock media. In this case, DMEM is supplemented with only 0.35g/L 
and with an additional 0.01M HEPES. The incubator used in these conditions 
must be set to atmospheric CO2 levels. 
 
Perfusion system 
Pump:  NE-1600 syringe pump 
Tubing:  1 mm I.D. ETFE tubing. Connection to luer fittings with 1 mm I.D 
silicone tubing 
Connectors: All connections were made with luer fittings 
Chambers: Ibidi µ-slide I, 0.6 
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Flow rate was 50 µl/hr. 
 
Experiments were run using immortalised PER2::LUC lung fibroblasts in a 
specially adapted ALLIGATOR, and imaged using an EMCCD camera. 
 
Technical protocol 
Cells are grown to confluence in ibidi µ-slides and synchronised using 
temperature cycles. Prior to experimentation, all tubing and buffer slides are 
flushed with 70% ethanol, sterile water and phosphate buffered saline (PBS) 
and connected up in the experimental configuration. The µ-slides containing 
cells are then changed in to the experimental media and the tubing flushed 
through with the same media. The µ-slides containing cells are then 
connected up with all tubing and the buffer slides and the whole system is 
flushed with approximately 1 ml of media. The entire system is then 
transferred to the experimental incubator or ALLIGATOR and the syringe fixed 
within the syringe pump. The entire system is flushed again with a further 1-
2ml of media, ensuring no bubbles remain within the tubing or slides, before 
the flow rate is set at 50µl/hr and recording initiated. 
 
3.1.10 Comparison of perfused and traditional cell culture methods 
As with the development of any new technique, it is of interest to consider 
how results achieved under perfusion compare against equivalent 
experimental conditions under static cell culture. Figure 3.9A compares the 
effect of culturing cells in pyruvate rather than glucose (replicated from Figure 
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4.6) in either static culture or under perfusion. It is clear that the rapid damping 
of PER2 expression observed in the static pyruvate condition is not replicated 
in cells treated with pyruvate under perfusion. Furthermore, analysis of the 
circadian period of cells under these conditions shows that the ~2 hr increase 
in period observed in the static pyruvate condition is not replicated in the 
perfused pyruvate condition, which does not exhibit a period that is 
significantly different from either of the glucose-treated conditions. It is of note 
here that the cells under perfused conditions are exposed to a lower absolute 
concentration of pyruvate than those in static conditions, with the 
concentration of pyruvate used being equivalent to the amount of glucose 
used in both conditions. However, it is not possible to discount the possibility 
that the differing effects observed between the two set-ups is the result of the 
difference in concentration, rather than the effect of perfusion itself. 
 
Similarly, PF670462 is a well-characterised inhibitor of casein kinase 1 (CK1) 
and is widely documented to greatly increase the period of the circadian 
oscillation (Meng et al. 2010). In cells maintained in static culture, 3µM 
PF670462 increases circadian period to over 60 hours. However, when the 
same concentration of inhibitor is applied to cells under perfusion, the 
increase in period is significantly reduced to slightly less than 29 hours (Figure 
3.10A,B). Interestingly, this is much closer to the behavioural period observed 
in when animals are treated with PF670462 in vivo (Meng et al. 2010). 
 








Perfusion with pyruvate 
A Bioluminescence from PER2::LUC fibroblasts under perfusion and in 
static conditions with either glucose or an equivalent concentration of 
pyruvate (n=3, mean±SEM). B Analysis of period following fitting to a 
damped cosine wave (extra-sum-of-squares F test vs a straight line 
p<0.0001,Two-way ANOVA, Tukey’s multiple comparisons test). 
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3.1.11 Modification of the perfusion system 
A basic setup for perfused circadian tissue culture has been described above, 
but the system possesses a huge amount of flexibility, with potential for many 
modifications. For example, it is possible to collect the media outflow from the 
system for further analysis – as in Figure 4.13, either manually or through use 
of a fraction collector. Alternatively, as shown in Figure 5.5, it is possible to 
deliver timed boli of treatments to cells under perfusion without disrupting the 
rate of flow. This allows for observation of the effect of acute perturbations 
without the confounding effects of serum shock that occur when media is 
changed in cells in static culture (Balsalobre et al. 1998). This is achieved 
using a system of luer valves in the tubing prior to the first buffer slide (Figure 
3.11A). 
Figure 3.10 
Perfusion with ck1δ inhibitors 
A Bioluminescence from PER2::LUC fibroblasts under perfusion and in 
static conditions with 3µM CK1 inhibitor PF670462 (n=3, mean±SEM).  
B Analysis of period difference between perfused and static conditions with 
and without CK1 inhibition (extra-sum-of-squares F test vs a straight line 
p<0.0001, Two-way ANOVA, Holm-Sidak’s multiple comparisons test). 




In this chapter, I have described the development and utility of a system for 
perfused cell culture that functions over durations sufficient for circadian 
measurements. This provides a unique ability to measure multiple parameters 












3.2.1 Comparison of perfused and static systems 
When comparing data obtained from cells under traditional static conditions to 
those obtained from identically treated cells under perfusion (Figure 3.9, 3.10), 
it is striking that clear differences are observed, particularly with regard to the 
effect of pharmacological manipulations. The exact biological reason for this 
difference is unclear. On the one hand, it is possible that the smaller volume 
of the perfusion chambers – 150µl compared with 1ml under static conditions 
Figure 3.11 
Application of timed boli 
A Schematic diagram of a luer valve 
system for applying a single boli of 
defined length. The length of tubing 
flanked by the two valves is filled with 
media containing the drug of interest 
and bubbles excluded. The valves are 
then closed and the rest of the system 
filled and perfusion begun as in the 
basic protocol. When application of boli 
is required, luer valves are turned to 
divert flow only through the drug-
containing loop. 
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– which results in a lower ratio of drug per cell in this condition, might lead to 
differing pharmacokinetics and so a different response between these two 
conditions. Such a small volume:cell ratio cannot be readily tested in static 
experiments, due to the metabolism of and excretion into the extracellular 
media and the associated change in media composition. Alternatively, it is 
possible that higher concentration of bicarbonate per cell in the perfused 
condition may affect drug transport in to the cell, which may also influence the 
pharmacokinetics of any manipulation. Further experiments will be required, 
however in order to determine the exact factors that give rise to the 
differences observed between static and perfused cell culture. 
 
3.2.2 Further optimisation 
Although entirely functional, countless modifications of the perfused system 
are possible, allowing for the effects of complex manipulations to be studied. It 
would be possible, for example, to perfuse with multiple media types, or to 
apply pharmacological agents acutely through injection port. 
 
For certain applications, it may also be useful to manufacture specific 
components for the system. In particular, it would be of interest to see if 
meaningful modifications or improvements could be made on the ibidi µ-slide 
chamber, possibly using PDMS (Halldorsson et al. 2015; Shrirao et al. 2012). 
Previous work has placed a variety of biosensors in to these chambers (Luka 
et al. 2015). Given the circadian oscillations observed in cellular oxygen and 
glucose consumption in the next chapter, it might well be useful to be capable 
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of measuring these parameters in cells under perfusion in order to provide an 
alternative readout for cellular circadian state. 
 
One continuing issue with the system is the relatively low throughput, making 
assays using this system slow when compared to traditional cell culture 
methods. To increase throughput, it would be desirable to have multiple 
independent cell chambers being fed media by the same syringe. However, 
problems can arise when it comes to splitting a single flow of media into 
multiple equal streams. This could potentially be overcome by manufacturing 
a slide where splitting of fluid streams occurs within the slide, rather than prior 
to the slide. This modification would also have the benefit of making the 
system much quicker to use, as the most time-consuming part of setting up 
this system is the sterilisation of the tubing. 
 
3.2.3 Summary 
In this chapter, I have described the development and optimisation of a 
system for perfusion circadian cell culture. This system allows for 
bioluminescent recording of mammalian cells over at least two weeks under 
conditions where cells display clear circadian rhythms in clock gene 
expression. It is also possible to vary the media applied to cells and to apply 
acute boli without the disruptive effects of media change. Furthermore, this 
system allows for collection and analysis of the extracellular media outflow 
form the cells, making the system suitable for a number of metabolomic 
assays. 
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Chapter 4: Cellular Metabolism as a Circadian Regulator 
4.0.1 Current understanding  
Circadian rhythms are a cellular phenomenon found across phylogenetic 
kingdoms. The model for how cells maintain a daily cycle is commonly 
proposed to consist of a transcription-translation feedback loop (TTFL). In its 
simplest form, this model proposes transcription and translation of a certain 
gene (or genes), with the resulting protein then translocating to the nucleus to 
inhibit its own transcription. Over time, the protein is degraded, releasing 
repression at the gene’s own promotor, thereby allowing it to be transcribed 
again and the cycle to restart - the assumption being that this cycle takes 
approximately 24 hours, although how this critical time-delay is achieved is 
currently not fully elucidated (Johnson 2010). The resulting cycles in core 
clock gene expression are thought to drive further cycles in the expression of 
a number of so-called “clock-controlled” genes. It is the cycling of these genes 
that is proposed to bring about the vast majority of circadian rhythms in 
cellular processes. One of these processes, as described at length in the 
introduction to this thesis, is cellular metabolism, which has been shown to be 
rhythmic at a number of points, including glucose uptake (Feneberg & 
Lemmer 2004) and oxidative phosphorylation (Peek et al. 2013). 
 
Although the model of TTFL negative feedback remains consistent across all 
organisms known to exhibit circadian rhythms, the specific genes and proteins 
that make up this cycle show very little homology between kingdoms. This has 
been taken by some as evidence of convergent evolution of circadian 
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rhythmicity (Rosbash 2009), arguing that the ability to predict external daily 
events confers such an evolutionary advantage that it is extremely likely to be 
favoured when it arises. 
 
At odds with this hypothesis, an increasing body of work has shown that it is 
possible to observe circadian rhythmicity even in the absence of nascent 
transcription, which is required for the canonical TTFL model (O’Neill et al. 
2011; O’Neill & Reddy 2011; Cho et al. 2014). In particular, a number of redox 
and metabolic pathways continue to exhibit rhythms under these conditions. 
The most well-known marker of these post-transcriptional oscillations is 
probably the oxidation state of peroxiredoxin (PRX-SO2/3), although rhythms in 
redox co-factors, such as NADPH, have also been reported. These rhythms 
have been observed across phylogenetic kingdoms, despite the lack of 
homology between their canonical TTFL mechanisms (Edgar et al. 2012). 
This and related observations have fuelled the prior speculation about the 
existence and nature of an underlying post-transcriptional circadian oscillator 
that is present in all organisms that display circadian rhythmicity and that was 
present in the last eukaryotic common ancestor (LECA) (Putker & O’Neill 
2016), analogous to the KaiABC oscillator in cyanobacteria. Such an oscillator 
would potentially be capable of providing answers to problems with the 
current TTFL model, including the mechanistic explanation for the 24-hour 
period (Lakin-Thomas 2000). That cellular redox metabolism might be 
implicated in this seems increasingly probable when one considers that a 
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number of the core clock genes have ben proposed to be redox sensitive 
(Yoshii et al. 2014; Schmalen et al. 2014; Rutter et al. 2001). 
 
4.0.2 Challenges 
Within cells, the primary determinant of redox state is the relative quantities of 
oxidising reactive oxygen species (ROS) and reducing equivalents NADH and 
NADPH. Both of these are produced and utilised during processes of primary 
cellular metabolism (Ying 2008; Andreyev et al. 2005). As such, many have 
speculated that any kind of core conserved circadian oscillator that influences 
cellular redox state might be 
intimately linked with cellular 
metabolism. This is supported by 
the observation that a number of 
metabolic processes are known to 
be rhythmic in at least some 
organisms (Figure 4.1A). To date, 
work has focussed on steady-state 
levels of redox co-factors when 
attempting to determine the 
metabolic or redox state of the cell. 
However, it is the rate of flux 
through the relevant pathways that 
would have to vary for a cellular 
Figure 4.1 
Schematic of primary metabolism 
A Schematic overview of primary 
metabolism. Processes previously 
described to be under circadian control, 
and those about which rhythmicity is 
unknown, are indicated as ‘?’ 
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rhythm in NADH, NADPH or ROS to arise. Therefore, new approaches are 




Given the previously described debate concerning the presence and nature of 
a post-transcriptional circadian oscillator, three possible hypotheses for the 
nature of the relationship between cellular redox/metabolism and cellular 
timekeeping exist. Firstly, it is possible that there is rhythmic flux through 
cellular metabolism in such a way that there is rhythmic variation in production 
of NAD(P)H and/or ROS and this is required for cellular rhythms in clock 
proteins to persist (this should also persist in the absence of a functioning 
TTFL). Importantly, this should be capable of determining periodicity. 
Alternatively, it may be the case that there is rhythmic flux through 
metabolism, but this is a post-translational clock output and has no bearing on 
maintenance of a cellular circadian rhythm. Thirdly, there may be rhythmic flux 
through metabolism, which is both a clock output and input, but is not 
essential for rhythms to persist. 
 
The aim of this project was to determine which of these hypotheses might 
account for the previously observed oscillation in cellular redox state and so 
determine whether such a circadian variation in flux might make up a more 
evolutionarily conserved circadian oscillator. 
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4.1 Results 
4.1.1 Metabolic pathways are rhythmic in their function 
A well known marker of circadian rhythms in cellular redox state is the over- 
and hyperoxidation of peroxiredoxins, a highly abundant family of antioxidant 
proteins (Edgar et al. 2012). However, it important to note that oxidation of 
PRX proteins of itself is not essential for observation of cellular rhythmicity, 
since when the oxidation of PRX is inhibited in fibroblasts through use of 
conoidin A, a potent inhibitor of mammalian PRXs (Liu et al. 2010), 
PER2::LUC rhythmicity  continues to be observed (Figure 4.2A,B). As such, it 
is important to note that PRX oxidation is merely a post-transcriptional marker 
for timekeeping and is unlikely to be involved cellular timekeeping mechanism 
itself. Instead, as PRX state oxidation is an indicator of cellular redox state, 
Figure 4.2 
PRX2 inhibition does not affect cellular rhythmicity 
A Fibroblasts in the presence of PRX inhibitor conoidin A (n=16, 
mean±SEM). B 24 hour moving average detrended data from A more clearly 
shows that there is no loss of PER2::LUC rhythmicity in the presence of 
conoidin A. 
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we postulate that oscillations in the abundance of PRX- SO2/3 are associated 
with an underlying rhythmic regulation of cytosolic redox balance.  
 
It has been previously observed that a number of metabolic pathways display 
a circadian variation in their function (Peek et al. 2013; Altman et al. 2015; 
Feneberg & Lemmer 2004). In order to test whether our PER2::LUC 
fibroblasts also showed cell-autonomous circadian rhythms in metabolism, 
both maximal and basal respiration and maximal and maximal glycolytic 
capacity was determined across the circadian cycle though use of a Seahorse 
respirometer (Figure 4.3). Maximal respiratory capacity was determined 
following treatment with mitochondrial uncoupler FCCP, whilst maximal 
glycolytic capacity was measured following treatment with ATP synthase 
inhibitor oligomycin. Respiratory measurements were determined by 
measuring the oxygen consumption rate of the cells (OCR), whilst glycolytic 
capacity is determined using the extracellular acidification rate (ECAR), with 
the rate of non-glycolytic acidification (determined following glucose 
starvation) subtracted. From this we see that all four of these parameters 
show variation across a circadian cycle, peaking at a comparable phase to the 
peak in PER2 expression recorded from control cultures. 
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4.1.2 Glucose metabolism pathways are required for cellular rhythmicity 
Having confirmed that cellular metabolism varies across the circadian cycle in 
our chosen cell line, the next question is whether flux through primary 
carbohydrate metabolism is required for cellular rhythmicity to be observed. It 
was noted that cells cultured in varying concentrations of glucose, including in 
Figure 4.3 
Circadian variation in primary metabolism 
A Measurement of primary metabolism shows significant variation in basal 
glycolysis, maximal glycolytic capacity, basal respiration and maximal 
respiratory capacity across the circadian cycle (n=16, mean±SEM, Tukey’s 
multiple comparisons test). Glycolytic capacity is determined using 
extracellular acidification rate (ECAR) following the addition of oligomycin, 
whilst basal and maximal respiration are determined using the oxygen 
consumption rate (OCR) in the absence of pharmacological agents and in 
the presence of FCCP respectively. PER2::LUC (n=4, mean±SEM) is 
shown to indicate related circadian phase. 
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the absence of extracellular glucose, still exhibited robust circadian rhythms 
(Figure 4.4A), with minimal changes in period, although an amplitude 
 decrease was observed in cells cultured in 30mM glucose compared 
to those culture in 10mM or lower (Figure 4.4B); this observation is 
somewhat surprising when one considers that the concentration of 
glucose in the DMEM formulation most commonly used for cell culture 
is 27.8mM. Similarly, cells cultured in the absence of extracellular glucose 
Figure 4.4 
Glucose starvation does not abolish PER2::LUC rhythms 
A Varying extracellular glucose concentration incrementally from 30mM to 
0mM has no major effect on cellular period although B there is a slight 
increase in amplitude observed when glucose concentration is lowered (n=4, 
mean±SEM). C Substitution of glucose in cellular media with fructose has no 
effect on PER2::LUC rhythmicity (n=4, mean±SEM). D Quantification of 
period from C (Welch’s t-test). 
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but in the presence of an equivalent concentration of fructose showed no 
significant difference in circadian gene expression compared to controls 
(Figure 4.4C,D). These data indicate that extracellular glucose concentration 












Inhibition of early primary carbohydrate metabolism supresses 
PER2::LUC expression 
A,B(inset) Inhibition of both glycolysis and the pentose phosphate pathway with 
2-deoxyglucose (2DG) results in loss observable rhythms in PER2::LUC (n=4, 
mean±SEM, comparison of fits prefers a first order polynomial, p<0.0001). 2DG 
is applied in ratio with glucose, such that the total molarity of the two combined 
is always 30mM. C 2DG applied in this manner is sufficient to significantly 
reduce glycolytic flux after 24 hours, as measured by ECAR (n=10, mean±SEM, 
Holm-Sidak’s multiple comparisons test). D 2DG applied in a 20:10 ratio also 
increases the NADP+:NADPH ratio within cells, creating a significantly more 
oxidized intracellular environment (n=4, mean±SEM, Dunnett’s multiple 
comparisons test). E Application of 2DG does not reduce SV40:LUC signal 
(n≥4, mean±SEM). 
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In contrast when, rather than being starved of glucose, cells were cultured in 
the presence of the anti-metabolite 2-deoxyglucose (2DG), a profound 
suppression of PER2::LUC rhythmicity was observed, which was reversed 
following media change in to 2DG-free media, suggesting that this effect was 
not merely a result of cell death (Figure 4.5A,B). Here, 2DG was applied in 
ratio with glucose, such that the final concentration of the two combined was 
always 30mM. Upon transport into the cell via glucose transporters 2DG, like 
glucose, is phosphorylated by hexokinase (see Figure 3.11 for schematic) to 
form 2DG-6-P. However, this cannot be further metabolised through either 
glycolysis or the pentose phosphate pathway, but instead dose-dependently 
inhibits both pathways (Barban & Schulze 1961). The effect of 2DG on 
glycolysis was further confirmed by ECAR (Figure 4.5C), whilst 
NADP+:NADPH assays showed 2DG to increase this ratio, suggesting a more 
oxidised intracellular environment in the presence of this drug (Figure 4.5D). 
Furthermore, this effect appears to have some specificity for PER2, as 
application of 2DG to cells constitutively expressing luciferase under the SV40 
promoter did not show any loss of bioluminescent signal (Figure 4.5E, this 
control experiment was done with the assistance of Kevin Feeney). This also 
confirms that ATP levels, which are required for the activity of luciferase, were 
not greatly reduced by 2DG treatment. From these observations, we can 
conclude that 2DG acts to supress PER2::LUC expression not through 
glucose starvation or ATP depletion but through some alternative mechanism. 
 
 













That the effect of glycolytic and PPP inhibition on cellular rhythmicity is so 
different from the effect of glucose starvation may initially appear counter 
intuitive. However, as fibroblasts are capable of gluconeogenesis (Sumbilla et 
al. 1983), autophagy and β-oxidation, it is likely that cells experiencing 
glucose starvation are still experience some glycolytic and PPP flux. 
Figure 4.6 
Inhibition of glycolysis alone does not abolish PER2::LUC rhythmicity 
A 10µM GADPH inhibitor koningic acid (KA) greatly reduces glycolysis 
rate, as measured by ECAR (n≥5, mean±SEM, Holm-Sidak’s multiple 
comparisons test). B Application of KA has minimal effects on PER2::LUC 
rhythmicity (n=4, mean±SEM) whilst C producing a small decrease in 
period (Dunnett’s multiple comparisons test) and D a small and 
inconsistant effect on the amplitude of the PER2::LUC oscillation 
(Dunnett’s multiple comparisons test). 
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Meanwhile, 2DG inhibition prevents flux through both glycolysis and the PPP, 
thereby having a much more profound effect on cellular metabolism and 
NADPH production and thus producing the observed effects of cellular 
timekeeping. 
 
4.1.3 Neither glycolysis or the TCA cycle are essential for circadian 
rhythmicity 
As 2DG inhibits the very initial stages of primary carbohydrate metabolism, it 
is unclear through use of this drug alone as to which aspect of carbohydrate 
metabolism is required for observation of PER2::LUC rhythmicity. In order to 
determine which aspect is responsible for this change in PER2 expression, 
pharmacological inhibitors of each pathway were applied and the effects on 
PER2::LUC expression recorded. Despite having clear effects on basal 
glycolysis (Figure 4.6A), GADPH inhibitor koninigic acid had only minimal 
effects on PER2::LUC expression (Figure 4.6B), showing a decrease in period 
under 1 hour (Figure 4.6C), which does not increase when KA is applied at 
higher concentrations (data not shown) and a variable effect on amplitude 
(Figure 4.6D).  
Pyruvate analogue 3-bromopyruvate (3-Br-Pyr), which acts as an inhibitor of 
entry in to the TCA cycle, whilst significantly reducing cellular respiratory 
capacity (Figure 4.7A) has no apparent effect on PER2::LUC rhythms (Figure 
4.7B). Similarly, mouse embryonic kidney cells that lack fumarate hydratase 
(FH1-/-) and therefore lack a competent TCA cycle (Frezza et al. 2011), still 
exhibit rhythms in the transcriptional circadian reporter Bmal1:LUC (Figure 
Cellular metabolism as a circadian regulator 
 110 
 Figure 4.7 
TCA cycle inhibition does not mimic the effect of 2-DG 
A Pyruvate analogue 3-bromopyruvate (3-Br-Pyr) reduces respiratory 
capacity at both basal and maximal levels, determined prior to drug 
addition and following FCCP respectively (n≥5, mean±SEM). B 3-Br-Pyr 
has minimal effects on the cellular oscillation as reported by PER2::LUC. 
Arrow indicates drug wash-off (n=4, mean±SEM). C Mouse kidney cells 
that lack the enzyme fumarate hydratase (FH) and so a functional TCA 
cycle still show rhythms in Bmal1:LUC bioluminescence (n=3, mean±SEM). 
       Continued on next page  
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 4.7C). These rhythms are comparable to cells in which FH1 has been 
genetically rescued (pFH). It is also noted that cells lacking FH1 show a 
reduction in cellular period of slightly over 1 hour (Figure 4.7D). 
In contrast, cells cultured in the absence of extracellular glucose and instead 
with an equivalent concentration of pyruvate showed a marked increase in 
period, accompanied by a decrease in the amplitude of PER2::LUC 
expression, although this was not as marked as the effects seen with 2DG 
(Figure 4.7E,F). The discrepancy between these observations we feel can be 
explained in light of further findings described below. 
 
From these data, it is possible to conclude that, although both glycolysis and 
the TCA cycle are competent to contribute to cellular timekeeping, they are 
not essential for the observation of cellular rhythmicity. Certainly, none of the 
manipulations described above in anyway recapitulate the suppression of 
circadian gene expression observed with 2DG treatment.  
 
4.1.4 PPP inhibition recapitulates the effects of 2DG 
As neither perturbation of glycolysis or the TCA cycle were capable of 
recapitulating the effects of 2DG, the effects of pentose phosphate pathway 
(PPP) inhibition alone was investigated. The pentose phosphate pathway runs 
parallel to glycolysis, taking glucose-6-phosphate and converting it to  
D These cells do show a small decrease in period (1.07hrs±0.2, Welch’s t-
test).  E,F Replacing glucose in the extracellular media with an equivalent 
concentration of pyruvate significantly lengthens period in PER2::LUC 
fibroblasts (n=3, mean±SEM, Welch’s t-test). Period change is 1.9hrs±0.2. 
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pentoses, including ribose-5-phosphate, in what is known as the oxidative 
stage (see Figure 4.11 for schematic). This step also generates 2 NADPH 
molecules per glucose-6-phosphate molecule. Those pentose sugars may be 
utilised for nucleotide synthesis, but otherwise are subjected to a number of 
rearrangements during the non-oxidative phase of the pentose phosphate 
pathway, and are ultimately returned to the glycolytic pathway as either 
fructose-6-phosphate or as glyceraldehyde-3-phosphate. Both flavoprotein 
inhibitor Diphenyleneiodonium (DPI) and steroid and non-competitive glucose-
6-phosphate dehydrogenase inhibitor Dehydroepiandrosterone (DHEA) act as 
inhibitors of the oxidative stage of the PPP (Riganti et al. 2004; Drummond et 
al. 2011),whilst producing no significant reduction in glycolytic function (Figure 
4.8E). When applied to PER2::LUC fibroblasts, both drugs produced a rapid 
dampening of PER2::LUC expression which was rescued with successive 
wash-off (Figure 4.8A,B,C,D). This is reminiscent of the effects seen on PER2 
in the presence of 2DG. It is also noteworthy here that although both drugs act 
to rapidly decrease the amplitude of the PER2::LUC oscillation, the period of 
Figure 4.8 
Inhibition of the oxidative PPP phenocopies the effect of 2DG 
A,B Application of PPP inhibitor DPI attenuates PER2::LUC rhythmicity, as 
does C,D DHEA (n=4±SEM). E Neither of these drugs significantly reduce 
glycolytic flux as m easured by ECAR; indeed DHEA causes a significant 
increase in ECAR (n=4±SEM, Dunnett’s multiple comparisons test). F,G 
Neither DPI nor DHEA have significant effects on period, measured as the 
time between peaks (Welch’s t-test). H Transketolase inhibitor oxythiamine 
has a small effect on period, (0.56hrs±0.0, n=4, mean±SEM) and G 
produces a small suppression of PER2::LUC amplitude (Dunnett’s multiple 
comparisons test). Oxythiamine treatment was performed by Kevin Feeney. 
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the oscillation is not significantly affected (Figure 4.8E,F), although we did 
note a phase shift following application of DHEA . 
 
In contrast, when the non-oxidative portion of the PPP was inhibited, in this 
case with oxythiamine, a competitive inhibitor of transketolase (Boros et al. 
1998), no large suppression of PER2 expression is observed (Figure 4.8G, 
this experiment was performed by Kevin Feeney). There is a small dose-
dependent decrease in the amplitude of PER2 expression (Figure 4.8H). A 
small period increase was also observed with oxythiamine, but as this was at 
most approximately 30 minutes, it was not considered biologically relevent. 
 
This suggests that PER2::LUC expression is particularly sensitive to inhibition 
of the oxidative PPP over the non-oxidative PPP, glycolysis and the TCA. 
Since application of oxidative PPP inhibitors results in a particularly large 
decrease in the NAD+:NADH ratio (Figure 4.13D), is plausible that the effect of  
both DPI and DHEA on cellular rhythmicity is the result of major changes in 
the cellular redox state following from greatly reduced PPP flux (Figure 
4.13B).  
 
4.1.5 Genetic knockdown and over-expression of PPP enzymes 
In order to confirm the observations made following pharmacological 
perturbation, siRNA knockdown was performed in PER2::LUC fibroblasts 
against four major glycolytic and PPP enzymes, namely glucose 6-phosphate 
dehydrogenase (G6PDH) and phosphoglucose isomerase (GPI), the entry  
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points in to the PPP and glycolysis respectively, 6-phosphogluconate 
dehydrogenase (PGD), the second NADPH-producing enzyme in the PPP 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Figure 
4.9A,B,C,D). Although knockdown was approximately 50% for all enzymes, 
the only consistent effect observed was that knockdown of G6PDH produced 
a small but significant decrease in amplitude (Figure 4.9E). Knockdown of 
G6PDH and GAPDH also sometimes produced small decreases in period, but 
this effect was inconsistent between experiments and so is not quantified 
here.  
As metabolic enzymes are generally appreciably more abundant than cellular 
demand requires, it is possible that the comparatively small effects observed 
above stem from the fact that there is still a sufficient quantity of these above 
stem from the fact that there is still a sufficient quantity of these enzymes 
available for normal cell function. However, glucose 6-phosphate 
dehydrogenase is generally thought to be the rate-limiting enzyme in the PPP 
(Stanton 2012), which may explain why the only consistent effect is observed 
Figure 4.9 
siRNA knockdown of PPP enzymes 
A siRNA knockdown of glucose 6-phosphate dehydrogenase (G6PDH, 
48±11%), B phosphoglucose isomerase (PGI, 48±16%), C 6-
phosphogluconate dehydrogenase (PGD, 56±11%) or glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, 60±6%) D had small and variable 
effects on cellular period (n≥3, mean±SEM). Knockdown quantified by 
western blot (right panel, Welch’s t-test). E Although some small effects on 
amplitude were observed, these effects were inconsistent, with the exception 
of G6PDH knockdown, which produced a small but significant decrease in 
amplitude (Dunnett’s multiple comparisons test) 
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when this enzyme is targeted.  However, transient over-expression of 
bacterial isoforms of glucose 6-phosphate dehydrogenase (ZWF) and 6-
phosphogluconate dehydrogenase (GND) did not produce significant effects 
on the cellular oscillation (Figure 4.10A,B). This, combined with the minimal 
effects seen following enzymatic knockdown, suggest that these enzymes are 
able to support normal cellular function within a wide range of expression. 
This is further supported by the fact that humans that are genetically deficient 
in these enzymes display relatively few symptoms when not experiencing 
unusual oxidative stress, generally brought about by certain foods, drugs or 
infection (Beutler 2008). 
 
Figure 4.10 
Overexpression of bacterial PPP enzymes 
A Transient overexpression of ZWF, the bacterial isoform of glucose 6-
phosphate dehydrogenase and B GND, the bacterial isoform of 6-
phosphogluconate, shows inconsistent effects on PER2::LUC rhythms (n=4, 
mean±SEM). Overexpression was determined by western blot. 




Schematic describing metabolic labelling strategy 
A Schematic explaining the metabolism of 1,2,3-13C labelled glucose. See 
text for full explanation. 
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4.1.6 Metabolic labelling 
If the PPP is the source of the rhythm in cellular redox state, then it must 
follow that flux through the PPP is rhythmic. To test this hypothesis, a 
metabolic labelling approach in was used in continuously perfused cells.  
 
Classically, either singly or doubly 13C labelled glucose has been used to 
investigate flux through the PPP (Dusick et al. 2007; Brekke et al. 2012). 
Figure 4.12 
End products of labelled glucose metabolism 
A Catabolism of 1,2,3-13C labelled glucose results in different products 
depending on the pathways through which it has been metabolised. If 
glucose is only metabolised through glycolysis, the products are 3 fully 
labelled pyruvate molecules and 3 fully unlabelled pyruvate molecules for 
every 3 glucose molecules metabolised. 6 NADH molecules are also 
formed. B If instead, the glucose passes through the PPP before 
glycolysis, each three glucose molecules produces 2 fully labelled and 3 
fully unlabelled pyruvate molecules, in addition to 6 NADPH and 5 NADH 
molecules. 
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Glucose passing though the PPP loses its first carbon molecule as CO2 during 
the oxidative phase, following which, rearrangements in the non-oxidative 
PPP produce differently labelled metabolites to those from glucose that has 
passed solely through glycolysis, allowing for calculation of PPP flux. 
However, 13C may also be present at additional glucose carbons due to its 
natural abundance (~1 %) or due to impurities from the enrichment process. 
This has the potential to introduce error into calculations of the relative fluxes 
between glycolysis and the PPP using either the singly or doubly labelled 
method. To avoid this problem, 1,2,3-13C labelled glucose was utilized as a 
labelled substrate (Figure 4.10A). Metabolism of 1,2,3-13C glucose through 
either glycolysis or the PPP produces fully 13C labelled or completely 
unlabelled (12C) 3-carbon metabolites, which either serve as substrates for 
mitochondrial respiration or are exported into the cell culture media. 13C and 
12C lactate/pyruvate are produced in different ratios depending on which 
metabolic pathways they have passed through: flux through glycolysis 
produces a 1:1 ratio of 13C-labeled to 12C-unlabeled product, whilst flux 
through the PPP produces a ratio of 2:3 (Figure 4.12A). Assuming no 
preference for PPP or glycolytic products for further mitochondrial metabolism, 
analysis of the ratios of these two metabolites in the extracellular media 
allows for accurate determination of the relative metabolic fluxes between the 
two pathways. This method is not affected by 3-carbon metabolites produced 
by other pathways or as a result of impurities in the labelled glucose, as these 
will be singly or doubly labelled, allowing for more accurate determination of 
primary metabolic flux. 
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In order to validate this method, cells were treated with a number of known 
glycolytic and PPP inhibitors and the effects on the ratio of products in the 
extracellular media analysed by LC-MS (Figure 4.13 A,B). As predicted, those 
drugs that inhibited the PPP, thereby ensuring that flux passed entirely 
Figure 4.13 
Validation of labelling strategy 
A Inhibition of glycolysis and/or the PPP shifts the proportions of 13C 
labelled and unlabelled 3-carbon products produced by PER2::LUC 
fibroblasts (n=4). B This can also be represented as a ratio (n=4, 
mean±SEM, Holm-Sidak’s multiple comparisons test). C Analysis of lactate 
and pyruvate in these same samples shows that inhibition of glycolysis or 
the PPP also impacts upon total lactate and pyruvate production, a 
measure of glycolytic flux and D lactate:pyruvate ratio, which is a good 
proxy for NAD+:NADH ratio (Holm-Sidak’s multiple comparisons test). 
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through glycolysis alone, produced ratios of labelled to unlabelled products of 
close to 1. Following from this, inhibitors of glycolysis would be predicted to 
produce ratios of 0.6. However, the actual ratio in the presence of GAPDH 
inhibitor KA is lower than this. This can be accounted for if there is repeated 
cycling of products through the PPP – a likely occurrence in the event of 
GAPDH inhibition. 2DG also produced a ratio substantially below 0.6, 
suggesting that 2DG might preferentially inhibit glycolysis over the PPP. 
However, 2DG is clearly still a major inhibitor of both pathways, as the total 
flux through either pathway is very small, as evidenced by the total sum of 3-
carbon products produced in the presence of this drug (Figure 4.13C), 
suggesting that very little glucose catabolism of any kind occurs in the 
presence of 2DG. In contrast, inhibition of both the oxidative and non-
oxidative arms of the PPP significantly increased total glucose catabolism. 
 
Overall, we take these results as validation, both that this method of labelling 
is a reliable and sensitive way of determining relative glycolytic and PPP flux 
and also of the function of the inhibitors that we have previously used to 
investigate glycolysis and the PPP. 
 
4.1.7 Perfused cell culture 
When seeking to investigate longitudinal changes in metabolism, one is 
required to take samples at multiple time points. If one is using classic static 
tissue culture techniques for such an assay, two major issues arise. Firstly, 
extracting the extracellular media for mass spectrometry analysis (as 
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described in the labelling section above) is generally an end-point procedure. 
This means that it is not possible to repeatedly test the same population of 
cells. Instead, one has to have a large number of identically-treated dishes of 
cells running in parallel, a number of which can be sampled and then 
disposed of at each time point. Although extremely similar, there are some 
subtle variations between different dishes of otherwise identically treated 
cells, arising from a number of uncontrollable factors, such as dish 
microenvironment, heterogeneity in the cell population or stochastic variation 
in seeding density. This adds an extra degree of variability to data collected in 
this way, which can make it difficult to detect more subtle changes in 
metabolite levels with confidence. Previous attempts in our group to study 
PPP flux using static methods have found this to be the case. 
 
Secondly, when using labelled substrates to study primary metabolism, these 
substrates are generally pulsed in to the cellular media for a short period of 
time before those cells are sampled. This provides a snapshot of the 
metabolic activity of those cells in the few hours prior to sample collection. 
However, there is some evidence that glucose pulses are capable of resetting 
the circadian phase of cells in culture (Hirota et al. 2002). This makes a 
pulsed approach inappropriate for studying circadian changes in metabolism, 
as cells would not be in true free-run when sampled. 
 
The problems described above make traditional static tissue culture 
inappropriate for the study of metabolic flux longitudinally. In order to 
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overcome this, a novel system of continuously perfused tissue culture was 
used. The design and optimisation of this is fully described in chapter 3. 
Briefly, cells are grown in a microfluidics slide and modified cell culture media 
is then driven across the slide at a low rate by a syringe pump. Media that has 
passed across the cells can then be collected on ice and snap-frozen at 
regular intervals. Metabolites were extracted from these samples and 
analysed using mass spectrometry. This technique overcomes both of the 
problems described above: there is no variability between different dishes at 
different time points as sequential measurements are being taken from the 
same population of cells and there is also no need to acutely pulse the cells 
with labelled glucose, so there is no potential for circadian resetting. 
 
4.1.8 Rhythms in total glycolytic flux drive oscillations in cellular 
NAD(P)H 
Having validated the technique for metabolic labelling under constant 
perfusion, cells were entrained using temperature cycles and then allowed to 
free-run under perfused conditions with 5.5 mM 1,2,313C-labelled glucose. 
After an initial 17 hour period, where cells were left to equilibrate intracellular 
stores with extracellular labelled glucose, the perfusate was collected every 3 
hours for 3 days. Mass spectrometry analysis of this perfusate revealed 
significant variation in the total quantity of lactate and pyruvate produced by 
cells; this being a measure for total glycolytic flux (Figure 4.14A). The 
abundance of pyruvate and lactate peaked at a comparable time to 
PER2::LUC, which was simultaneously recorded. 
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In contrast, a significant circadian variation was not observed in ratio of 
labelled to unlabelled lactate and pyruvate produced by these same cells  
 
(Figure 4.13B). We also did not detect a rhythm in lactate:pyruvate ratio 
(Figure 4.13C), this ratio being a good report of the free NAD+:NADH ratio 
within cells (Christensen et al. 2014). From this, it is possible to conclude that 
any oscillation in these two measurements is below the detection threshold of 
this assay. As such, it is likely that previously observed rhythms in NADH and 
Figure 4.14 
Longitudinal measurement of 
glycolytic and PPP flux 
A Mass spectrometry on samples of 
extracellular media taken from 
PER2::LUC fibroblasts in perfused 
with 1,2,3-13C labelled glucose 
shows a significant variation 
(cosinor analysis, p<0.0001) in total 
pyruvate and lactate production 
across the circadian cycle, (n=4, 
mean±SEM). B Analysis of the ratio 
of 13C to 12C labelled pyruvate and 
lactate in these same samples does 
not show a significant variation in 
the relative ratios. C Analysis of the 
total lactate:pyruvate ratios of these 
samples also showed no clear 
circadian variation. PER2::LUC 
bioluminescence is reproduced in 
all graphs to aid interpretation.  
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NADPH are the result of changes in total flux through both glycolysis and the 
PPP, rather than regulated changes in the proportion of flux shared between 




In this chapter, I have investigated the relationship between primary 
carbohydrate metabolism and circadian gene expression in cultured cells. It 
has been demonstrated using a novel labelling technique that there is 
circadian variation in the total flux passing through glycolysis and the PPP, but 
no evidence was found for circadian variation in the proportion of flux shared 
between these two pathways. This suggests that any oscillation observed in 
cellular NAD(P)H levels is most likely the result of changes in total flux 
through glycolysis and the PPP combined. 
 
Furthermore, I have shown that although flux through total glycolysis is 
rhythmic, inhibition of either glycolysis or the TCA does not prevent 
observation of cellular rhythmicity. In contrast, pharmacological inhibition of 
the oxidative pentose phosphate pathway, a major source of cellular reducing 
equivalents, results in rapid loss of amplitude of circadian gene expression but 
with no major effect on the period of the oscillation was observed.  
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 Figure 4.15 
Redox balance regulates the amplitude of circadian rhythms in 
mouse fibroblasts. 
A. Effect of chronic glucose oxidase (GOX) and 2-mercaptoethanol (2ME) 
treatment on PER2::LUC rhythms, with treatment beginning at two opposite 
circadian phases (circadian time, CT0 or CT12) (representative 
mean±SEM (n=4)).  
Continued on next page 
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4.2.2 Redox state as a modulator of the cellular clock 
As one of the major effects of pharmacological PPP inhibition is a shift 
towards a more oxidised cellular redox state (Figure 4.12D), it is possible that 
the effects on circadian gene expression observed under these conditions is 
as a result of changes in cellular redox state. In line with this prediction, in 
collaborative work with Marrit Putker, the effect of application of either 
reducing reagent 2-mercaptoethanol (2ME) or glucose oxidase (GOX), an 
enzyme that catalyses glucose to D-glucono-1,5-lactone whilst continuously 
producing H2O2, was investigated (Figure 4.14). Here, the two perturbations 
were applied at a range of concentrations at two circadian phases. We 
observed that the application of 2ME reduced the amplitude of the PER2::LUC 
oscillations, whilst application of GOX produced an initial increase and then a 
subsequent reduction in in amplitude. Most importantly, as with PPP 
inhibition, only very minimal effects were observed on the period of the 
oscillation, with by far the greatest effect of redox perturbation being to reduce 
the amplitude of PER2 expression. The similarity in the effect of these two 
treatments suggests that redox perturbation is likely to be the cause of the 
loss in amplitude of PER2 expression observed during PPP inhibition. 
 
 
Small period effects were observed here, but they were highly variable and 
therefore not considered significant B Both BME and C GOX have effects 
on the amplitude PER2 expression, as measured at the first circadian 
peak. This experiment was performed by John O’Neill. 
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4.2.3 Redox oscillations do not constitute a conserved clock mechanism 
Wide-spread observation of circadian rhythms in the abundance of 
hyperoxidised peroxiredoxins has led to speculation about the presence of a 
universal “redox oscillator” within cells that might represent an evolutionarily 
conserved mechanism for circadian timekeeping (Rey & Reddy 2015; Reddy 
& Rey 2014; Bass & Takahashi 2011). As the primary, although admittedly not 
the sole, source of both reactive oxygen species (ROS) and cellular reducing 
equivalents is primary metabolism, the thinking has been that oscillations in 
metabolic function might be responsible for the circadian variation in redox. 
The data shown here demonstrates that flux through multiple branches of 
primary metabolism varies on a circadian basis and therefore could be 
capable of producing rhythms in both ROS and cellular reducing equivalents 
although, unlike previous studies in other cell types (O’Neill & Reddy 2011; 
Wang et al. 2012), this was not sufficiently high amplitude to be directly 
detected by the methods used here. Furthermore, we demonstrate that 
changes in cellular redox state, either through metabolic perturbation or direct 
manipulation is capable of influencing the amplitude of expression of cellular 
clock proteins. 
 
Both 2ME and GOX treatments and metabolic inhibition provide reducing and 
oxidative stresses far beyond the physiological range. Despite this, we were 
unable to observe any major effects of redox perturbation and metabolic 
inhibition on circadian period; in fact, the period of the oscillation was 
remarkably robust against large changes in both intracellular and extracellular 
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redox state. This, and the results of manipulation of primary metabolism, is 
difficult to reconcile with the hypothesis of a conserved cellular ‘redox 
oscillator’ capable of setting and maintaining cellular circadian period. In such 
a case, one would expect to observe much larger effects of metabolic or redox 
perturbation on cellular period. Instead, it appears that a certain redox range 
is permissive for the observation of cellular rhythms, and that cellular redox 
state is both rhythmically regulated and capable of modulating some aspects 
of cellular timekeeping, but that rhythmicity in cellular redox state is not 
essential for the timekeeping mechanism itself.  
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Chapter 5: Insulin regulates the circadian clock via PER2 
5.0.1 Introduction 
In mammals, time of feeding and light exposure are the two major factors that 
entrain the phase of the biological circadian clock to the 24 hour cycle of day 
and night (Damiola et al. 2000). In natural environments, this allows variations 
in food availability and day length to adjust the phase of an animal’s innate 
circadian rhythm in behaviour and physiology, so that it resonates with and 
anticipates daily environmental cycles.  
 
The mechanism by which humans, and other mammals, entrain to temporal 
lighting cues is well established: photic information is detected by 
photoreceptive cells in the retina, processed by associated retinal ganglion 
cells, and then relayed to the hypothalamic suprachiasmatic nucleus (SCN) – 
the mammalian master pacemaker (Berson et al. 2002; Jagannath et al. 
2013). The SCN integrates external photic timing cues into its molecular and 
electrophysiological rhythms, and subsequently synchronises cells across the 
rest of the brain and body via local synaptic and distal humoral 
communication (Buijs et al., 1999). 
 
Daily feeding cycles are also sufficient to entrain the phase of both cellular 
and behavioural circadian rhythms (Saini et al., 2013). This is not always 
immediately apparent when studying animal behaviour, both in the wild and in 
the laboratory, as animals generally feed during their most active phase, 
which is primarily determined by the light-dark cycle. It is only when animals 
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cease to be fed ad libitum, either as a result of natural shortage or 
experimental intervention that it is possible to dissociate entrainment to 
feeding from entrainment due to light. This is often referred to as a restricted 
feeding (RF) schedule, where food is only available within a certain time 
window. If this window is sufficiently out of phase with lighting cues, then 
animals can be seen to shift their behaviour over time such that their most 
active phase is in line with the time of food availability, even if this is out of 
phase with the normal phase of activity with respect to the light-dark cycle 
(Stokkan et al., 2001). This shift in behaviour is accompanied by a shift in the 
phase of expression of clock genes within the cells of a wide range of tissue 
(Saini et al., 2013). This effect is also observed in circadian mutants, which 
are capable of entraining to feeding cues even if incapable of maintaining a 
behavioural rhythm in constant conditions (Storch & Weitz 2009). 
 
In contrast to light entrainment, the underlying mechanism by which food 
entrainment occurs is not understood (Stephan 2002). It is certain that, unlike 
entrainment to daily light-dark cycles, entrainment to daily feed-fast cycles 
does not require SCN input, as food entrainment persists following SCN 
ablation (Marchant & Mistlberger 1997). Furthermore, the SCN itself, unlike 
the rest of the body, does not show clear changes in phase of clock gene 
expression in response to feeding cues (Damiola et al., 2000). There must 
therefore exist alternative, potent and SCN-independent pathways that 
facilitate entrainment of circadian phase of clock gene expression in 
peripheral tissues and cells to feeding time (Dattolo et al. 2016). 
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The nature of these SCN-independent pathways continues to be the subject 
of some dispute, particularly with regard to two main points. Firstly, the 
preferred hypothesis for many years has been that there must exist an 
anatomical locus at which time of feeding information is co-ordinated and 
relayed to the rest of the body. This would parallel our existing understanding 
of how the SCN co-ordinates light information. Appreciable effort has been 
expended by a number of groups in the search for just such a central locus, 
both within the brain and at other anatomical sites (Stephan, 2002, Gooley et 
al., 2006, LeSauter et al., 2009). However, to date, no such locus has been 
identified. 
 
The second major unresolved question with regards to food entrainment 
concerns the nature of the signal (or signals) that trigger entrainment to 
feeding cycles. Previous studies have suggested roles for metabolic signals 
such as post-prandial glucose surge (Stephan & Davidson 1998), as well as 
more complex hormonal signals, including insulin (Yamajuku et al. 2012; Sato 
et al. 2014), glucagon (Mukherji, Kobiita, Damara, et al. 2015; Mukherji, 
Kobiita & Chambon 2015), ghrelin (Verhagen et al. 2011) and oxyntomodulin 
(Landgraf et al. 2015). However, these studies have mostly focused on cell 
types that are highly metabolically sensitive, such as liver and adipose tissue, 
and have been unable to show shifts in behavior or peripheral tissues that are 
comparable to that seen with food entrainment. As such, work published thus 
far has not addressed the universal mechanisms of cellular clock entrainment 
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that would be required for rapid, systemic, SCN-independent synchronisation 
of peripheral cellular clocks and behaviour to feeding. 
 
This chapter goes some way towards resolving both of the issues described 
above. These data suggest that the metabolic hormone insulin is sufficient to 
determine key parameters of the circadian rhythm in multiple cell types in a 
manner comparable to that observed with food entrainment. Furthermore, I 
demonstrate that this effect does not require any central co-ordination. Given 
that biological timekeeping is cell-autonomous, and the failure to identify any 
dominant neuroanatomical locus for entrainment to feeding cycles, I propose 
that circadian entrainment to feeding cycles occurs directly in every cell 
individually, without central co-ordination of a feeding signal. 
 
Insulin and insulin-like growth factor are particularly pertinent candidates for 
the role of a universal feeding signal, as the insulin receptor (IR) and related 
insulin-like growth factor receptor (IGFR) are expressed in almost every 
mammalian cell, and are activated upon feeding by increased circulating 
levels of insulin and free IGF-1 (Bailyes et al. 1997). Moreover IR and IGFR 
have overlapping functions and communicate via the same, ubiquitous 
intracellular signal transduction network. In addition, components of these 
pathways are highly represented in assays for circadian expression of 
transcripts (Zhang et al. 2014). 
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Here, I demonstrate the effects of insulin on mammalian circadian rhythmicity 
ex vivo and in vitro and identify a molecular mechanism for its action on the 
cellular clockwork. Furthermore, I propose a mechanism for this by 




5.1.1 Cell culture supplement B-27® modulates rhythms in PER2 
B-27® is a common cell culture supplement, initially devised as a serum-
replacement to provide greater consistency for neuronal cell culture, due to its 
well-defined composition (Brewer et al. 1993). For historical reasons, B-27® is 
also included as a component in “Air Medium” in addition to serum (Hastings 
et al 2005). Although this medium was originally designed for the 
bioluminescent recording of SCN organotypic slices under ambient oxygen 
and carbon dioxide levels, it has subsequently been widely used for the 
bioluminescent recording of a variety of cell types in culture. The effect of B-
27® on circadian activity in non-neuronal cells has not been investigated, 
however, any observation of such effects would also have been confounded 
by the fact that the serum in “Air Medium” is well established to produce 
effects on subsequent circadian rhythmicity, although the specific factor or 
factors which stimulates this are unknown (Balsalobre et al., 2000). It is only 
when cells are changed in a modified “Air Medium”, where serum has been 
removed, that any effects of B-27® become clear (Fig 5.1A). Under these 
conditions, cells that are changed into media containing B-27® show a much  




B-27® supplement affects rhythms in PER2::LUC fibroblasts 
A Media change from standard serum-containing culture media  to serum-
free media containing media supplement B-27® results in an acute induction 
of PER2 expression, followed by a shift in phase of PER2 expression (n=4, 
mean±SEM) B The presence of B-27® in serum-free cell medium decreases 
the period of the oscillation by around 30 minutes (-B-27® = 26.25±0.11 hrs, 
+ B-27® = 25.70±0.06 hrs, Welch’s t –test). C The rate of dampening of the 
oscillation was also reduced in the presence of B-27® (-B-27® = 0.02±0.001, 
+ B-27® = 0.01±0.001 , Welch’s t –test, not including first 24 hours). D,E 
Phase response curve of insulin addition (n=4±SEM, R2=0.978). 
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larger initial increase in PER2::LUC bioluminescence than those cells in the 
absence of B-27®. B-27® also affects cellular oscillations in the longer term, 
with cells in the presence of B-27® exhibiting a circadian period approximately 
30 minutes shorter than cells in the absence of B-27® (Fig 5.1B). Cells in the  
 
Figure 5.2 
Insulin and corticosterone have distinct 
effects on cellular rhythmicity 
A Addition of insulin or corticosterone to 
PER2::LUC fibroblasts induces PER2 
expression (n=3, mean±SEM). Arrow 
indicates time of addition. Insulin was 
added at 600nM, corticosterone at 58nM.	
B Of the components of  27® tested, only insulin and corticosterone resulted 
in a significantly increase level of PER2 expression compared to vehicle 
within the first 12 hours following addition, as measured by the AUC for this 
time period (n≥3, mean±SEM, one-way ANOVA, Tukey’s multiple 
comparisons test). C The shift in phase produced by insulin is significantly 
different to that brought about by B27 or corticosterone alone (n=3, 
mean±SEM, one-way ANOVA, Tukey’s multiple comparisons test). 	
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presence of B-27® also show a reduced rate of amplitude damping when 
fitted to a damped cos wave (constant k, Fig 5.1C). However, most striking is 
the fact that addition of B-27® to produces strong type 1 resetting of the 
cellular oscillation (Fig 5.1D). 
 
As described above, B-27® was originally designed as a serum replacement 
and as such, it contains a number of different components. In order to 
determine which of these might be responsible for the effect of B-27® on 
PER2 expression, components were added to cells in serum and B-27®-free 
media in isolation and the effect on the subsequent PER2 oscillation recorded 
(Fig 5.2A). As an induction in initial PER2 expression was a key feature of the 
effect of complete B-27® PER2 expression, the effect of B-27® components 
was quantified using the area under the curve in the first 12 hours following B-
27® addition, this being a measure for PER2 expression (Fig 5.2B). Using this 
criterion, only two factors had a significant effect of PER2: corticosterone and 
insulin. The capacity of corticosterone and other glucocorticoids to influence 
cellular rhythmicity has been previously described by a number of groups to 
selectively induce PER expression through activation of glucocorticoid 
response elements and was thus not particularly surprising (Balsalobre, 
Brown, et al. 2000; Cheon et al. 2013). In contrast, effects of insulin on 
cellular rhythms in fibroblasts have not previously been reported, and so this 
phenomenon was investigated further. 
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5.1.2 Insulin administration induces PER2 to modulate phase, period 
and amplitude of cellular rhythms. 
Administration of insulin to PER2::LUC fibroblasts resulted in an acute 
induction of PER2 expression (Fig 5.3A), a sustained increase in the 
Figure 5.3 
Insulin alone influences all aspects of cellular rhythms 
A (Left panel) Addition of insulin stimulates a rapid increase in PER2 
expression, (Right panel) followed by a shift in the phase of the PER2 
oscillation (n=4, mean±SEM). B Insulin also significantly increases the 
amplitude of the resultant oscillation, as measured at the first circadian peak 
(n=4, mean±SEM). C Addition of insulin results in an increase in circadian 
period from 23.05±0.44 without insulin to 25.19±0.10 with insulin (n≥8, 
mean±SEM). D Phase-response curve of time of insulin addition against 
resultant circadian phase shows type 0 resetting, with a first order polynomial 
as the preferred fit (extra sum-of-squares F-test, n=4, mean±SEM). 	
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amplitude of circadian gene expression (Fig 5.3B) and an approximately 2-
hour increase in the period of the oscillation (Fig 5.3C). These effects were  
observed independent of the circadian phase at which insulin was applied. 
Moreover, insulin significantly affected the subsequent phase of cellular 
PER2::LUC rhythms, resetting the cellular clock to the same circadian phase 
(CT12) regardless of the biological time of insulin addition (Fig 5.3D). 
Importantly, insulin concentrations as low as 1nM were sufficient to affect 
cellular rhythms, well within the physiological range (0.5-50nM) (Fig 5.4A).  
 
However, as with most experiments performed in vitro, the kinetics of drug 
exposure in static culture differ greatly from conditions encountered in vivo, 
due to a number of factors such as lack of clearing mechanisms. We therefore 
assessed the impact of transient exposure to insulin, which we assume to be 
Figure 5.4 
Insulin dose-response curve 
A Representative traces from insulin dose-response curve. Cells were 
treated at CT 0 (n=4, mean±SEM). B Dose response curve for insulin 
concentration against subsequent phase shift. Insulin was added at CT 0. 
EC50= 21.14±2.27 nM (n=6, mean±SEM). 
Insulin regulates the circadian clock via PER2 
 141 
more reflective of the natural post-prandial insulin surge. Cells exposed to a 
single 3-hour bolus of insulin under perfusion (Fig 5.5A) exhibited the same 
acute induction of PER2 that we observed in static cultures (Fig 5.5B). 
 
Thus, insulin is sufficient to determine the phase, period and amplitude of 
circadian gene expression rhythms as reported by PER2::LUC, the essential 
parameters of the cellular circadian clock, in cultured mammalian cells. These 
observations are of particular interest when considered in the context of 
mammalian circadian entrainment to feeding cycles, as described in the 
introduction to this chapter, as one could consider insulin as a potential 
coordinating signal in response to feeding. However, as entrainment to food 
influences circadian gene expression in a large number of different tissues 
(Damiola, Le Minli, et al. 2000), for insulin to be a possible candidate for 
Figure 5.5 
Rhythms in perfused cultures are affected by transient insulin 
treatment 
A Application of insulin as a 3-hour bolus to cells in perfused culture also 
induces an acute increase in PER2 expression (representative, n≥3±SEM). 
B Quantification of the acute increase in PER2 following insulin application 
under perfused culture (n≥3±SEM, Welch’s t-test). 
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signaling entrainment to food, it must show the capacity to influence rhythms 
in a similar manner in most, if not all, mammalian tissues. 
 
5.1.3 Insulin is chronoactive in primary cells and tissues 
To explore the relevance of these observations in immortalised fibroblasts to 
other mammalian tissues, insulin addition experiments were repeated using 
primary dissociated cortical neurons (Fig 5.6A,B) and organotypic lung and 
kidney slices (Fig 5.6C) isolated from PER2::LUC mice. These experiments 
were also repeated using primary fibroblast cultures (Fig 5.6DE). In all cases, 
a rapid induction of PER2 expression, increased amplitude of reporter 
rhythms and shifts in phase following insulin addition were observed. Since 
acute changes in PER protein levels are a ubiquitous mechanism by which 
cellular clocks adjust to external timing cues across all tissues (Chen et al. 
2009), the rapid response of PER2 to insulin supports the role of insulin as a 
potential entraining factor. One can therefore hypothesize a general 
mechanism by which time-of-feeding is communicated by insulin and adjusts 
the phase of clock gene expression in every cell of the body in vivo to 
resonate with any external cycles of food availability. 




Insulin affects circadian gene expression in a wide range of tissues 
A,B Addition of insulin to dissociated cortical neurons induces PER2 
expression (n=8±, meanSEM, Welch’s t-test). C Insulin also induces PER2 
expression in organotypic slices of lung and kidney (n≥4, mean±SEM, 
Welch’s t-test). D,E The induction following insulin is also observable in 
primary PER2::LUC fibroblasts (n=4, mean±SEM, Welch’s t-test).  
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5.1.4 Insulin also affects clock gene expression in the SCN 
The suprachiasmatic nucleus of the hypothalamus (SCN) is the central 
circadian pacemaker in mammals, coordinating circadian organization of 
behaviour and physiology with the 24 h light:dark cycle of the natural world. 
Unlike the rest of the body, the SCN does not respond to temporal shifts in 
feeding schedule (Damiola, Le Minh, et al. 2000). However, as SCN neurons 
express insulin receptors (Anhê et al. 2004) and both insulin and IGF-1 are 
capable of crossing the blood-brain barrier (Reinhardt & Bondy 1994), the 
SCN should therefore be capable of responding to feeding-related insulin 
signals. It was therefore hypothesized that strong interneuronal circadian 
coupling within the SCN might account for this apparent contradiction, 
rendering the SCN robust against feeding cues, as it is to temperature (Buhr 
et al. 2010). To test this, organotypic SCN slices from PER2::LUC mice were 
treated with insulin in the presence or absence of tetrodotoxin (TTX, 1μM), a 
Na+-channel blocker (this experiment was performed by Ryan Hamnett). This 
revealed that insulin profoundly affects the SCN clock, but only in the absence 
of action potential generation (Fig 5.7A,B). Interestingly, the resultant 
waveform had two distinct peaks, suggesting that there might exist both 
insulin-sensitive and insulin-insensitive populations within the SCN, revealed 
by the uncoupling effect of TTX (Yamaguchi et al. 2003). Further analysis of 
TTX and insulin-treated SCN slices imaged using an EMCCD camera showed 
a lateral region of the SCN to be particularly responsive to insulin and to 
display this splitting pattern, which dorsal and ventral regions did not (Fig 
5.E,F). In control SCN slices, insulin had no significant effect on the phase or  
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 Figure 5.7 
SCN network properties provide robustness to insulin 
A Addition of insulin to intact organotypic slices of the SCN does not induce 
PER2 expression, nor does it affect the phase or period of the oscillation. In 
contrast, slices pre-treated with TTX show both an acute induction in PER2 
expression and a change in the waveform following addition of insulin (n≥3, 
representative). B Quantification of the PER2 induction following insulin 
treatment in intact and TTX-treated SCN slices (n≥3±SEM, Welch’s t-test). 
       Continued on next page 
Insulin regulates the circadian clock via PER2 
 146 
 period of PER2 rhythms (Fig 5.7C), although we did observe a small but 
significant increase in PER2::LUC amplitude (Fig 5.7D) when insulin was 
applied during the falling limb of expression (CT20) but not during the rising 
limb (data not shown), suggesting that insulin might act phase-dependently to 
amplify SCN rhythms when feeding cues are received at the appropriate 
biological time.  
 
5.1.5 The increase in bioluminescent signal following insulin is specific 
to PER2 
To examine the selectivity of insulin action upon PER2::LUC, we compared 
the bioluminescent response in PER2::LUC fibroblasts with control fibroblasts 
stably expressing firefly luciferase under the SV40 promoter. In contrast with 
PER2::LUC, insulin administration did not affect bioluminescence from mouse 
fibroblasts expressing luciferase constitutively, demonstrating that insulin 
induction of PER2::LUC does not reflect an increase in luciferase activity or 
global translation but results from the targeted up-regulation of certain 
proteins, including PER2 (Fig 5.8A). Supporting this, administration of insulin 
to fibroblast cultures expressing cry1:LUC, (CRY1 being a repressive partner 
C Addition of insulin to intact SCN slices has no significant effect on the 
period of the oscillation (n≥3, mean±SEM, Welch’s t-test). D Addition of 
insulin to intact SCN slices does result in a modest increase in the 
subsequent amplitude, as measured over the 3 successive cycles (n≥3, 
mean±SEM, Welch’s t-test). E Schematic showing representative sub-
regions of the SCN sampled. F Lateral regions of the SCN showed an ability 
to respond to insulin not observed in ventral or lateral regions (n=3, 
representative). SCN slices were taken and treated by Ryan Hamnett. 	
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to PER2) did not result in an acute induction of Cry1 promoter activity but did 
shift the phase of gene expression (Fig 5.8B). Western blotting for CRY1, as 
well as CRY2 and PER1 did not show a significant increase in the abundance 
of these proteins following insulin treatment (Fig 5.8C,D,E,F). This suggests 
that, given the pivotal role of PER proteins in circadian gene expression 
rhythms, insulin elicits an acute and selective induction of PERIOD protein 
expression.  
Figure 5.8 
Increase in protein expression has specificity for PER2 
A Addition of insulin to fibroblasts expressing SV40:Luc does not affect 
luciferase activity (n=3, mean±SEM, two-way ANOVA). B Addition of 
insulin to cry1:Luc fibroblasts does not produce an acute induction in 
cry1:Luc signal, but does produce a subsequent change in phase of 
expression (n=4, mean±SEM). C Representative western blot following 
insulin treatment. Samples shown were treated for 60 minutes. D,E,F 
Quantification of western blots (n=3, mean±SEM). 
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5.1.6 Increase in PER2::LUC signal does not require the TTFL 
Another pertinent question when looking at the circadian response to insulin is 
whether this response requires a functioning canonical timekeeping 
mechanism. A significant body of literature shows that animals that lack 
essential timekeeping genes still show the capacity to entrain their behaviour 
to times of food availability (Pitts et al., 2003, Storch and Weitz 2009). The 
exception to this is PER2, where animals carrying PER2bdrm1 have been 
shown have an impaired ability to entrain to food (Feillet et al., 2006). As  
such, for insulin to be a good candidate for a major entraining stimulus in 
response to feeding, one would expect to see effects on PER2 persist in the 
absence of these timekeeping genes. The effect of insulin on cells lacking 
either Bmal1 or cells lacking both Cry1 and Cry2 was therefore investigated 
(Fig 5.9A,B). Both cells lines showed a significant increase in PER2::LUC 
bioluminescence following insulin addition, although the magnitude of this 
effect was small in Bmal-/- cells compared to their Cry1-/-/Cry2-/- counterparts. 
It was hypothesized that this was a result of the low activity at the PER2 
promoter in the absence of BMAL1. This was confirmed by the observation 
that the relative magnitude of the PER2 induction by insulin could be greatly 
increased if cells were treated with forskolin and IBMX for at least 24 hours 
prior to insulin addition (Fig5.9C,D). As forskolin is documented to increase 
Per2 mRNA abundance in this timeframe (Yagita and Okamura, 1999), it 
appears that increased availability of the PER2 transcript may be implicated in 
this increased response. This observation is further addressed below. 
 




Insulin-induced increase in PER2 persists in the absence of the TTFL 
A, B The acute increase in PER2 expression following insulin addition 
persists in cells lacking  essential components of the canonical mammalian 
circadian clock, BMAL1 and CRY1/2 (n≥3, mean±SEM, Welch’s t-test). C,D 
The acute response to insulin can be amplified in cells lacking BMAL1 by 
subjecting the cells to prior treatment with IBMX and forskolin (n≥3, 
mean±SEM, Welch’s t-test). 	
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5.1.7 Effects of insulin are modulated under specific kinase inhibition 
Casein kinase 1 (CK1) and glycogen synthase kinase 3 (GSK3) are two well 
conserved kinase families which, in addition to a wide range of other roles 
within the cell, have been demonstrated to influence the period cellular 
rhythms across kingdoms, although their proposed targets differ (Meng et al., 
2010, Hirota et al., 2008). Furthermore, GSK3 is a well-established part of the 
insulin signaling cascade. It is therefore plausible that either of these kinases 
might be involved in the PER2 response to insulin. To test this, insulin was 
added to PER2::LUC fibroblasts in the presence of either CK1 inhibitor PF-
670462 (Fig 5.10A,B) or GSK3 inhibitor CHIR-99021 (Fig 5.10C,D). Whilst 
inhibition of GSK3 had no significant effect on the PER2 response, inhibition 
of CK1 resulted in a significant increase in the PER2 response following 
insulin. As phosphorylation by CK1 is required for nuclear translocation of 
PERIOD proteins (Lee et al. 2011), thereby allowing them to repress the 
activation of their own promoter, the increase in the PER2 induction seen in 
the presence of CK1 inhibition may either be the result of greater PER2 
promoter activation or greater PER2 accumulation in the cytoplasm. In the 
context of mammalian entrainment to feeding, this lends further support to 
insulin as a major feeding signal, as mice lacking CK1ε show capacity to 
entrain to feeding faster than wild-type animals (Pers. Comm., David 
Bechtold). 






Effects of insulin are modulated by selective kinase inhibition 
A The induction in PER2 following insulin is significantly increased in cells 
pre-treated with inhibitor of casein kinase 1 PF-670462 (n=4, mean±SEM). B 
Quantification of the acute increase in PER2 expression following insulin in 
the presence or absence of 3µM PF-670462 (two-way ANOVA, Tukey’s 
multiple comparisons test). C Inhibition of glycogen synthase kinase 3 with 
CHIR-99021(3 µM) has no significant effect on the PER2 induction following 
insulin (n=4, mean±SEM). D Quantification of the acute increase in PER2 
following insulin in the presence and absence of CHIR-99021 (two-way 
ANOVA, Tukey’s multiple comparisons test). 	
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5.1.8 Increased PER2::LUC bioluminescence indicates increased PER2 
translation 
Following the addition of insulin to PER2::LUC fibroblasts, a significant 
increase in the total bioluminescent signal from these cells is observed in 
under 1 hour (Fig 5.11A,B). This is reflective of an increase in the abundance 
of PER2 protein. Insulin is reported to increase ribosome association and so 
translation of certain transcripts, often through recognition of certain 
sequences in the 5’ UTR of the transcript, such as TOP or TISU sequences 
(Gandin et al. 2016). Transcripts containing these elements have also been 
previously shown to be circadian regulated in response to feeding cycles 
(Atger et al. 2015). Although no such element could be clearly identified in the 
Per2 transcript, it was nevertheless hypothesized that increased association 
of the Per2 transcript with ribosomes might be observed following insulin 
addition. To test this, cells were lysed and polysome fractions (with 
simultaneous UV spectra) collected by average density after one hour of 
insulin treatment. qPCR was then performed on all fractions. This showed a 
significant difference in the distribution of Per2 mRNA across fractions in 
insulin-treated cells when compared to the vehicle-treated condition (Fig 
5.11C), thereby suggesting altered recruitment of Per2 mRNA to translational 
machinery. 
 
5.1.9 The acute PER2 response to insulin does not require transcription 
For the abundance of a cellular protein to increase, one of three processes 
must occur: an increase in transcription and translation, an increase in 
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translation of existing mRNA or a decrease in protein degradation. 
When PER2 abundance increases during the cellular circadian 
oscillation, this increase is largely attributable to increased Per2 mRNA 
levels and their ensuing translation (Lowrey and Takahashi 2004; Putker 
et al, submitted). As such, one might well assume the increase in PER2 
protein abundance following insulin addition most likely to be the result of 
increased transcriptional activity. 
Figure 5.11 
Increased PER2::LUC bioluminescence is the result of increased PER2 
translation 
A,B  A significant increase in the bioluminescent signal produced by 
PER2::LUC cells can be observed within one hour of insulin application (n=4, 
mean±SEM, Welch’s t-test). C Representative UV polysome trace of cells 1 
hr after the addition of insulin or vehicle. Arrow indicate 80S peak. D 
Polysome fractionation of cells treated with insulin shows a significant shfift 
in the location of available Per2 transcript compared to the untreated 
condition (n=3, mean±SEM, Welch’s t-test). 	
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 Figure 5.12 
Initial increase in PER2 translation does not depend upon 
transcription 
A Acute increase in PER2 expression following insulin is still observed in 
the presence of transcriptional inhibitor alpha-amanatin oleate (aao, 
200µM), but not in the presence of translational inhibitor cycloheximide 
(chx, 17µM). Addition of inhibitor of proteosomal degradation MG132 
(10µM) does not recapitulate the effect of insulin (n≥3, mean±SEM). B 
Quantification of the induction in PER2 expression in the presence of these 
inhibitors (two-way ANOVA). C Cells expressing reporter of Per2 
transcription Per2:Luc do not show an acute induction in luciferase 
expression following insulin addition (n=4, mean±SEM).  
      Continued on the next page 
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In order to confirm the basis of the increase in PER2 protein abundance, the 
persistence of the PER2 induction was investigated in the presence of 
pharmacological inhibitors of transcription (α-amanatin oleate, aao),  
translation (cycloheximide, CHX) and proteosomal degredation (MG132) (Fig 
5.12A,B). Although a significant attenuation of the insulin response was 
observed, aao did not reduce the acute induction of PER2 to mock-treated 
levels, nor did addition of MG132 recapitulate the effect of insulin, suggesting 
that neither an increase in transcription nor a decrease in proteosomal 
degradation is sufficient to explain the increase in PER2 expression following 
insulin addition. Cycloheximide abolished the bioluminescent signal in both 
conditions, as did inhibitor of cap-dependent translation 4EGI-1 (Fig 5.13A,B). 
 
This absence of increased Per2 transcription despite increased PER2 protein 
abundance is supported by the observation that cells expressing the reporter 
of Per2 transcription, Per2:LUC, despite retaining insulin sensitivity (Fig 
5.12D), do not show an acute increase in bioluminescent signal following 
insulin addition (Fig 5.12C). This suggests that the change in bioluminescent 
signal observed in the PER2::LUC line is due to the use of a translational 
D 3T3 fibroblasts expressing Per2:LUC still show robust phosphorylation of 
S6 kinase following insulin addition. All phosphorylation is abolished in the 
presence of mTOR inhibitor torin1 (n=3, all replicates shown). E qPCR at 30 
and 60 minutes following insulin addition show no significant increase in 
PER2 transcript in any fractions after 30 minutes and still no increase in 
cytoplasmic transcript after 60 minutes (n=5, mean±SEM). 	
Insulin regulates the circadian clock via PER2 
 156 
reporter. These cells were not treated at a circadian phase at which phase Figure 5.13 
Inhibition of nuclear export attenuates the PER2 response to insulin 
A 4EGI-1, an inhibitor of cap-dependent translation, completely abolishes the 
response of PER2 to insulin (n=4, mean±SEM). B Quantification of PER2 
induction in the presence and absence of 4EGI-1 (two-way ANOVA). C Pre-
treatment with leptomycin B (LMB), an inhibitor of nuclear export, attenuates 
the response of PER2 to insulin treatment (n=4, mean±SEM). D 
Quantification of the acute PER2 induction in the presence and absence of 
LMB (two-way ANOVA). E qPCR showing PER2 levels at 90 and 180 
minutes following insulin addition (n=4, mean±SEM, two-way ANOVA). 	
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shift due to insulin is expected. Furthermore, and perhaps most strikingly, 
qPCR analysis of insulin-treated cells at 30 and 60 min following insulin 
application showed no significant increase in Per2 mRNA in any cellular 
fraction at 30 minutes following insulin addition and no increase in cytoplasmic 
Per2 mRNA after 1 hr (Fig 5.12D), despite a significant increase in 
PER2::LUC protein levels occurring within this timeframe (Fig 5.11A,B). 
It does appear however that some movement across the nuclear membrane is 
required for the full response to insulin to occur, as cells pre-treated with 
nuclear export inhibitor leptomycin B (LMB) show an attenuated, although still 
highly significant, response to insulin (Fig 5.13C,D). It is possible that this 
represents a later transcriptional component of the PER2 response to insulin. 
This concept of a secondary transcriptional component to the PER2 response 
is supported by the observation that although an increase in Per2 mRNA is 
not observed at 30 minutes following insulin, and not in the cytoplasm at 60 
minutes (Fig 5.12 D), a much greater abundance of the Per2 transcript is 
observed at 90 and 180 minutes following insulin addition (Fig 5.13E). 
 
From these data, it is reasonable to conclude that the initial increase in PER2 
following insulin addition results from increased translation of pre-existing 
Per2 mRNA. This conclusion is strengthened by the earlier observation that 
insulin produced only a small (but significant) increase in PER2 levels in cells 
that lack Bmal1, a transcription factor that is essential for E-box-mediated 
activation of Per2 transcription (Fig 5.9A,B). However, when we stimulated 
Per2 mRNA production in these cells, via promoter Ca2+/cAMP-response 
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elements using forskolin/IBMX (Fig 5.9C,D), we observed that insulin addition 
did elicit greatly increased PER2 levels. In light of the observation that insulin 
increases Per2 mRNA association with single (non-polysomal) ribsosomes 
(Fig5.10D), we can infer that the greater increase in signal that we see in this 
condition is due to the increased pool of untranslated Per2 in the cytoplasm 
which is available for translation following stimulation with insulin. 
 
5.1.10 Glucose alone does not elicit the PER2 response to insulin 
The experiments reported above reveal a pronounced effect of insulin on 
PER2 expression in ex vivo tissue culture and cell lines in vitro. We next 
sought to define the mechanism by which insulin selectively increases PER2 
expression. We first confirmed that the effect of insulin is indeed due to 
IR/IGFR activation, by confirming that in the presence of the dual IR/IGFR 
antagonist, BMS-754807, the acute increase in PER2 expression was very 
significantly reduced (Figure 5.14A,B). 
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One of the effects of insulin in many cell types is to increase cellular uptake of 
glucose, primarily through translocation of vesicles containing new GLUT3 or 
GLUT4 transporters to the membrane (Uemura and Greenlee, 2005, Lizunov 
et al., 2005). Previous work has suggested that changes in glucose have the 
capacity to modulate cellular rhythms (Hirota et al. 2002). To determine 
whether the effects on PER2 that we observe following insulin were simply the 
Figure 5.14 
PER2 induction following insulin is not the result of increased glucose 
uptake 
A,B Inhibition of IR and IGF-1R with 1µM BMS greatly attenuates the PER2 
increase following insulin (n=4, mean±SEM, two-way ANOVA). C An acute 
induction in PER2 expression is observed in the absence of extracellular 
glucose (n=4, mean±SEM). D Quantification of the induction in PER2 
luciferase following insulin addition in the presence and absence of 
extracellular glucose (two-way ANOVA, Tukey’s multiple comparisons test). 	
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result of increased intracellular glucose, insulin was added to cells in the 
presence and absence of extracellular glucose (Fig 5.14C,D). Although the 
absence of extracellular glucose did slightly attenuate the effect of insulin, a 
clear induction was still observed, suggesting that increased glucose uptake 
alone is not the primary event responsible for increased PER2 expression 
following insulin, although it does facilitate higher translation rates following 






5.1.11 PER2 response to insulin is dependent on PI3K signaling 
Ligand binding at the insulin receptor results in the activation of two signal 
transduction pathways: Mitogen-activated Protein Kinase (MAPK) and 
Phosphatidylinositol-3-Kinase (PI-3K, Fig 5.15), which then activate their 
respective downstream signaling cascades (Siddle	2011). To determine which 
arm of the insulin signaling pathway was responsible for PER2 induction, we 
targeted each of these enzyme families pharmacologically using MAPK 
inhibitor UO126 and PI-3K inhibitor LY294002 (Fig 5.16A,B). MAPK inhibition 
had no significant effect on the response to insulin in PER2::LUC cells, whilst 
Figure 5.15 
Schematic showing the major 
effectors in the insulin-
signalling cascade 	
Insulin regulates the circadian clock via PER2 
 161 
LY294 treatment abolished any PER2 response to insulin. This implicates PI-
3K as the primary effector pathway from the insulin receptor to PER2 
expression. 
 
5.1.12 Insulin-induced PER2 increase occurs through mTOR 
Once activated, PI-3K phosphorylates protein kinase B (PKB/Akt), for which 
downstream targets include activation of mTOR. Pharmacological inhibition of 
mTOR (via rapamycin and torin 1) produced significant attenuation of PER2 
expression induced by insulin, indicating an essential requirement for mTOR 
in the response (Fig 5.17A,B,C,D). However, activation of mTOR alone is not 
sufficient to phenocopy the effect of insulin on PER2 expression, as 
Figure 5.16 
PI3K is required for PER2 response to insulin 
A Inhibition of MEK1/2 with UO126 (4µM) has no significant effect on the 
insulin-induced change in PER2 expression, whilst PI3K inhibitor LY294002 
(100 µM) abolishes the induction due to insulin (n=4, mean±SEM). B 
Quantification of the acute insulin-induced PER2 response under PI3K and 
MEK1/2 inhibition (two-way ANOVA, Tukey’s multiple comparisons test). 
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pharmacological stimulation of mTOR (Fig 5.18A) does not induce PER2 
expression. Thus, mTOR activation is necessary for insulin induction of PER2 
expression, but is not sufficient to drive PER2 expression in isolation, implying 
other factors must be required. 
Figure 5.17 
mTOR is required for PER2 response to insulin 
A Pre-treating cells with mTOR inhibitor torin 1 (1 µM) inhibits the acute 
increase in PER2 (n=4, mean±SEM). B Quantification of effect of torin 1 on 
PER2 induction (two-way ANOVA, Tukey’s multiple comparisons test). C 
Pre-treatment with classical mTOR inhibitor rapamycin (400nM) also 
significantly attenuates the effect of insulin on acute PER2 levels (n=4, 
mean±SEM). D Quantification of the effect of rapamycin on acute PER2 
induction (two-way ANOVA, Tukey’s multiple comparisons test). 	
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It was therefore asked which additional effects of insulin on cell biology might 
act, in concert with activation of mTOR, to give facilitate increased PER2 
translation. Another consequence of insulin receptor activation is the 
inactivation of Phosphatase and tensin homolog (PTEN): the phosphatase 
that dephosphorylates phosphatidylinositol-3,4,5-trisphosphate generated by 
PI3K, resulting in increased PIP3 abundance (Nakashima	 et	 al.	 2000). It was 
hypothesized that a coincident increase in available PIP3 might be required, in 
addition to mTOR activation, to replicate the PER2 response to insulin (Fig 
5.18B). However, when cells were treated with both mTOR activator 
MHY1485 and PTEN inhibitor VO-OHpic, an acute increase in PER2 
expression was not induced in a manner comparable to insulin treatment, 
although there was a clear change in the subsequent PER2 waveform.  
Figure 5.18 
mTOR activation alone is insufficient to recapitulate the effect of 
insulin 
A Treatment with mTOR activator MHY 1485 does not produce an acute 
increase in PER2 expression (n=4, mean±SEM). B Simultaneous 
pharmacological mTOR activation and PTEN inhibition is also insufficient 
to induce PER2 expression (n=4, mean±SEM).  
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5.1.13 IGF-1 also activates PER2 expression through mTOR 
Following the observation that insulin can modulate cellular timekeeping, 
through PER2 it was posited that other growth factors with tyrosine kinase 
receptors might also produce this effect; in particular insulin-like growth factor 
1 (IGF-1), which also has some affinity for the insulin receptor and vice versa. 
In order to test the selectivity of this PER2 induction, we tested the effects of 
Figure 5.19 
IGF-1 also acts on PER2 through mTOR 
A,B,C Whilst growth factors EGF, FGF and IGF-1 all elicit some induction in 
PER2::LUC , only the effects of IGF-1 are attenuated in the presence of mTOR 
inhibitor rapamycin (n≥3, mean±SEM). D Quantification on the PER2 induction 
in the presence and absence of rapamycin (Welch’s t-test). 	
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IGF-1, as well as fibroblast growth factor (FGF) and epidermal growth factor 
(EGF) on PER2::LUC fibroblasts. We found that all growth factors tested 
stimulated some induction in PER2 (Fig 5.19A,B,C), although inductions 
following EGF and FGF were modest in comparison to those following IGF-1 
or insulin. Critically, the effect of IGF-1, but not EGF or FGF, was significantly 
attenuated by rapamycin inhibition of the mTOR signaling complex, which 
functions downstream of both the insulin and IGF-1 receptors (Fig 5.19D). 
This suggests that IGF-1 and insulin may stimulate an increase in PER2 
expression through similar, if not the same, mechanism, whilst other growth 
factors do so through alternative pathways.  
 
In the context of acute responses to feeding, insulin and IGF-1 are likely to be 
more physiologically relevant humoral cues than other growth factors, since 
Figure 5.20 
Insulin-regulated miRNAs bind to the 3’UTR of per1 and per2 
A Schematic showing sites of miRNA binding in the 3’UTR of Per1 and 
Per2 mRNA. 
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both increase in response to certain dietary cues: insulin levels increase in 
response to dietary carbohydrates, whereas IGF-1 responds to dietary protein 
(Levine et al. 2002).  As such, it is more likely that it is these cues that 
synergistically stimulate circadian responses to feeding in vivo. 
 
5.1.14 miRNA down- regulation following insulin addition 
Recent studies have shown that translation of Per1 and Per2 mRNA is 
regulated by three microRNAs, namely miR24, miR29a and miR30a (Fig 
5.20A, Chen et al., 2013). These miRNA are complementary to sections of the 
3’UTR of their target mRNAs, thereby reducing translation of these mRNA 
through the RNA-induced silencing complex (RISC). Furthermore, several 
miRNAs, including those that regulate PER expression, have been reported  
 to be down-regulated in response to insulin (Granjon et al. 2009). qPCR was 
used to confirm that down-regulation of these specific miRNA also occurs in 
PER2::LUC fibroblasts after 60 minutes exposure to insulin (Fig 5.21A,B,C). It 
was thus hypothesized that a decrease in PER-regulating miRNA levels might 
be implicated in the increase in PER2 observed following insulin treatmen. It 
was therefore tested whether knockdown of these three miRNAs (confirmed 
by qPCR, Fig 5.21D,E,F) in combination with pharmacological activation of 
mTOR and/or inactivation of PTEN might be sufficient to recapitulate the. 
effect of insulin on PER expression (Fig 5.22A,B).  Unlike mTOR activation 
alone, it was observed that mTOR activation in the presence of miRNA 
knockdown facilitated an acute induction of PER2 expression. However, this 
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was significantly decreased in magnitude compared with the induction 
observed following insulin addition. Significantly, PTEN inhibition alone, or in 
combination with mTOR activation or microRNA knockdown had no significant 
effect upon PER2 levels. However, microRNA knockdown in combination with 
both mTOR activation and PTEN inhibition completely phenocopied the effect 
of insulin upon PER2 induction, producing an increase in PER2 expression 
that is statistically indistinguishable from that produced by insulin itself.  
Figure 5.21 
Per1/2-regulating miRNAs are down-regulated following insulin 
A,B,C qPCR on samples taken 60 minutes after insulin addition shows a 
significant decrease in expression of miR24, miR29 and miR30 respectively 
following insulin treatment compared to vehicle controls (n=4, mean±SEM). 
D,E,F qPCR validating miRNA knockdown by antisense oligos compared to 
a control oligos (n=4, mean±SEM). 




Combined RNAi and pharmacological interventions are required to 
recapitulate the effect of insulin on PER2 
A (left panel) Neither mTOR activator MHY 1485, PTEN inhibitor VO-
OHpic or a combination of these treatments is sufficient to induce an acute 
induction in PER2 levels in the presence of a control oligo. (Right panel) In 
the presence of antisense oligos, mTOR activation alone produces a 
significant increase in acute PER2 levels. Simultaneous activation of 
mTOR and inhibition of PTEN induces PER2 acutely in a manner not 
significantly different from insulin (n=4, mean±SEM). B Quantification of the 
effects of PTEN inhibition and mTOR activation in the presence and 
absence of antisense oligos (two-way ANOVA, Tukey’s multiple 
comparisons test). 	
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Together these studies reveal a universal action of insulin signaling to 
enhance PER protein translation via a three-way coincidence detection 
mechanism, which allows the cellular clock to respond appropriately to 
exogenous timing cues whilst remaining unperturbed by other cues that signal 
via PI3K/mTOR (Fig 15.23. It is plausible that this pathway serves in vivo to 




In this chapter, I have shown that the metabolic hormone insulin directly 
affects circadian rhythms ex vivo and in vitro. In particular, insulin is sufficient 
to modulate all of the key parameters of the circadian rhythm in a wide range 
of tissue and cell types. This is mediated by an acute induction of PER protein 
translation through an activation cascade involving specific coincident 
signaling within the insulin-signaling pathway (Figure 5.23A). 
Previous work has shown insulin to be chronoactive, but its mechanism of 
action and possible role in entrainment to feeding cycles has not been firmly 
established. Evidence has been generally limited to cell types that are highly 
insulin sensitive, such as liver and adipose tissue (Balsalobre et al., 2000; 
Tahara et al., 2009; Sato et al., 2014; Yamajuku et al., 2012) . As such, insulin 
has been considered to be only one of a number of factors required to 
coordinate shifts in peripheral circadian gene expression during restricted 
feeding protocols. Here its is shown that the action of insulin upon the 
circadian clock is not restricted to any particular tissue and is observable  
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 in tissue types that are typically considered less insulin-sensitive, including 
the suprachiasmatic nucleus. Our findings strongly suggest that insulin acts 
as an entraining stimulus (or zeitgeber) for all peripheral tissues through the 
ubiquitously expressed IR, with an overlapping and partially redundant role for 
IGF-1 and the IGFR, both of these receptors being very widely expressed. As 
such the insulin signaling pathway is likely to be a major synchronizer of the 
circadian clock in all peripheral tissues after fast-feeding, acting directly to 
Figure 5.23 
Proposed mechanism of insulin-induced PER2 expression 	
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communicate timing cues to each cell individually, including those brain areas 
responsible for some aspects of animal behaviour.  
 
 Why previous studies have not observed the universal effect of insulin upon 
peripheral circadian rhythms we have identified is not entirely clear but, as 
serum and serum replacements often contain comparatively high 
concentrations of insulin, it is plausible that insulin receptors in less insulin-
sensitive tissues become desensitized, preventing an acute increase in 
extracellular insulin from being communicated to the cellular clockwork. 
Moreover constitutive activation of the insulin signaling pathway is a common 
hallmark of cancer cell lines (Chang et al., 2002), highlighting the importance 
of using untransformed cells for investigation of circadian cellular function.  
 
A role for insulin in adjusting the phase of the molecular clock to the timing of 
food intake is consistent with the current state of knowledge surrounding food 
entrainment. Recent work has shown that fluctuations in circulating glucose 
and insulin during imposed fasting/feeding cycles are permissive for the 
entrainment of circadian rhythms to restricted feeding in vivo (Mukherji,	Kobiita	&	Chambon	2015;	Mukherji,	Kobiita,	Damara,	et	al.	2015). Moreover, it 
has been demonstrated previously that the feeding-induced rise in hepatic 
PER2 expression typically observed in pre-fasted mice, is lost in 
streptozotocin (STZ)-induced diabetic mice (Tahara et al 2011), suggesting 
that insulin is essential for anticipation of and early circadian responses to 
feeding cues. Davidson and colleagues showed behavioural anticipation and 
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the restricted feeding-induced phase shift of Per1:luc in the liver to be 
attenuated but maintained in rats treated with a single bolus of STZ. It is noted 
however, that whilst STZ at a sufficient dose should ablate the insulin-
producing β cells of the pancreas, it would not affect IGF-1-mediated 
responses to feed-fast cycles, providing redundancy within this system of 
entrainment. Moreover, liver slice cultures derived from STZ-treated rats do 
exhibit greatly increased dispersion of circadian phase reported by per1:luc 
bioluminescence (Davidson et al 2002; Tahara et al 2011) suggesting that 
insulin does indeed act to synchronize the phase of peripheral clocks under 
ad libitum feeding conditions. 
 
5.2.2 A role for insulin in vivo 
The ultimate proof of principle for the role of insulin in mammalian entrainment 
to food would be to show that the effects of insulin on cellular and tissue 
rhythms described in this chapter are also observed in vivo. As a result of 
collaboration with David Bechtold and Alex West at the University of 
Manchester, it was possible to test this. Initially, mice were singly house in 
constant conditions and wheel running behavior recorded. They were then 
fasted for 24 hours before receiving an intraperitoneal injection of either 
glucose or saline at the end of the active phase (Fig 5.24A). Those animals 
that received a glucose bolus (and so experienced an associated increase in 
circulating insulin) showed a significant delay in the onset of activity following 
the treatment (Fig 5.24B). Similarly, animals treated with either vehicle, 
glucose (3g/kg) or insulin (2.25U/kg), also showed significant increase in 
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 Figure 5.24 
Insulin influences behaviour and gene expression in vivo 
A,B Glucose administration was effective in causing a phase delay in 
wheel-running activity in fasted mice (3g/kg, ip at CT22; n=5-8/group, 
Students’ t-test). C Peripheral administration of insulin (2.25U/kg, ip) or  
Continued on next page 
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PER2::LUC signal when observed using LESA-biolumicorder cages (Yoo et 
al. 2004; Saini et al. 2013) after one hour (Fig 5.24C), although this was no 
longer significant after two hours (Fig 5.24D), in contrast to earlier 
observations in vitro, where the peak of the PER2::LUC response occurs 
approximately 3 hours after the addition of insulin. However, administration of  
insulin alone leads to hypoglycemia in the mice, which is likely to produce 
conflicted effects on gene expression. Furthermore, the transient pulse in 
insulin following intraperitoneal injection of insulin is likely to be much shorter 
than pulses of endogenous insulin release. When animals were instead 
injected with both glucose and insulin combined, a much more physiologically 
relevant cue than rapid increases in glucose or insulin alone as it mimics the 
glucose (3g/kg, ip) caused a rapid, yet transient induction in PER2::LUC 
bioluminescence in pre-fasted mice after 1 hour, although D this was no 
longer significant after 2 hours. E In contrast, injection with insulin and 
glucose simultaneously produced a more prolonged induction in PER2 
point in the untreated control. Arrow (E) and red dot (A) indicates injection 
timing.F Quantification of the change in phase of PER2 bioluminescence 
following insulin addition (n≥5, mean±SEM, Welch’s t-test, p=0.5, 150 
mins±68).. which was still significant after 2 hours (n=4-6/group, One-Way 
ANOVA, Dunnet’s multiple comparisons test). Induction is quantified as the 
change in bioluminescent signal (ΔPER2::LUC) from time of insulin 
addition to the peak in bioluminescence following insulin addition, or the 
equivalent time point in the untreated control. Arrow (E) and red dot (A) 
indicates injection timing. F Quantification of the change in phase of PER2 
bioluminescence following insulin addition (n≥5, mean±SEM, Welch’s t-
test, p=0.5, 150 mins±68). All experiments and analysis were performed by 
Alex West and David Bechtold 
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response to food, a rapid rise in PER2::LUC driven bioluminescence was 
observed, and this remained sustained for over 2 hours (Fig 5.24E). 
Furthermore, following the induction in PER2::LUC, it is possible to observe a 
shift in phase of bioluminesence of around 2 hours (Fig 5.24F). However, it is 
plausible that larger phase shifts might be seen if it were possible to apply 
such a stimulus in repeated circadian cycles in a manner equivalent to food 
entrainment. Thus, these data suggests that insulin is capable of influencing 
both behaviour and cellular rhythms in vivo, the two major effects of the 
mammalian circadian response to feeding. This confirms insulin as a relevant 
and primary cue involved in mammalian food entrainment. 
 
5.2.3 A new model for mammalian entrainment to food 
Based upon the observations described in this chapter, it is possible to 
propose a new model for mammalian food entrainment. Here there is no 
central ‘food-entrainable oscillator’ (Gooley et al., 2006, LeSauter et al., 2009, 
Stefan 2002), but instead insulin and IGF-1 released in response to food 
entrains each cell in the body individually, via induction of PER2.  
 
Under normal 24 h light-dark cycles, animals feed during their active phase 
leading to increased plasma glucose levels which trigger insulin release from 
the pancreas, as well as IGF-1 from other tissues including the liver (Sjögren 
et al., 1999). Activation of the insulin-signaling pathway fine-tunes the timing 
of the expression of PER (and likely other clock-relevant) proteins in all 
tissues, including the brain, to resonate with and confer behavioural and 
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physiological anticipation of food availability. This surge in PER protein 
translation normally acts later than, and acts synergistically with, the earlier 
increase in plasma glucocorticoids stimulated by the SCN-dependent signals 
that elicit increased Per transcription towards the end of the rest phase 
(Balsalobre et al., 2000, Van Cauter et al., 1996). If this model is correct then 
corticosterone should reset the cellular clock to an earlier circadian phase 
than insulin does, concomitant with the approximately 4 h separation of peak 
glucocorticoid and insulin signaling following early feeding in vivo (Shamsi et 
al. 2014). This was observed to be the case (Fig 5.2A) in the initial 
experiments in vitro following the observation that both corticosterone and 
insulin can shift the phase of the PER2 oscillation. Here, the peaks of PER2 
following insulin and corticosterone were approximately 3 hours apart, with 
insulin resetting to an earlier phase. We therefore predict that in vivo, animals 
experience a surge in circulating corticosterone before the start of the active 
phase, which is then followed 3 or 4 hours later by an increase in circulating 
insulin in response to feeding at the start of the active phase. These two 
signals will reinforce each other, producing an induction in PER2 greater than 
that achieved by either hormone alone.  
 
We speculate that when instead, feeding occurs out-of-phase with the 
predicted active phase and so corticosterone release – such as in restricted 
feeding protocols - insulin directly simulates a feeding-induced PER-mediated 
phase shift in clock gene expression in peripheral tissues, resulting in 
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changes in the phase and amplitude of clock gene expression and possible 
internal desynchrony. Repeated events of this kind would lead to the 
uncoupling of circadian rhythms in peripheral tissues from those in the SCN, 
as has been previously described (Damiola et al. 2000). This speculation is 
Figure 5.25 
Conflicting entrainment signals influence amplitude of PER2 
expression 
A Addition of insulin before, after or at the same time as a corticosterone 
pulse (mimicking normal, shift-worked and early wake-up time conditions) 
has a significant effect on B the size of the PER2 induction and C the 
amplitude of the subsequent cycles, measured at the first circadian cycle 
after treatment (n≥3, mean±SEM, one-way ANOVA, Tukey’s multiple 
comparisons test). Corticosterone was added at CT10, with insulin added 
at either CT 4, CT10 or CT16. 
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supported by observations in fibroblasts that have been treated with insulin 
either after, at the same time as or before a corticosterone pulse applied at a 
physiologically relevant time (Fig 5.25A). These conditions correlate with the 
signals that we expect to see in normal conditions, unusually early wake-up 
times (early start) and shift-workers respectively. It is clear here that 
application of insulin before corticosterone, analogous with food consumption 
during the night in humans, results in a significantly lower PER2 induction 
than the “normal” or “early-start” conditions, as well as lower amplitude of the 
next circadian cycle compared to the “normal” condition. 
 
5.2.4 Clinical implications 
The work described here has the potential to inform some medically relevant 
applications. Humans do not generally experience an enforced restricted-
feeding protocol, but they do experience both shiftwork and jet-lag. In such 
situations, feeding occurs out-of-phase with the light-dark cycle, to which the 
SCN is primarily entrained. As such, individuals experiencing shift-work or jet-
lag will likely show the same kind of internal desynchrony observed in mice 
under restricted feeding. These individuals show a higher propensity to 
develop hypertension, some cancers, metabolic syndrome and obesity 
(Karlsson et al. 2001), attributed to this uncoupling of central and peripheral 
clocks. 
 
Knowledge of the possible mechanism by which feeding out-of-phase with 
photic cues might entrain peripheral tissues allows us to predict behaviours 
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that might reduce the detrimental effects of shift work or jet-lag. For example, 
individuals engaging in occasional shift might be best advised not to consume 
food during the dark if at all possible, and to instead eat their largest meal in 
the morning, as the time when the phase of the PER2 response following 
insulin reinforces the PER2 response to early-morning cortisol release from 
the adrenal glands. Similarly, it might be possible to minimise the severity of 
jet-lag by controlling the timing to food intake around the time of flight and 
ensuring consumption of a large meal at dawn at an individual’s destination to 
promote synchrony with the new timing environment. Should the model of 
food entrainment described in this chapter be correct, implementation of such 
simple behaviours could have a significant impact on the long-term health of 
those engaging in shift work or those who frequently cross multiple time-
zones. 
 
Another potential application of the findings in this chapter concerns the 
treatment of certain cancerous tumors. With the increasing move towards 
personalized medicine, chronotherapeutic treatment of certain cancers is 
likely to become increasingly common. Both efficacy and side-effects of a 
number of cancer treatments vary across the circadian cycle and as such, 
varying the dose of these drugs in a circadian manner has a number of 
benefits for patient outcome (Dallman et al., 2016). However, it has been 
observed that a proportion of cancerous tumours have distinctly different 
circadian gene expression to the rest of the host tissues (Chen et al., 2005, 
Lin et al. 2008). It has also been noted that a significant proportion of 
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cancerous tumours are insulin-insensitive as a result of constitutive activation 
of the insulin-signaling pathway (Chang et al., 2002). It is plausible that these 
two observations are causative, and that tumours that have distinctly different 
expression of circadian genes to the host do so because their insulin-
insensitivity prevents them from entraining to time-of feeding. As such, when 
considering when to administer anti-cancer drugs that are known to show a 
circadian variation in their efficacy and pharmacokinetics, it may be 
worthwhile considering the insulin sensitivity of the tumour itself when 
designing a circadian protocol of administration. 
 
5.2.5 Conclusion 
This chapter demonstrates that stimulation of the insulin signaling pathway is 
sufficient to reset the circadian clock in peripheral cells and the whole animal, 
but not the intact SCN master clock. A three-way coincidence detection 
mechanism downstream of the insulin receptor is proposed as the means by 
which insulin and IGF-1 produce this effect. This may explain the strong link 
between metabolic syndrome and shift work (Salgado-Delgado et al., 2013). 
Moreover these findings predict that appropriately timed schedules of fasting 
and feeding will reduce the time taken by the human biological clock to adjust 
during jet-lag and shift-work. Given that ~15% of the adult workforce engage 
in shift work, these findings have the potential to inform strategies to alleviate 





6.0 General Discussion 
6.0.1 The relationship between circadian rhythms and metabolism 
That links exists between circadian rhythmicity and metabolism has been 
appreciated for the majority of the history of the modern field. Early 
experiments showed that food intake (and so associated gross metabolism) in 
whole animals was rhythmic and furthermore that rhythms in food intake could 
be used to modulate the phase of circadian animal behaviour (Stephan et al. 
1979). With the identification of the SCN as the central circadian pacemaker in 
mammals it was further noted that, whilst the SCN itself shows circadian 
rhythmicity in nutrient uptake (Cassone et al. 1988) the SCN itself, unlike 
peripheral tissues and animal behaviour, is not entrained by feeding cues 
(Damiola et al. 2000) and is not required for entrainment to feeding (Stephan 
et al. 1979). This discrepancy was an early indicator of the existence of 
biological pace-making outside of the SCN, a property that was later attributed 
to almost every cell (Balsalobre et al. 1998). 
 
With the discovery that circadian timekeeping is cell autonomous and occurs 
in every cell of the body, there has been an increasing number of 
observations connected circadian timekeeping to metabolic processes. Both 
nutrient uptake and utilisation displays clear circadian rhythmicity (Peek et al. 
2013; Paulose et al. 2012; Altman et al. 2015), as does the activity of a 
number of organs, particularly those with an endocrine function (Perelis et al. 
2015). With the identification of TTFL mechanisms for cellular timekeeping, it 
has been possible to correlate and in many cases directly links between TTFL 
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events and metabolic processes (Shinohara et al. 1998). This has led to the 
hypothesis that, like many other processes in the cell, circadian rhythms in 
metabolism are driven by TTFL activity. 
 
However, a number of observations are at odds with this idea. More recent 
work has shown that rhythms in nutrient uptake can persist in the absence of 
TTFL rhythmicity, as in embryonic stem cells (Paulose et al. 2012). Most 
strikingly, rhythms in PRX hyperoxidation persist in the absence of nascent 
transcription (O’Neill & Reddy 2011; O’Neill et al. 2011) and are observed 
across kingdoms (Edgar et al. 2012). These rhythms even persist in cells from 
what have been generally considered arrhythmic genetic backgrounds.  It has 
also been noted that the TTFL in multiple organisms can be perturbed by 
alterations in metabolic events (Martinek et al. 2001). Observations such as 
these have given rise to the hypothesis that rhythms in metabolism might 
constitute an evolutionarily conserved mechanism of cellular timekeeping that 
feeds in to the TTFL, possibly to the extent that the two cannot be dissociated 
from each other (Asher & Schibler 2011). 
 
6.0.2 Contributions of this thesis 
The initial aim of this thesis was to attempt to elucidate the nature of the 
relationship between metabolism and the cellular circadian clock. Of particular 
interest was testing the second hypothesis above, that cellular metabolism 
might constitute an essential component of cellular timekeeping. Emphasis 
was placed on the pathways of carbohydrate metabolism, both because the 
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pathways of carbohydrate metabolism are amongst the most evolutionarily 
conserved and also because this is the sole source of ATP generation in 
erythrocytes, which display circadian rhythmicity in the absence of a 
functioning TTFL. Combined genetic, pharmacological and metabolomic 
investigation of these pathways indicated that, although capable of influencing 
both phase and amplitude of the cellular oscillation, flux through any 
constituent pathway of carbohydrate metabolism make only minimal 
contribution to the period of the TTFL circadian oscillation. There does, 
however, appear to be a permissive redox range within which it is possible to 
observe circadian TTFL activity, but this range far exceeds the range of redox 
states found under physiological conditions. 
 
A comparable result was seen when considering the cellular response to 
changes in whole organism nutrient status. That time of feeding is capable of 
entraining both animal behaviour and cellular circadian phase has been 
known for some time, although any precise mechanism had not previously 
been elucidated. We see in the final experimental chapter of this thesis that 
the metabolic signalling hormone insulin is capable of recapitulating the 
effects of food entrainment and provide a mechanism by which this is 
communicated to the cellular TTFL. However, even this hormone, which 
signals major metabolic change within both a whole organism and the 
individual cell, although capable of influencing the amplitude and phase of 




In light of this work, I propose that, contrary to prior hypothesis, cellular 
metabolism is unlikely to represent a fundamental component of cellular 
timekeeping. Whilst metabolism is of course required for cell viability, it does 
not appear to be a state variable of cellular rhythms. Instead, the experiments 
shown here support a third hypothesis: that metabolism is capable of 
contributing to cellular timekeeping and is permissive for it, but is not an 
essential component of the timekeeping mechanism itself. 
 
6.0.3 Features of a conserved oscillator 
If the pathways of cellular metabolism do not contain an essential component 
of cellular timekeeping then the natural question is: what else might such an 
oscillator? 
 
Firstly, it is useful to consider what conditions this non-TTFL oscillator would 
have to satisfy. It would, most likely, have to conform to the basic definition of 
a circadian rhythm – that is to say, it must have a free-running period of 
around 24 hours, it must be capable of entrainment and it must be 
temperature compensated (Pittendrigh 1960). It addition, it must be capable of 
running in the absence of nascent transcription (O’Neill et al. 2011; O’Neill & 
Reddy 2011). Thirdly, it should be evolutionarily conserved (Edgar et al. 
2012). 
 
These criteria, although by no means capable of elucidating the identity of 
such a post-transcriptional oscillator, do enable us to pick out certain clues 
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from the existing literature. For example, the fact that both ck1 and GSK3-β 
have clear circadian effects in multiple organisms, despite the apparent 
differences in the canonical TTFL mechanisms within these organisms, 
suggests that these enzymes, or their some of their conserved targets, might 
be components of a non-TTFL oscillator (van Ooijen et al. 2013; Meng et al. 
2010; Hirota et al. 2008; O’Neill et al. 2011). This might be suggestive of a 
phosphorylative oscillator, as in cyanobacteria. 
 
Alternatively, it is also of potential utility to consider older models of circadian 
rhythmicity, prior to the dominance of the TTFL model. Proposed in 1974, the 
Njus-Sulzman-Hastings model of the circadian oscillator posits a mechanism 
for cellular timekeeping that is entirely post-transcriptional (Njus et al. 1974). 
Here, the model proposes a system of cellular timekeeping that is dependent 
upon flux of ions (most likely K+ and Na+) across the extracellular membrane 
and intra- and extracellular ion concentration, where the gating of transport 
proteins or channels in the membrane is determined by the relevant ion 
concentrations. Phase shifts can be effected by acute opening of channels 
than also transport these ions. Temperature compensation is provided by the 
lipid bilayer, which is established to have a well-regulated lipid content in 
order to maintain a constant fluidity. As movement of proteins within a 
membrane is dependent on the membrane viscosity, this regulation could 
provide temperature compensation. 
Although by no means proven to act as an oscillator, let alone one of 
fundamental importance to cellular timekeeping, this model for a post-
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transcriptional circadian oscillator cannot currently be excluded and makes a 
number of testable predictions (Nitabach et al. 2005). With regards to this 
thesis, it is of interest to note that inhibition of the PPP can result in the 
increased opening of voltage-gated potassium channels in a number of cell 
types, which might provide an alternative explanation for the effects seen with 
these drugs (Gupte et al. 2002). 
 
6.0.4 Identification of a conserved oscillator 
In addition to further investigation of the possible circadian mechanism 
models described above, it may be useful to take a less directed approach 
when attempting to identify components of a possible conserved post-
transcriptional oscillator. As Pittendrigh described, one of the essential 
features of a circadian rhythm is the ability to entrain to external cues 
(Pittendrigh 1960). Any evolutionarily conserved oscillator should exhibit this 
ability. It is also interesting to note that relatively few external events are 
capable of entraining circadian oscillators, and a number of these appear to 
be common across organisms. Prominent amongst these is entrainment to 
light and temperature cycles, both of which are capable of entraining 
organisms as diverse as mammals, flies and the bread mould Neurospora 
crassa (Brown et al. 2002; Zimmerman et al. 1968; Liu 1998). Even 
entrainment to feeding has been suggested to be exhibited in both vertebrates 
and invertebrates (Stephan 2002; Frisch & Aschoff 1987). We currently have 
varied levels of knowledge as to the exact mechanisms by which these 
external events entrain the cellular oscillator. However, given the universal 
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nature of these entrainment pathways, it is plausible that they might act to 
entrain a conserved oscillator rather than, or in addition to, feeding directly in 
to the TTFL of each organism. As such, it may be of utility to consider 
similarities in the cellular effects of each of these entraining factors when 
looking for components of a conserved circadian oscillator, in addition to the 
other approaches described above. 
 
6.0.5 Concluding remarks 
It is clear that over the almost six decades since Pittendrigh defined the 
features of a circadian rhythm there has been an enormous expansion in our 
knowledge of this area, with crucial developments, such as the identification 
of central pacemakers and of cell autonomous oscillations. Despite this, we 
are still somewhat in the dark when it comes to the exact molecular 
mechanisms by which these essential characteristics – namely period, 
entrainability and temperature compensation – particularly in a mammalian 
context. It is my hope that this thesis has contributed in some way towards a 
greater understanding of at least two of these features and will assist in future 
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